id	sid	tid	token	lemma	pos
easat-3113	1	1	edelweiss	edelweiss	PROPN
easat-3113	1	2	applied	apply	VERB
easat-3113	1	3	science	science	NOUN
easat-3113	1	4	and	and	CCONJ
easat-3113	1	5	technology	technology	NOUN
easat-3113	1	6	issn	issn	PROPN
easat-3113	1	7	:	:	PUNCT
easat-3113	1	8	2576	2576	NUM
easat-3113	1	9	-	-	SYM
easat-3113	1	10	8484	8484	NUM
easat-3113	1	11	vol	vol	NOUN
easat-3113	1	12	.	.	PROPN
easat-3113	1	13	8	8	NUM
easat-3113	1	14	,	,	PUNCT
easat-3113	1	15	no	no	INTJ
easat-3113	1	16	.	.	NOUN
easat-3113	1	17	6	6	NUM
easat-3113	1	18	,	,	PUNCT
easat-3113	1	19	5075	5075	NUM
easat-3113	1	20	-	-	SYM
easat-3113	1	21	5081	5081	NUM
easat-3113	1	22	2024	2024	NUM
easat-3113	1	23	publisher	publisher	NOUN
easat-3113	1	24	:	:	PUNCT
easat-3113	1	25	learning	learn	VERB
easat-3113	1	26	gate	gate	NOUN
easat-3113	1	27	doi	doi	PROPN
easat-3113	1	28	:	:	PUNCT
easat-3113	1	29	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	1	30	©	©	PROPN
easat-3113	1	31	2024	2024	NUM
easat-3113	1	32	by	by	ADP
easat-3113	1	33	the	the	DET
easat-3113	1	34	authors	author	NOUN
easat-3113	1	35	;	;	PUNCT
easat-3113	1	36	licensee	licensee	PROPN
easat-3113	1	37	learning	learning	NOUN
easat-3113	1	38	gate	gate	NOUN
easat-3113	1	39	©	©	PROPN
easat-3113	1	40	2024	2024	NUM
easat-3113	1	41	by	by	ADP
easat-3113	1	42	the	the	DET
easat-3113	1	43	authors	author	NOUN
easat-3113	1	44	;	;	PUNCT
easat-3113	1	45	licensee	licensee	PROPN
easat-3113	1	46	learning	learn	VERB
easat-3113	1	47	gate	gate	NOUN
easat-3113	1	48	*	*	PUNCT
easat-3113	1	49	correspondence	correspondence	NOUN
easat-3113	1	50	:	:	PUNCT
easat-3113	1	51	bagus.setyoboedi@fk.unair.ac.id	bagus.setyoboedi@fk.unair.ac.id	PUNCT
easat-3113	1	52	the	the	DET
easat-3113	1	53	applications	application	NOUN
easat-3113	1	54	of	of	ADP
easat-3113	1	55	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	1	56	acid	acid	NOUN
easat-3113	1	57	in	in	ADP
easat-3113	1	58	infant	infant	NOUN
easat-3113	1	59	with	with	ADP
easat-3113	1	60	cholestasis	cholestasis	NOUN
easat-3113	1	61	:	:	PUNCT
easat-3113	1	62	a	a	DET
easat-3113	1	63	retrospective	retrospective	ADJ
easat-3113	1	64	cohort	cohort	NOUN
easat-3113	1	65	analysis	analysis	NOUN
easat-3113	1	66	nur	nur	VERB
easat-3113	1	67	hanifah1,2	hanifah1,2	PROPN
easat-3113	1	68	,	,	PUNCT
easat-3113	1	69	bagus	bagus	PROPN
easat-3113	1	70	setyoboedi1,2	setyoboedi1,2	PROPN
easat-3113	1	71	*	*	PROPN
easat-3113	1	72	,	,	PUNCT
easat-3113	1	73	citrawati	citrawati	PROPN
easat-3113	1	74	dyah	dyah	PROPN
easat-3113	1	75	kencono	kencono	PROPN
easat-3113	1	76	wungu3,4	wungu3,4	PROPN
easat-3113	1	77	,	,	PUNCT
easat-3113	1	78	rendi	rendi	PROPN
easat-3113	1	79	aji	aji	PROPN
easat-3113	1	80	prihaningtyas1,2	prihaningtyas1,2	PROPN
easat-3113	1	81	1department	1department	NUM
easat-3113	1	82	of	of	ADP
easat-3113	1	83	child	child	NOUN
easat-3113	1	84	health	health	PROPN
easat-3113	1	85	,	,	PUNCT
easat-3113	1	86	dr	dr	PROPN
easat-3113	1	87	.	.	PROPN
easat-3113	1	88	soetomo	soetomo	PROPN
easat-3113	1	89	general	general	PROPN
easat-3113	1	90	academic	academic	ADJ
easat-3113	1	91	hospital	hospital	NOUN
easat-3113	1	92	,	,	PUNCT
easat-3113	1	93	surabaya	surabaya	PROPN
easat-3113	1	94	,	,	PUNCT
easat-3113	1	95	indonesia	indonesia	PROPN
easat-3113	1	96	.	.	PUNCT
easat-3113	2	1	2department	2department	NUM
easat-3113	2	2	of	of	ADP
easat-3113	2	3	child	child	NOUN
easat-3113	2	4	health	health	NOUN
easat-3113	2	5	,	,	PUNCT
easat-3113	2	6	faculty	faculty	NOUN
easat-3113	2	7	of	of	ADP
easat-3113	2	8	medicine	medicine	NOUN
easat-3113	2	9	–	–	PUNCT
easat-3113	2	10	universitas	universita	NOUN
easat-3113	2	11	airlangga	airlangga	NOUN
easat-3113	2	12	,	,	PUNCT
easat-3113	2	13	surabaya	surabaya	PROPN
easat-3113	2	14	,	,	PUNCT
easat-3113	2	15	indonesia	indonesia	PROPN
easat-3113	2	16	;	;	PUNCT
easat-3113	2	17	bagus.setyoboedi@fk.unair.ac.id	bagus.setyoboedi@fk.unair.ac.id	X
easat-3113	2	18	(	(	PUNCT
easat-3113	2	19	b.s	b.s	PROPN
easat-3113	2	20	.	.	PROPN
easat-3113	2	21	)	)	PUNCT
easat-3113	2	22	.	.	PUNCT
easat-3113	3	1	3department	3department	NUM
easat-3113	3	2	of	of	ADP
easat-3113	3	3	physiology	physiology	NOUN
easat-3113	3	4	and	and	CCONJ
easat-3113	3	5	medical	medical	ADJ
easat-3113	3	6	biochemistry	biochemistry	NOUN
easat-3113	3	7	,	,	PUNCT
easat-3113	3	8	faculty	faculty	NOUN
easat-3113	3	9	of	of	ADP
easat-3113	3	10	medicine	medicine	NOUN
easat-3113	3	11	,	,	PUNCT
easat-3113	3	12	universitas	universita	NOUN
easat-3113	3	13	airlangga	airlangga	PROPN
easat-3113	3	14	university	university	PROPN
easat-3113	3	15	,	,	PUNCT
easat-3113	3	16	surabaya	surabaya	PROPN
easat-3113	3	17	,	,	PUNCT
easat-3113	3	18	indonesia	indonesia	PROPN
easat-3113	3	19	.	.	PUNCT
easat-3113	4	1	4institute	4institute	NUM
easat-3113	4	2	of	of	ADP
easat-3113	4	3	tropical	tropical	ADJ
easat-3113	4	4	disease	disease	NOUN
easat-3113	4	5	,	,	PUNCT
easat-3113	4	6	universitas	universita	NOUN
easat-3113	4	7	airlangga	airlangga	NOUN
easat-3113	4	8	,	,	PUNCT
easat-3113	4	9	surabaya	surabaya	PROPN
easat-3113	4	10	,	,	PUNCT
easat-3113	4	11	indonesia	indonesia	PROPN
easat-3113	4	12	.	.	PUNCT
easat-3113	5	1	abstract	abstract	ADJ
easat-3113	5	2	:	:	PUNCT
easat-3113	5	3	biliary	biliary	ADJ
easat-3113	5	4	atresia	atresia	NOUN
easat-3113	5	5	is	be	AUX
easat-3113	5	6	the	the	DET
easat-3113	5	7	predominant	predominant	ADJ
easat-3113	5	8	etiology	etiology	NOUN
easat-3113	5	9	of	of	ADP
easat-3113	5	10	cholestasis	cholestasis	NOUN
easat-3113	5	11	in	in	ADP
easat-3113	5	12	early	early	ADJ
easat-3113	5	13	infancy	infancy	NOUN
easat-3113	5	14	.	.	PUNCT
easat-3113	6	1	impairment	impairment	NOUN
easat-3113	6	2	of	of	ADP
easat-3113	6	3	bile	bile	NOUN
easat-3113	6	4	fluid	fluid	NOUN
easat-3113	6	5	excretion	excretion	NOUN
easat-3113	6	6	results	result	NOUN
easat-3113	6	7	in	in	ADP
easat-3113	6	8	elevated	elevated	ADJ
easat-3113	6	9	bilirubin	bilirubin	NOUN
easat-3113	6	10	levels	level	NOUN
easat-3113	6	11	,	,	PUNCT
easat-3113	6	12	causing	cause	VERB
easat-3113	6	13	a	a	DET
easat-3113	6	14	yellowing	yellowing	NOUN
easat-3113	6	15	of	of	ADP
easat-3113	6	16	the	the	DET
easat-3113	6	17	skin	skin	NOUN
easat-3113	6	18	.	.	PUNCT
easat-3113	7	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	7	2	acid	acid	PROPN
easat-3113	7	3	is	be	AUX
easat-3113	7	4	well	well	ADV
easat-3113	7	5	-	-	PUNCT
easat-3113	7	6	established	establish	VERB
easat-3113	7	7	to	to	PART
easat-3113	7	8	enhance	enhance	VERB
easat-3113	7	9	liver	liver	NOUN
easat-3113	7	10	function	function	NOUN
easat-3113	7	11	when	when	SCONJ
easat-3113	7	12	taken	take	VERB
easat-3113	7	13	promptly	promptly	ADV
easat-3113	7	14	.	.	PUNCT
easat-3113	8	1	the	the	DET
easat-3113	8	2	application	application	NOUN
easat-3113	8	3	of	of	ADP
easat-3113	8	4	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	8	5	acid	acid	NOUN
easat-3113	8	6	for	for	ADP
easat-3113	8	7	treating	treat	VERB
easat-3113	8	8	cholestasis	cholestasis	NOUN
easat-3113	8	9	in	in	ADP
easat-3113	8	10	pediatric	pediatric	ADJ
easat-3113	8	11	patients	patient	NOUN
easat-3113	8	12	remains	remain	VERB
easat-3113	8	13	contentious	contentious	ADJ
easat-3113	8	14	.	.	PUNCT
easat-3113	9	1	the	the	DET
easat-3113	9	2	objective	objective	NOUN
easat-3113	9	3	of	of	ADP
easat-3113	9	4	this	this	DET
easat-3113	9	5	study	study	NOUN
easat-3113	9	6	is	be	AUX
easat-3113	9	7	to	to	PART
easat-3113	9	8	assess	assess	VERB
easat-3113	9	9	the	the	DET
easat-3113	9	10	impact	impact	NOUN
easat-3113	9	11	of	of	ADP
easat-3113	9	12	ursodeoxycholic	ursodeoxycholic	ADJ
easat-3113	9	13	acid	acid	NOUN
easat-3113	9	14	treatment	treatment	NOUN
easat-3113	9	15	on	on	ADP
easat-3113	9	16	liver	liver	NOUN
easat-3113	9	17	biomarkers	biomarker	NOUN
easat-3113	9	18	in	in	ADP
easat-3113	9	19	infant	infant	NOUN
easat-3113	9	20	with	with	ADP
easat-3113	9	21	cholestasis	cholestasis	NOUN
easat-3113	9	22	.	.	PUNCT
easat-3113	10	1	this	this	PRON
easat-3113	10	2	was	be	AUX
easat-3113	10	3	retrospective	retrospective	ADJ
easat-3113	10	4	cohort	cohort	NOUN
easat-3113	10	5	study	study	NOUN
easat-3113	10	6	in	in	ADP
easat-3113	10	7	infant	infant	NOUN
easat-3113	10	8	with	with	ADP
easat-3113	10	9	cholestasis	cholestasis	NOUN
easat-3113	10	10	who	who	PRON
easat-3113	10	11	underwent	undergo	VERB
easat-3113	10	12	ursodeoxycholic	ursodeoxycholic	ADJ
easat-3113	10	13	acid	acid	NOUN
easat-3113	10	14	treatment	treatment	NOUN
easat-3113	10	15	for	for	ADP
easat-3113	10	16	two	two	NUM
easat-3113	10	17	weeks	week	NOUN
easat-3113	10	18	.	.	PUNCT
easat-3113	11	1	secondary	secondary	ADJ
easat-3113	11	2	data	datum	NOUN
easat-3113	11	3	including	include	VERB
easat-3113	11	4	aspartate	aspartate	NOUN
easat-3113	11	5	aminotransferase	aminotransferase	NOUN
easat-3113	11	6	,	,	PUNCT
easat-3113	11	7	alanine	alanine	NOUN
easat-3113	11	8	aminotransferase	aminotransferase	NOUN
easat-3113	11	9	,	,	PUNCT
easat-3113	11	10	total	total	ADJ
easat-3113	11	11	bilirubin	bilirubin	NOUN
easat-3113	11	12	,	,	PUNCT
easat-3113	11	13	and	and	CCONJ
easat-3113	11	14	direct	direct	ADJ
easat-3113	11	15	bilirubin	bilirubin	NOUN
easat-3113	11	16	were	be	AUX
easat-3113	11	17	extracted	extract	VERB
easat-3113	11	18	from	from	ADP
easat-3113	11	19	the	the	DET
easat-3113	11	20	medical	medical	ADJ
easat-3113	11	21	records	record	NOUN
easat-3113	11	22	of	of	ADP
easat-3113	11	23	the	the	DET
easat-3113	11	24	outpatient	outpatient	NOUN
easat-3113	11	25	clinic	clinic	NOUN
easat-3113	11	26	in	in	ADP
easat-3113	11	27	the	the	DET
easat-3113	11	28	department	department	NOUN
easat-3113	11	29	of	of	ADP
easat-3113	11	30	child	child	PROPN
easat-3113	11	31	health	health	PROPN
easat-3113	11	32	at	at	ADP
easat-3113	11	33	dr	dr	PROPN
easat-3113	11	34	.	.	PROPN
easat-3113	11	35	soetomo	soetomo	PROPN
easat-3113	11	36	general	general	PROPN
easat-3113	11	37	hospital	hospital	PROPN
easat-3113	11	38	,	,	PUNCT
easat-3113	11	39	indonesia	indonesia	PROPN
easat-3113	11	40	(	(	PUNCT
easat-3113	11	41	january	january	PROPN
easat-3113	11	42	2020	2020	NUM
easat-3113	11	43	december	december	PROPN
easat-3113	11	44	2023	2023	NUM
easat-3113	11	45	)	)	PUNCT
easat-3113	11	46	.	.	PUNCT
easat-3113	12	1	the	the	DET
easat-3113	12	2	data	datum	NOUN
easat-3113	12	3	was	be	AUX
easat-3113	12	4	devided	devide	VERB
easat-3113	12	5	into	into	ADP
easat-3113	12	6	two	two	NUM
easat-3113	12	7	groups	group	NOUN
easat-3113	12	8	based	base	VERB
easat-3113	12	9	on	on	ADP
easat-3113	12	10	biopsy	biopsy	NOUN
easat-3113	12	11	and	and	CCONJ
easat-3113	12	12	examined	examine	VERB
easat-3113	12	13	utilizing	utilize	VERB
easat-3113	12	14	spss	spss	PROPN
easat-3113	12	15	version	version	NOUN
easat-3113	12	16	23	23	NUM
easat-3113	12	17	.	.	PUNCT
easat-3113	13	1	this	this	DET
easat-3113	13	2	study	study	NOUN
easat-3113	13	3	included	include	VERB
easat-3113	13	4	64	64	NUM
easat-3113	13	5	participants	participant	NOUN
easat-3113	13	6	.	.	PUNCT
easat-3113	14	1	statistics	statistic	NOUN
easat-3113	14	2	show	show	VERB
easat-3113	14	3	an	an	DET
easat-3113	14	4	equal	equal	ADJ
easat-3113	14	5	gender	gender	NOUN
easat-3113	14	6	ratio	ratio	NOUN
easat-3113	14	7	.	.	PUNCT
easat-3113	15	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	15	2	acid	acid	PROPN
easat-3113	15	3	treatment	treatment	NOUN
easat-3113	15	4	in	in	ADP
easat-3113	15	5	paediatric	paediatric	ADJ
easat-3113	15	6	cholestasis	cholestasis	NOUN
easat-3113	15	7	patients	patient	NOUN
easat-3113	15	8	can	can	AUX
easat-3113	15	9	lower	lower	VERB
easat-3113	15	10	liver	liver	NOUN
easat-3113	15	11	biomarker	biomarker	NOUN
easat-3113	15	12	level	level	NOUN
easat-3113	15	13	.	.	PUNCT
easat-3113	16	1	levels	level	NOUN
easat-3113	16	2	of	of	ADP
easat-3113	16	3	total	total	ADJ
easat-3113	16	4	bilirubin	bilirubin	NOUN
easat-3113	16	5	and	and	CCONJ
easat-3113	16	6	direct	direct	ADJ
easat-3113	16	7	bilirubin	bilirubin	NOUN
easat-3113	16	8	diminished	diminish	VERB
easat-3113	16	9	in	in	ADP
easat-3113	16	10	individuals	individual	NOUN
easat-3113	16	11	both	both	DET
easat-3113	16	12	groups	group	NOUN
easat-3113	16	13	.	.	PUNCT
easat-3113	17	1	notable	notable	ADJ
easat-3113	17	2	levels	level	NOUN
easat-3113	17	3	were	be	AUX
easat-3113	17	4	recorded	record	VERB
easat-3113	17	5	in	in	ADP
easat-3113	17	6	individuals	individual	NOUN
easat-3113	17	7	with	with	ADP
easat-3113	17	8	normal	normal	ADJ
easat-3113	17	9	biopsy	biopsy	NOUN
easat-3113	17	10	outcomes	outcome	NOUN
easat-3113	17	11	(	(	PUNCT
easat-3113	17	12	p=0.007	p=0.007	X
easat-3113	17	13	and	and	CCONJ
easat-3113	17	14	p=0.012	p=0.012	NUM
easat-3113	17	15	)	)	PUNCT
easat-3113	17	16	.	.	PUNCT
easat-3113	18	1	administration	administration	NOUN
easat-3113	18	2	of	of	ADP
easat-3113	18	3	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	18	4	acid	acid	PROPN
easat-3113	18	5	markedly	markedly	ADV
easat-3113	18	6	elevated	elevate	VERB
easat-3113	18	7	alt	alt	ADJ
easat-3113	18	8	levels	level	NOUN
easat-3113	18	9	in	in	ADP
easat-3113	18	10	both	both	CCONJ
easat-3113	18	11	the	the	DET
easat-3113	18	12	normal	normal	ADJ
easat-3113	18	13	and	and	CCONJ
easat-3113	18	14	abnormal	abnormal	ADJ
easat-3113	18	15	liver	liver	NOUN
easat-3113	18	16	biopsy	biopsy	NOUN
easat-3113	18	17	outcome	outcome	NOUN
easat-3113	18	18	groups	group	NOUN
easat-3113	18	19	(	(	PUNCT
easat-3113	18	20	p=0.031	p=0.031	NOUN
easat-3113	18	21	and	and	CCONJ
easat-3113	18	22	p=0.006	p=0.006	NOUN
easat-3113	18	23	)	)	PUNCT
easat-3113	18	24	.	.	PUNCT
easat-3113	19	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	19	2	acid	acid	PROPN
easat-3113	19	3	has	have	AUX
easat-3113	19	4	been	be	AUX
easat-3113	19	5	shown	show	VERB
easat-3113	19	6	to	to	PART
easat-3113	19	7	be	be	AUX
easat-3113	19	8	effective	effective	ADJ
easat-3113	19	9	in	in	ADP
easat-3113	19	10	improving	improve	VERB
easat-3113	19	11	liver	liver	NOUN
easat-3113	19	12	function	function	NOUN
easat-3113	19	13	in	in	ADP
easat-3113	19	14	infant	infant	NOUN
easat-3113	19	15	with	with	ADP
easat-3113	19	16	cholestasis	cholestasis	NOUN
easat-3113	19	17	.	.	PUNCT
easat-3113	20	1	in	in	ADP
easat-3113	20	2	order	order	NOUN
easat-3113	20	3	to	to	PART
easat-3113	20	4	avoid	avoid	VERB
easat-3113	20	5	negative	negative	ADJ
easat-3113	20	6	effects	effect	NOUN
easat-3113	20	7	,	,	PUNCT
easat-3113	20	8	the	the	DET
easat-3113	20	9	medication	medication	NOUN
easat-3113	20	10	must	must	AUX
easat-3113	20	11	be	be	AUX
easat-3113	20	12	carefully	carefully	ADV
easat-3113	20	13	administered	administer	VERB
easat-3113	20	14	to	to	ADP
easat-3113	20	15	people	people	NOUN
easat-3113	20	16	who	who	PRON
easat-3113	20	17	already	already	ADV
easat-3113	20	18	have	have	VERB
easat-3113	20	19	liver	liver	NOUN
easat-3113	20	20	fibrosis	fibrosis	NOUN
easat-3113	20	21	.	.	PUNCT
easat-3113	21	1	keywords	keyword	NOUN
easat-3113	21	2	:	:	PUNCT
easat-3113	21	3	bilirubin	bilirubin	NOUN
easat-3113	21	4	,	,	PUNCT
easat-3113	21	5	infant	infant	NOUN
easat-3113	21	6	,	,	PUNCT
easat-3113	21	7	pediatric	pediatric	ADJ
easat-3113	21	8	cholestasis	cholestasis	NOUN
easat-3113	21	9	,	,	PUNCT
easat-3113	21	10	transaminase	transaminase	NOUN
easat-3113	21	11	,	,	PUNCT
easat-3113	21	12	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	21	13	acid	acid	NOUN
easat-3113	21	14	,	,	PUNCT
easat-3113	21	15	1	1	NUM
easat-3113	21	16	.	.	PUNCT
easat-3113	21	17	introduction	introduction	NOUN
easat-3113	21	18	cholestasis	cholestasis	NOUN
easat-3113	21	19	is	be	AUX
easat-3113	21	20	defined	define	VERB
easat-3113	21	21	as	as	ADP
easat-3113	21	22	a	a	DET
easat-3113	21	23	disturbance	disturbance	NOUN
easat-3113	21	24	in	in	ADP
easat-3113	21	25	the	the	DET
easat-3113	21	26	flow	flow	NOUN
easat-3113	21	27	of	of	ADP
easat-3113	21	28	bile	bile	NOUN
easat-3113	21	29	fluid	fluid	NOUN
easat-3113	21	30	,	,	PUNCT
easat-3113	21	31	characterized	characterize	VERB
easat-3113	21	32	by	by	ADP
easat-3113	21	33	an	an	DET
easat-3113	21	34	increase	increase	NOUN
easat-3113	21	35	in	in	ADP
easat-3113	21	36	direct	direct	ADJ
easat-3113	21	37	/	/	SYM
easat-3113	21	38	conjugated	conjugate	VERB
easat-3113	21	39	bilirubin	bilirubin	NOUN
easat-3113	21	40	levels	level	NOUN
easat-3113	21	41	(	(	PUNCT
easat-3113	21	42	>	>	SYM
easat-3113	21	43	1	1	NUM
easat-3113	21	44	mg	mg	PROPN
easat-3113	21	45	/	/	SYM
easat-3113	21	46	dl	dl	PROPN
easat-3113	21	47	or	or	CCONJ
easat-3113	21	48	>	>	X
easat-3113	21	49	17	17	NUM
easat-3113	21	50	mmol	mmol	NOUN
easat-3113	21	51	/	/	SYM
easat-3113	21	52	dl	dl	NOUN
easat-3113	21	53	)	)	PUNCT
easat-3113	22	1	[	[	X
easat-3113	22	2	1	1	NUM
easat-3113	22	3	]	]	PUNCT
easat-3113	22	4	.	.	PUNCT
easat-3113	23	1	unlike	unlike	ADP
easat-3113	23	2	in	in	ADP
easat-3113	23	3	adults	adult	NOUN
easat-3113	23	4	,	,	PUNCT
easat-3113	23	5	the	the	DET
easat-3113	23	6	majority	majority	NOUN
easat-3113	23	7	of	of	ADP
easat-3113	23	8	cholestasis	cholestasis	NOUN
easat-3113	23	9	in	in	ADP
easat-3113	23	10	children	child	NOUN
easat-3113	23	11	is	be	AUX
easat-3113	23	12	due	due	ADJ
easat-3113	23	13	to	to	ADP
easat-3113	23	14	immaturity	immaturity	NOUN
easat-3113	23	15	of	of	ADP
easat-3113	23	16	the	the	DET
easat-3113	23	17	liver	liver	NOUN
easat-3113	23	18	[	[	X
easat-3113	23	19	2	2	NUM
easat-3113	23	20	]	]	PUNCT
easat-3113	23	21	.	.	PUNCT
easat-3113	24	1	the	the	DET
easat-3113	24	2	incidence	incidence	NOUN
easat-3113	24	3	of	of	ADP
easat-3113	24	4	severe	severe	ADJ
easat-3113	24	5	neonatal	neonatal	ADJ
easat-3113	24	6	jaundice	jaundice	NOUN
easat-3113	24	7	in	in	ADP
easat-3113	24	8	southeast	southeast	PROPN
easat-3113	24	9	asia	asia	PROPN
easat-3113	24	10	ranged	range	VERB
easat-3113	24	11	from	from	ADP
easat-3113	24	12	251.3	251.3	NUM
easat-3113	24	13	out	out	ADP
easat-3113	24	14	of	of	ADP
easat-3113	24	15	100,000	100,000	NUM
easat-3113	24	16	live	live	ADJ
easat-3113	24	17	births	birth	NOUN
easat-3113	24	18	,	,	PUNCT
easat-3113	24	19	the	the	DET
easat-3113	24	20	second	second	ADJ
easat-3113	24	21	highest	high	ADJ
easat-3113	24	22	after	after	ADP
easat-3113	24	23	africa	africa	PROPN
easat-3113	25	1	[	[	X
easat-3113	25	2	3	3	NUM
easat-3113	25	3	]	]	PUNCT
easat-3113	25	4	.	.	PUNCT
easat-3113	26	1	management	management	NOUN
easat-3113	26	2	of	of	ADP
easat-3113	26	3	pediatric	pediatric	ADJ
easat-3113	26	4	cholestasis	cholestasis	NOUN
easat-3113	26	5	depends	depend	VERB
easat-3113	26	6	on	on	ADP
easat-3113	26	7	the	the	DET
easat-3113	26	8	underlying	underlie	VERB
easat-3113	26	9	etiology	etiology	NOUN
easat-3113	26	10	and	and	CCONJ
easat-3113	26	11	stage	stage	NOUN
easat-3113	26	12	of	of	ADP
easat-3113	26	13	the	the	DET
easat-3113	26	14	disease	disease	NOUN
easat-3113	26	15	.	.	PUNCT
easat-3113	27	1	treatment	treatment	NOUN
easat-3113	27	2	might	might	AUX
easat-3113	27	3	be	be	AUX
easat-3113	27	4	invasive	invasive	ADJ
easat-3113	27	5	or	or	CCONJ
easat-3113	27	6	supportive	supportive	ADJ
easat-3113	27	7	[	[	X
easat-3113	27	8	4	4	NUM
easat-3113	27	9	]	]	PUNCT
easat-3113	27	10	.	.	PUNCT
easat-3113	28	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	28	2	acid	acid	PROPN
easat-3113	28	3	is	be	AUX
easat-3113	28	4	a	a	DET
easat-3113	28	5	hydrophilic	hydrophilic	ADJ
easat-3113	28	6	bile	bile	NOUN
easat-3113	28	7	acid	acid	NOUN
easat-3113	28	8	that	that	PRON
easat-3113	28	9	is	be	AUX
easat-3113	28	10	designated	designate	VERB
easat-3113	28	11	as	as	ADP
easat-3113	28	12	a	a	DET
easat-3113	28	13	first	first	ADJ
easat-3113	28	14	-	-	PUNCT
easat-3113	28	15	line	line	NOUN
easat-3113	28	16	drug	drug	NOUN
easat-3113	28	17	for	for	ADP
easat-3113	28	18	primary	primary	ADJ
easat-3113	28	19	biliary	biliary	NOUN
easat-3113	28	20	cholangitis	cholangitis	NOUN
easat-3113	28	21	by	by	ADP
easat-3113	28	22	the	the	DET
easat-3113	28	23	food	food	NOUN
easat-3113	28	24	and	and	CCONJ
easat-3113	28	25	drug	drug	PROPN
easat-3113	28	26	administration	administration	NOUN
easat-3113	28	27	[	[	X
easat-3113	28	28	5,6	5,6	NUM
easat-3113	28	29	]	]	PUNCT
easat-3113	28	30	.	.	PUNCT
easat-3113	29	1	cholestasis	cholestasis	NOUN
easat-3113	29	2	,	,	PUNCT
easat-3113	29	3	apoptosis	apoptosis	NOUN
easat-3113	29	4	,	,	PUNCT
easat-3113	29	5	inflammation	inflammation	NOUN
easat-3113	29	6	,	,	PUNCT
easat-3113	29	7	and	and	CCONJ
easat-3113	29	8	free	free	ADJ
easat-3113	29	9	radicals	radical	NOUN
easat-3113	29	10	such	such	ADJ
easat-3113	29	11	as	as	ADP
easat-3113	29	12	reactive	reactive	ADJ
easat-3113	29	13	oxygen	oxygen	NOUN
easat-3113	29	14	species	specie	NOUN
easat-3113	29	15	(	(	PUNCT
easat-3113	29	16	ros	ros	PROPN
easat-3113	29	17	)	)	PUNCT
easat-3113	29	18	in	in	ADP
easat-3113	29	19	cholestasis	cholestasis	NOUN
easat-3113	29	20	are	be	AUX
easat-3113	29	21	inhibited	inhibit	VERB
easat-3113	29	22	by	by	ADP
easat-3113	29	23	this	this	DET
easat-3113	29	24	bile	bile	NOUN
easat-3113	29	25	acid	acid	NOUN
easat-3113	29	26	through	through	ADP
easat-3113	29	27	the	the	DET
easat-3113	29	28	mechanism	mechanism	NOUN
easat-3113	29	29	of	of	ADP
easat-3113	29	30	membrane	membrane	NOUN
easat-3113	29	31	and	and	CCONJ
easat-3113	29	32	nuclear	nuclear	ADJ
easat-3113	29	33	receptors	receptor	NOUN
easat-3113	29	34	activation	activation	NOUN
easat-3113	29	35	[	[	X
easat-3113	29	36	7,8	7,8	NUM
easat-3113	29	37	]	]	PUNCT
easat-3113	29	38	.	.	PUNCT
easat-3113	30	1	in	in	ADP
easat-3113	30	2	addition	addition	NOUN
easat-3113	30	3	,	,	PUNCT
easat-3113	30	4	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	30	5	acid	acid	PROPN
easat-3113	30	6	is	be	AUX
easat-3113	30	7	also	also	ADV
easat-3113	30	8	known	know	VERB
easat-3113	30	9	as	as	ADP
easat-3113	30	10	an	an	DET
easat-3113	30	11	immunomodulator	immunomodulator	NOUN
easat-3113	30	12	related	relate	VERB
easat-3113	30	13	to	to	ADP
easat-3113	30	14	the	the	DET
easat-3113	30	15	production	production	NOUN
easat-3113	30	16	of	of	ADP
easat-3113	30	17	immunoglobulin	immunoglobulin	NOUN
easat-3113	30	18	,	,	PUNCT
easat-3113	30	19	interleukin	interleukin	NOUN
easat-3113	30	20	and	and	CCONJ
easat-3113	30	21	tumor	tumor	NOUN
easat-3113	30	22	necrosis	necrosis	NOUN
easat-3113	30	23	factor	factor	NOUN
easat-3113	30	24	(	(	PUNCT
easat-3113	30	25	tnf	tnf	PROPN
easat-3113	30	26	-	-	PUNCT
easat-3113	30	27	α	α	NOUN
easat-3113	30	28	)	)	PUNCT
easat-3113	31	1	[	[	X
easat-3113	31	2	9	9	NUM
easat-3113	31	3	]	]	PUNCT
easat-3113	31	4	.	.	PUNCT
easat-3113	32	1	although	although	SCONJ
easat-3113	32	2	this	this	DET
easat-3113	32	3	drug	drug	NOUN
easat-3113	32	4	5076	5076	NUM
easat-3113	32	5	edelweiss	edelweiss	PROPN
easat-3113	32	6	applied	apply	VERB
easat-3113	32	7	science	science	NOUN
easat-3113	32	8	and	and	CCONJ
easat-3113	32	9	technology	technology	NOUN
easat-3113	32	10	issn	issn	PROPN
easat-3113	32	11	:	:	PUNCT
easat-3113	32	12	2576	2576	NUM
easat-3113	32	13	-	-	SYM
easat-3113	32	14	8484	8484	NUM
easat-3113	32	15	vol	vol	NOUN
easat-3113	32	16	.	.	PROPN
easat-3113	32	17	8	8	NUM
easat-3113	32	18	,	,	PUNCT
easat-3113	32	19	no	no	INTJ
easat-3113	32	20	.	.	NOUN
easat-3113	32	21	6	6	NUM
easat-3113	32	22	:	:	PUNCT
easat-3113	32	23	5075	5075	NUM
easat-3113	32	24	-	-	SYM
easat-3113	32	25	5081	5081	NUM
easat-3113	32	26	,	,	PUNCT
easat-3113	32	27	2024	2024	NUM
easat-3113	32	28	doi	doi	NOUN
easat-3113	32	29	:	:	PUNCT
easat-3113	32	30	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	32	31	©	©	PROPN
easat-3113	32	32	2024	2024	NUM
easat-3113	32	33	by	by	ADP
easat-3113	32	34	the	the	DET
easat-3113	32	35	authors	author	NOUN
easat-3113	32	36	;	;	PUNCT
easat-3113	32	37	licensee	licensee	PROPN
easat-3113	32	38	learning	learning	NOUN
easat-3113	32	39	gate	gate	NOUN
easat-3113	32	40	has	have	AUX
easat-3113	32	41	been	be	AUX
easat-3113	32	42	included	include	VERB
easat-3113	32	43	in	in	ADP
easat-3113	32	44	the	the	DET
easat-3113	32	45	national	national	ADJ
easat-3113	32	46	formulary	formulary	NOUN
easat-3113	32	47	,	,	PUNCT
easat-3113	32	48	its	its	PRON
easat-3113	32	49	use	use	NOUN
easat-3113	32	50	in	in	ADP
easat-3113	32	51	children	child	NOUN
easat-3113	32	52	is	be	AUX
easat-3113	32	53	still	still	ADV
easat-3113	32	54	controversial	controversial	ADJ
easat-3113	32	55	(	(	PUNCT
easat-3113	32	56	off	off	ADP
easat-3113	32	57	label	label	NOUN
easat-3113	32	58	)	)	PUNCT
easat-3113	33	1	[	[	X
easat-3113	33	2	10–12	10–12	NUM
easat-3113	33	3	]	]	PUNCT
easat-3113	33	4	.	.	PUNCT
easat-3113	34	1	some	some	DET
easat-3113	34	2	countries	country	NOUN
easat-3113	34	3	still	still	ADV
easat-3113	34	4	limit	limit	VERB
easat-3113	34	5	its	its	PRON
easat-3113	34	6	use	use	NOUN
easat-3113	34	7	in	in	ADP
easat-3113	34	8	infants	infant	NOUN
easat-3113	34	9	[	[	X
easat-3113	34	10	13	13	NUM
easat-3113	34	11	]	]	PUNCT
easat-3113	34	12	.	.	PUNCT
easat-3113	35	1	in	in	ADP
easat-3113	35	2	addition	addition	NOUN
easat-3113	35	3	to	to	ADP
easat-3113	35	4	providing	provide	VERB
easat-3113	35	5	mct	mct	PROPN
easat-3113	35	6	medium	medium	NOUN
easat-3113	35	7	chain	chain	NOUN
easat-3113	35	8	triglycerides	triglyceride	NOUN
easat-3113	35	9	(	(	PUNCT
easat-3113	35	10	mct	mct	PROPN
easat-3113	35	11	)	)	PUNCT
easat-3113	35	12	nutrition	nutrition	NOUN
easat-3113	35	13	and	and	CCONJ
easat-3113	35	14	fat	fat	ADJ
easat-3113	35	15	-	-	PUNCT
easat-3113	35	16	soluble	soluble	ADJ
easat-3113	35	17	vitamins	vitamin	NOUN
easat-3113	35	18	and	and	CCONJ
easat-3113	35	19	minerals	mineral	NOUN
easat-3113	35	20	,	,	PUNCT
easat-3113	35	21	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	35	22	acid	acid	PROPN
easat-3113	35	23	is	be	AUX
easat-3113	35	24	part	part	NOUN
easat-3113	35	25	of	of	ADP
easat-3113	35	26	the	the	DET
easat-3113	35	27	standard	standard	ADJ
easat-3113	35	28	regiment	regiment	NOUN
easat-3113	35	29	for	for	ADP
easat-3113	35	30	cholestasis	cholestasis	NOUN
easat-3113	35	31	and	and	CCONJ
easat-3113	35	32	acute	acute	ADJ
easat-3113	35	33	hepatitis	hepatitis	NOUN
easat-3113	35	34	in	in	ADP
easat-3113	35	35	infants	infant	NOUN
easat-3113	35	36	at	at	ADP
easat-3113	35	37	dr	dr	PROPN
easat-3113	35	38	.	.	PROPN
easat-3113	35	39	soetomo	soetomo	PROPN
easat-3113	35	40	hospital	hospital	PROPN
easat-3113	36	1	[	[	X
easat-3113	36	2	14	14	NUM
easat-3113	36	3	]	]	PUNCT
easat-3113	36	4	.	.	PUNCT
easat-3113	37	1	a	a	DET
easat-3113	37	2	dose	dose	NOUN
easat-3113	37	3	of	of	ADP
easat-3113	37	4	10	10	NUM
easat-3113	37	5	-	-	SYM
easat-3113	37	6	20	20	NUM
easat-3113	37	7	mg	mg	PROPN
easat-3113	37	8	/	/	SYM
easat-3113	37	9	kg	kg	NOUN
easat-3113	37	10	/	/	SYM
easat-3113	37	11	day	day	NOUN
easat-3113	37	12	divided	divide	VERB
easat-3113	37	13	into	into	ADP
easat-3113	37	14	2	2	NUM
easat-3113	37	15	-	-	SYM
easat-3113	37	16	3	3	NUM
easat-3113	37	17	doses	dose	NOUN
easat-3113	37	18	could	could	AUX
easat-3113	37	19	reduce	reduce	VERB
easat-3113	37	20	bilirubin	bilirubin	NOUN
easat-3113	37	21	and	and	CCONJ
easat-3113	37	22	ast	ast	NOUN
easat-3113	37	23	level	level	NOUN
easat-3113	37	24	,	,	PUNCT
easat-3113	37	25	while	while	SCONJ
easat-3113	37	26	reducing	reduce	VERB
easat-3113	37	27	pruritus	pruritus	NOUN
easat-3113	37	28	symptoms	symptom	NOUN
easat-3113	37	29	due	due	ADJ
easat-3113	37	30	to	to	ADP
easat-3113	37	31	cholestasis	cholestasis	NOUN
easat-3113	37	32	[	[	X
easat-3113	37	33	15	15	NUM
easat-3113	37	34	]	]	PUNCT
easat-3113	37	35	.	.	PUNCT
easat-3113	38	1	although	although	SCONJ
easat-3113	38	2	most	most	ADJ
easat-3113	38	3	hyperbilirubinemia	hyperbilirubinemia	NOUN
easat-3113	38	4	is	be	AUX
easat-3113	38	5	a	a	DET
easat-3113	38	6	physiological	physiological	ADJ
easat-3113	38	7	process	process	NOUN
easat-3113	38	8	,	,	PUNCT
easat-3113	38	9	it	it	PRON
easat-3113	38	10	is	be	AUX
easat-3113	38	11	necessary	necessary	ADJ
easat-3113	38	12	to	to	PART
easat-3113	38	13	evaluate	evaluate	VERB
easat-3113	38	14	for	for	ADP
easat-3113	38	15	liver	liver	NOUN
easat-3113	38	16	dysfunction	dysfunction	NOUN
easat-3113	38	17	as	as	ADV
easat-3113	38	18	early	early	ADV
easat-3113	38	19	as	as	ADP
easat-3113	38	20	possible	possible	ADJ
easat-3113	38	21	if	if	SCONJ
easat-3113	38	22	the	the	DET
easat-3113	38	23	onset	onset	NOUN
easat-3113	38	24	is	be	AUX
easat-3113	38	25	earlier	early	ADV
easat-3113	38	26	(	(	PUNCT
easat-3113	38	27	<	<	X
easat-3113	38	28	24	24	NUM
easat-3113	38	29	hours	hour	NOUN
easat-3113	38	30	)	)	PUNCT
easat-3113	38	31	or	or	CCONJ
easat-3113	38	32	more	more	ADJ
easat-3113	38	33	than	than	ADP
easat-3113	38	34	14	14	NUM
easat-3113	38	35	days	day	NOUN
easat-3113	38	36	to	to	PART
easat-3113	38	37	obtain	obtain	VERB
easat-3113	38	38	optimal	optimal	ADJ
easat-3113	38	39	results	result	NOUN
easat-3113	38	40	[	[	X
easat-3113	38	41	16	16	NUM
easat-3113	38	42	]	]	PUNCT
easat-3113	38	43	.	.	PUNCT
easat-3113	39	1	studies	study	NOUN
easat-3113	39	2	regarding	regard	VERB
easat-3113	39	3	the	the	DET
easat-3113	39	4	administration	administration	NOUN
easat-3113	39	5	of	of	ADP
easat-3113	39	6	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	39	7	acid	acid	NOUN
easat-3113	39	8	in	in	ADP
easat-3113	39	9	infant	infant	NOUN
easat-3113	39	10	is	be	AUX
easat-3113	39	11	important	important	ADJ
easat-3113	39	12	to	to	PART
easat-3113	39	13	understand	understand	VERB
easat-3113	39	14	the	the	DET
easat-3113	39	15	benefits	benefit	NOUN
easat-3113	39	16	,	,	PUNCT
easat-3113	39	17	risks	risk	NOUN
easat-3113	39	18	,	,	PUNCT
easat-3113	39	19	and	and	CCONJ
easat-3113	39	20	mechanisms	mechanism	NOUN
easat-3113	39	21	of	of	ADP
easat-3113	39	22	the	the	DET
easat-3113	39	23	drug	drug	NOUN
easat-3113	39	24	.	.	PUNCT
easat-3113	40	1	until	until	ADP
easat-3113	40	2	now	now	ADV
easat-3113	40	3	,	,	PUNCT
easat-3113	40	4	there	there	PRON
easat-3113	40	5	is	be	VERB
easat-3113	40	6	still	still	ADV
easat-3113	40	7	debate	debate	NOUN
easat-3113	40	8	regarding	regard	VERB
easat-3113	40	9	the	the	DET
easat-3113	40	10	administration	administration	NOUN
easat-3113	40	11	of	of	ADP
easat-3113	40	12	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	40	13	acid	acid	NOUN
easat-3113	40	14	at	at	ADP
easat-3113	40	15	a	a	DET
easat-3113	40	16	younger	young	ADJ
easat-3113	40	17	age	age	NOUN
easat-3113	40	18	.	.	PUNCT
easat-3113	41	1	therefore	therefore	ADV
easat-3113	41	2	,	,	PUNCT
easat-3113	41	3	this	this	DET
easat-3113	41	4	study	study	NOUN
easat-3113	41	5	was	be	AUX
easat-3113	41	6	conducted	conduct	VERB
easat-3113	41	7	to	to	PART
easat-3113	41	8	develop	develop	VERB
easat-3113	41	9	a	a	DET
easat-3113	41	10	strategy	strategy	NOUN
easat-3113	41	11	for	for	ADP
easat-3113	41	12	the	the	DET
easat-3113	41	13	management	management	NOUN
easat-3113	41	14	of	of	ADP
easat-3113	41	15	cholestasis	cholestasis	NOUN
easat-3113	41	16	therapy	therapy	NOUN
easat-3113	41	17	in	in	ADP
easat-3113	41	18	infant	infant	NOUN
easat-3113	41	19	.	.	PUNCT
easat-3113	42	1	2	2	X
easat-3113	42	2	.	.	X
easat-3113	42	3	materials	material	NOUN
easat-3113	42	4	and	and	CCONJ
easat-3113	42	5	methods	method	NOUN
easat-3113	42	6	this	this	DET
easat-3113	42	7	study	study	NOUN
easat-3113	42	8	employed	employ	VERB
easat-3113	42	9	an	an	DET
easat-3113	42	10	observational	observational	ADJ
easat-3113	42	11	and	and	CCONJ
easat-3113	42	12	analytical	analytical	ADJ
easat-3113	42	13	design	design	NOUN
easat-3113	42	14	,	,	PUNCT
easat-3113	42	15	utilizing	utilize	VERB
easat-3113	42	16	a	a	DET
easat-3113	42	17	retrospective	retrospective	ADJ
easat-3113	42	18	cohort	cohort	NOUN
easat-3113	42	19	methodology	methodology	NOUN
easat-3113	42	20	.	.	PUNCT
easat-3113	43	1	the	the	DET
easat-3113	43	2	data	datum	NOUN
easat-3113	43	3	collected	collect	VERB
easat-3113	43	4	consisted	consist	VERB
easat-3113	43	5	of	of	ADP
easat-3113	43	6	secondary	secondary	ADJ
easat-3113	43	7	data	datum	NOUN
easat-3113	43	8	from	from	ADP
easat-3113	43	9	pediatric	pediatric	ADJ
easat-3113	43	10	cholestasis	cholestasis	NOUN
easat-3113	43	11	patients	patient	NOUN
easat-3113	43	12	under	under	ADP
easat-3113	43	13	one	one	NUM
easat-3113	43	14	year	year	NOUN
easat-3113	43	15	old	old	ADJ
easat-3113	43	16	at	at	ADP
easat-3113	43	17	dr	dr	PROPN
easat-3113	43	18	.	.	PROPN
easat-3113	43	19	soetomo	soetomo	PROPN
easat-3113	43	20	hospital	hospital	PROPN
easat-3113	43	21	,	,	PUNCT
easat-3113	43	22	surabaya	surabaya	PROPN
easat-3113	43	23	,	,	PUNCT
easat-3113	43	24	indonesia	indonesia	PROPN
easat-3113	43	25	,	,	PUNCT
easat-3113	43	26	during	during	ADP
easat-3113	43	27	the	the	DET
easat-3113	43	28	period	period	NOUN
easat-3113	43	29	of	of	ADP
easat-3113	43	30	2020	2020	NUM
easat-3113	43	31	-	-	SYM
easat-3113	43	32	2023	2023	NUM
easat-3113	43	33	.	.	PUNCT
easat-3113	44	1	the	the	DET
easat-3113	44	2	subjects	subject	NOUN
easat-3113	44	3	of	of	ADP
easat-3113	44	4	this	this	DET
easat-3113	44	5	investigation	investigation	NOUN
easat-3113	44	6	were	be	AUX
easat-3113	44	7	infants	infant	NOUN
easat-3113	44	8	and	and	CCONJ
easat-3113	44	9	children	child	NOUN
easat-3113	44	10	attending	attend	VERB
easat-3113	44	11	the	the	DET
easat-3113	44	12	outpatient	outpatient	NOUN
easat-3113	44	13	clinic	clinic	NOUN
easat-3113	44	14	of	of	ADP
easat-3113	44	15	the	the	DET
easat-3113	44	16	department	department	PROPN
easat-3113	44	17	of	of	ADP
easat-3113	44	18	child	child	PROPN
easat-3113	44	19	health	health	PROPN
easat-3113	44	20	at	at	ADP
easat-3113	44	21	dr	dr	PROPN
easat-3113	44	22	.	.	PROPN
easat-3113	44	23	soetomo	soetomo	PROPN
easat-3113	44	24	hospital	hospital	PROPN
easat-3113	44	25	in	in	ADP
easat-3113	44	26	surabaya	surabaya	PROPN
easat-3113	44	27	,	,	PUNCT
easat-3113	44	28	who	who	PRON
easat-3113	44	29	underwent	undergo	VERB
easat-3113	44	30	treatment	treatment	NOUN
easat-3113	44	31	with	with	ADP
easat-3113	44	32	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	44	33	acid	acid	NOUN
easat-3113	44	34	from	from	ADP
easat-3113	44	35	2020	2020	NUM
easat-3113	44	36	to	to	ADP
easat-3113	44	37	2023	2023	NUM
easat-3113	44	38	.	.	PUNCT
easat-3113	45	1	the	the	DET
easat-3113	45	2	participants	participant	NOUN
easat-3113	45	3	in	in	ADP
easat-3113	45	4	this	this	DET
easat-3113	45	5	study	study	NOUN
easat-3113	45	6	consisted	consist	VERB
easat-3113	45	7	of	of	ADP
easat-3113	45	8	individuals	individual	NOUN
easat-3113	45	9	who	who	PRON
easat-3113	45	10	fulfilled	fulfil	VERB
easat-3113	45	11	the	the	DET
easat-3113	45	12	specified	specify	VERB
easat-3113	45	13	inclusion	inclusion	NOUN
easat-3113	45	14	and	and	CCONJ
easat-3113	45	15	exclusion	exclusion	NOUN
easat-3113	45	16	criteria	criterion	NOUN
easat-3113	45	17	.	.	PUNCT
easat-3113	46	1	the	the	DET
easat-3113	46	2	study	study	NOUN
easat-3113	46	3	's	's	PART
easat-3113	46	4	inclusion	inclusion	NOUN
easat-3113	46	5	criteria	criterion	NOUN
easat-3113	46	6	consisted	consist	VERB
easat-3113	46	7	of	of	ADP
easat-3113	46	8	patients	patient	NOUN
easat-3113	46	9	aged	age	VERB
easat-3113	46	10	1	1	NUM
easat-3113	46	11	-	-	SYM
easat-3113	46	12	12	12	NUM
easat-3113	46	13	months	month	NOUN
easat-3113	46	14	,	,	PUNCT
easat-3113	46	15	diagnosed	diagnose	VERB
easat-3113	46	16	with	with	ADP
easat-3113	46	17	cholestasis	cholestasis	NOUN
easat-3113	46	18	(	(	PUNCT
easat-3113	46	19	direct	direct	ADJ
easat-3113	46	20	/	/	SYM
easat-3113	46	21	conjugated	conjugate	VERB
easat-3113	46	22	bilirubin	bilirubin	NOUN
easat-3113	46	23	>	>	PROPN
easat-3113	46	24	1mg	1mg	PROPN
easat-3113	46	25	/	/	SYM
easat-3113	46	26	dl	dl	PROPN
easat-3113	46	27	or	or	CCONJ
easat-3113	46	28	>	>	ADP
easat-3113	46	29	17mmol	17mmol	NUM
easat-3113	46	30	/	/	SYM
easat-3113	46	31	l	l	NOUN
easat-3113	46	32	)	)	PUNCT
easat-3113	46	33	prior	prior	ADV
easat-3113	46	34	to	to	ADP
easat-3113	46	35	starting	start	VERB
easat-3113	46	36	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	46	37	acid	acid	PROPN
easat-3113	46	38	treatment	treatment	NOUN
easat-3113	46	39	.	.	PUNCT
easat-3113	47	1	participants	participant	NOUN
easat-3113	47	2	had	have	VERB
easat-3113	47	3	to	to	PART
easat-3113	47	4	have	have	AUX
easat-3113	47	5	received	receive	VERB
easat-3113	47	6	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	47	7	acid	acid	NOUN
easat-3113	47	8	at	at	ADP
easat-3113	47	9	a	a	DET
easat-3113	47	10	dosage	dosage	NOUN
easat-3113	47	11	of	of	ADP
easat-3113	47	12	10	10	NUM
easat-3113	47	13	mg	mg	PROPN
easat-3113	47	14	/	/	SYM
easat-3113	47	15	kgbw	kgbw	PROPN
easat-3113	47	16	/	/	SYM
easat-3113	47	17	day	day	NOUN
easat-3113	47	18	,	,	PUNCT
easat-3113	47	19	divided	divide	VERB
easat-3113	47	20	into	into	ADP
easat-3113	47	21	three	three	NUM
easat-3113	47	22	doses	dose	NOUN
easat-3113	47	23	,	,	PUNCT
easat-3113	47	24	for	for	ADP
easat-3113	47	25	a	a	DET
easat-3113	47	26	minimum	minimum	NOUN
easat-3113	47	27	of	of	ADP
easat-3113	47	28	14	14	NUM
easat-3113	47	29	days	day	NOUN
easat-3113	47	30	.	.	PUNCT
easat-3113	48	1	the	the	DET
easat-3113	48	2	drug	drug	NOUN
easat-3113	48	3	was	be	AUX
easat-3113	48	4	prescribed	prescribe	VERB
easat-3113	48	5	by	by	ADP
easat-3113	48	6	the	the	DET
easat-3113	48	7	pharmacy	pharmacy	NOUN
easat-3113	48	8	installation	installation	NOUN
easat-3113	48	9	of	of	ADP
easat-3113	48	10	dr	dr	PROPN
easat-3113	48	11	.	.	PROPN
easat-3113	48	12	soetomo	soetomo	PROPN
easat-3113	48	13	hospital	hospital	PROPN
easat-3113	48	14	.	.	PUNCT
easat-3113	49	1	additionally	additionally	ADV
easat-3113	49	2	,	,	PUNCT
easat-3113	49	3	there	there	PRON
easat-3113	49	4	was	be	VERB
easat-3113	49	5	a	a	DET
easat-3113	49	6	requirement	requirement	NOUN
easat-3113	49	7	for	for	ADP
easat-3113	49	8	data	datum	NOUN
easat-3113	49	9	on	on	ADP
easat-3113	49	10	total	total	ADJ
easat-3113	49	11	bilirubin	bilirubin	NOUN
easat-3113	49	12	levels	level	NOUN
easat-3113	49	13	,	,	PUNCT
easat-3113	49	14	direct	direct	ADJ
easat-3113	49	15	bilirubin	bilirubin	NOUN
easat-3113	49	16	,	,	PUNCT
easat-3113	49	17	ast	ast	NOUN
easat-3113	49	18	,	,	PUNCT
easat-3113	49	19	and	and	CCONJ
easat-3113	49	20	alt	alt	VERB
easat-3113	49	21	to	to	PART
easat-3113	49	22	be	be	AUX
easat-3113	49	23	available	available	ADJ
easat-3113	49	24	both	both	CCONJ
easat-3113	49	25	before	before	ADP
easat-3113	49	26	and	and	CCONJ
easat-3113	49	27	after	after	ADP
easat-3113	49	28	the	the	DET
easat-3113	49	29	administration	administration	NOUN
easat-3113	49	30	of	of	ADP
easat-3113	49	31	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	49	32	acid	acid	PROPN
easat-3113	49	33	.	.	PUNCT
easat-3113	50	1	laboratory	laboratory	NOUN
easat-3113	50	2	examinations	examination	NOUN
easat-3113	50	3	were	be	AUX
easat-3113	50	4	conducted	conduct	VERB
easat-3113	50	5	at	at	ADP
easat-3113	50	6	the	the	DET
easat-3113	50	7	pathology	pathology	NOUN
easat-3113	50	8	clinic	clinic	NOUN
easat-3113	50	9	installation	installation	NOUN
easat-3113	50	10	of	of	ADP
easat-3113	50	11	dr	dr	PROPN
easat-3113	50	12	.	.	PROPN
easat-3113	50	13	soetomo	soetomo	PROPN
easat-3113	50	14	general	general	ADJ
easat-3113	50	15	hospital	hospital	NOUN
easat-3113	50	16	.	.	PUNCT
easat-3113	51	1	analysis	analysis	NOUN
easat-3113	51	2	of	of	ADP
easat-3113	51	3	liver	liver	NOUN
easat-3113	51	4	biopsy	biopsy	NOUN
easat-3113	51	5	performed	perform	VERB
easat-3113	51	6	at	at	ADP
easat-3113	51	7	the	the	DET
easat-3113	51	8	clinical	clinical	ADJ
easat-3113	51	9	pathology	pathology	NOUN
easat-3113	51	10	department	department	PROPN
easat-3113	51	11	of	of	ADP
easat-3113	51	12	dr	dr	PROPN
easat-3113	51	13	.	.	PROPN
easat-3113	51	14	soetomo	soetomo	PROPN
easat-3113	51	15	general	general	ADJ
easat-3113	51	16	hospital	hospital	NOUN
easat-3113	51	17	.	.	PUNCT
easat-3113	52	1	the	the	DET
easat-3113	52	2	criteria	criterion	NOUN
easat-3113	52	3	for	for	ADP
easat-3113	52	4	exclusion	exclusion	NOUN
easat-3113	52	5	in	in	ADP
easat-3113	52	6	this	this	DET
easat-3113	52	7	study	study	NOUN
easat-3113	52	8	included	include	VERB
easat-3113	52	9	patients	patient	NOUN
easat-3113	52	10	with	with	ADP
easat-3113	52	11	incomplete	incomplete	ADJ
easat-3113	52	12	medical	medical	ADJ
easat-3113	52	13	records	record	NOUN
easat-3113	52	14	,	,	PUNCT
easat-3113	52	15	individuals	individual	NOUN
easat-3113	52	16	whose	whose	DET
easat-3113	52	17	alt	alt	ADJ
easat-3113	52	18	,	,	PUNCT
easat-3113	52	19	ast	ast	ADJ
easat-3113	52	20	,	,	PUNCT
easat-3113	52	21	total	total	ADJ
easat-3113	52	22	and	and	CCONJ
easat-3113	52	23	direct	direct	ADJ
easat-3113	52	24	bilirubin	bilirubin	NOUN
easat-3113	52	25	data	datum	NOUN
easat-3113	52	26	were	be	AUX
easat-3113	52	27	collected	collect	VERB
easat-3113	52	28	at	at	ADP
easat-3113	52	29	varying	vary	VERB
easat-3113	52	30	times	time	NOUN
easat-3113	52	31	,	,	PUNCT
easat-3113	52	32	and	and	CCONJ
easat-3113	52	33	those	those	PRON
easat-3113	52	34	identified	identify	VERB
easat-3113	52	35	as	as	ADP
easat-3113	52	36	extreme	extreme	ADJ
easat-3113	52	37	outliers	outlier	NOUN
easat-3113	52	38	.	.	PUNCT
easat-3113	53	1	the	the	DET
easat-3113	53	2	study	study	NOUN
easat-3113	53	3	employed	employ	VERB
easat-3113	53	4	a	a	DET
easat-3113	53	5	total	total	ADJ
easat-3113	53	6	sampling	sampling	NOUN
easat-3113	53	7	method	method	NOUN
easat-3113	53	8	utilizing	utilize	VERB
easat-3113	53	9	a	a	DET
easat-3113	53	10	non	non	ADJ
easat-3113	53	11	-	-	ADJ
easat-3113	53	12	random	random	ADJ
easat-3113	53	13	sampling	sampling	NOUN
easat-3113	53	14	technique	technique	NOUN
easat-3113	53	15	,	,	PUNCT
easat-3113	53	16	encompassing	encompass	VERB
easat-3113	53	17	all	all	DET
easat-3113	53	18	subjects	subject	NOUN
easat-3113	53	19	who	who	PRON
easat-3113	53	20	satisfied	satisfy	VERB
easat-3113	53	21	the	the	DET
easat-3113	53	22	inclusion	inclusion	NOUN
easat-3113	53	23	and	and	CCONJ
easat-3113	53	24	exclusion	exclusion	NOUN
easat-3113	53	25	criteria	criterion	NOUN
easat-3113	53	26	.	.	PUNCT
easat-3113	54	1	the	the	DET
easat-3113	54	2	sample	sample	NOUN
easat-3113	54	3	was	be	AUX
easat-3113	54	4	categorized	categorize	VERB
easat-3113	54	5	into	into	ADP
easat-3113	54	6	two	two	NUM
easat-3113	54	7	study	study	NOUN
easat-3113	54	8	groups	group	NOUN
easat-3113	54	9	according	accord	VERB
easat-3113	54	10	to	to	ADP
easat-3113	54	11	liver	liver	NOUN
easat-3113	54	12	biopsy	biopsy	NOUN
easat-3113	54	13	results	result	NOUN
easat-3113	54	14	:	:	PUNCT
easat-3113	54	15	normal	normal	ADJ
easat-3113	54	16	(	(	PUNCT
easat-3113	54	17	group	group	NOUN
easat-3113	54	18	1	1	NUM
easat-3113	54	19	)	)	PUNCT
easat-3113	54	20	and	and	CCONJ
easat-3113	54	21	abnormal	abnormal	ADJ
easat-3113	54	22	findings	finding	NOUN
easat-3113	54	23	(	(	PUNCT
easat-3113	54	24	group	group	NOUN
easat-3113	54	25	2	2	NUM
easat-3113	54	26	)	)	PUNCT
easat-3113	54	27	.	.	PUNCT
easat-3113	55	1	secondary	secondary	ADJ
easat-3113	55	2	data	datum	NOUN
easat-3113	55	3	were	be	AUX
easat-3113	55	4	obtained	obtain	VERB
easat-3113	55	5	from	from	ADP
easat-3113	55	6	medical	medical	ADJ
easat-3113	55	7	record	record	NOUN
easat-3113	55	8	books	book	NOUN
easat-3113	55	9	and	and	CCONJ
easat-3113	55	10	electronic	electronic	ADJ
easat-3113	55	11	medical	medical	ADJ
easat-3113	55	12	records	record	NOUN
easat-3113	55	13	(	(	PUNCT
easat-3113	55	14	emr	emr	PROPN
easat-3113	55	15	)	)	PUNCT
easat-3113	55	16	.	.	PUNCT
easat-3113	56	1	the	the	DET
easat-3113	56	2	collected	collect	VERB
easat-3113	56	3	data	datum	NOUN
easat-3113	56	4	underwent	underwent	NOUN
easat-3113	56	5	examination	examination	NOUN
easat-3113	56	6	,	,	PUNCT
easat-3113	56	7	validation	validation	NOUN
easat-3113	56	8	,	,	PUNCT
easat-3113	56	9	coding	coding	NOUN
easat-3113	56	10	,	,	PUNCT
easat-3113	56	11	recapitulation	recapitulation	NOUN
easat-3113	56	12	,	,	PUNCT
easat-3113	56	13	and	and	CCONJ
easat-3113	56	14	tabulation	tabulation	NOUN
easat-3113	56	15	,	,	PUNCT
easat-3113	56	16	followed	follow	VERB
easat-3113	56	17	by	by	ADP
easat-3113	56	18	appropriate	appropriate	ADJ
easat-3113	56	19	statistical	statistical	ADJ
easat-3113	56	20	analysis	analysis	NOUN
easat-3113	56	21	.	.	PUNCT
easat-3113	57	1	descriptive	descriptive	ADJ
easat-3113	57	2	analysis	analysis	NOUN
easat-3113	57	3	was	be	AUX
easat-3113	57	4	employed	employ	VERB
easat-3113	57	5	to	to	PART
easat-3113	57	6	ascertain	ascertain	VERB
easat-3113	57	7	the	the	DET
easat-3113	57	8	characteristics	characteristic	NOUN
easat-3113	57	9	of	of	ADP
easat-3113	57	10	the	the	DET
easat-3113	57	11	study	study	NOUN
easat-3113	57	12	subjects	subject	NOUN
easat-3113	57	13	,	,	PUNCT
easat-3113	57	14	including	include	VERB
easat-3113	57	15	age	age	NOUN
easat-3113	57	16	,	,	PUNCT
easat-3113	57	17	gender	gender	NOUN
easat-3113	57	18	,	,	PUNCT
easat-3113	57	19	weight	weight	NOUN
easat-3113	57	20	,	,	PUNCT
easat-3113	57	21	height	height	NOUN
easat-3113	57	22	,	,	PUNCT
easat-3113	57	23	total	total	ADJ
easat-3113	57	24	bilirubin	bilirubin	NOUN
easat-3113	57	25	levels	level	NOUN
easat-3113	57	26	,	,	PUNCT
easat-3113	57	27	direct	direct	ADJ
easat-3113	57	28	bilirubin	bilirubin	NOUN
easat-3113	57	29	,	,	PUNCT
easat-3113	57	30	ast	ast	NOUN
easat-3113	57	31	,	,	PUNCT
easat-3113	57	32	and	and	CCONJ
easat-3113	57	33	alt	alt	ADJ
easat-3113	57	34	.	.	PUNCT
easat-3113	58	1	the	the	DET
easat-3113	58	2	shapiro	shapiro	PROPN
easat-3113	58	3	-	-	PUNCT
easat-3113	58	4	wilk	wilk	NOUN
easat-3113	58	5	test	test	NOUN
easat-3113	58	6	was	be	AUX
easat-3113	58	7	employed	employ	VERB
easat-3113	58	8	to	to	PART
easat-3113	58	9	assess	assess	VERB
easat-3113	58	10	the	the	DET
easat-3113	58	11	normality	normality	NOUN
easat-3113	58	12	of	of	ADP
easat-3113	58	13	each	each	DET
easat-3113	58	14	study	study	NOUN
easat-3113	58	15	variable	variable	NOUN
easat-3113	58	16	.	.	PUNCT
easat-3113	59	1	a	a	DET
easat-3113	59	2	paired	pair	VERB
easat-3113	59	3	ttest	ttest	NOUN
easat-3113	59	4	was	be	AUX
easat-3113	59	5	conducted	conduct	VERB
easat-3113	59	6	when	when	SCONJ
easat-3113	59	7	normal	normal	ADJ
easat-3113	59	8	results	result	NOUN
easat-3113	59	9	were	be	AUX
easat-3113	59	10	obtained	obtain	VERB
easat-3113	59	11	(	(	PUNCT
easat-3113	59	12	p>0.05	p>0.05	NOUN
easat-3113	59	13	)	)	PUNCT
easat-3113	59	14	.	.	PUNCT
easat-3113	60	1	in	in	ADP
easat-3113	60	2	cases	case	NOUN
easat-3113	60	3	where	where	SCONJ
easat-3113	60	4	the	the	DET
easat-3113	60	5	results	result	NOUN
easat-3113	60	6	are	be	AUX
easat-3113	60	7	abnormal	abnormal	ADJ
easat-3113	60	8	(	(	PUNCT
easat-3113	60	9	p<0.05	p<0.05	NOUN
easat-3113	60	10	)	)	PUNCT
easat-3113	60	11	,	,	PUNCT
easat-3113	60	12	a	a	DET
easat-3113	60	13	difference	difference	NOUN
easat-3113	60	14	test	test	NOUN
easat-3113	60	15	will	will	AUX
easat-3113	60	16	be	be	AUX
easat-3113	60	17	conducted	conduct	VERB
easat-3113	60	18	using	use	VERB
easat-3113	60	19	the	the	DET
easat-3113	60	20	wilcoxon	wilcoxon	ADJ
easat-3113	60	21	test	test	NOUN
easat-3113	60	22	.	.	PUNCT
easat-3113	61	1	the	the	DET
easat-3113	61	2	difference	difference	NOUN
easat-3113	61	3	in	in	ADP
easat-3113	61	4	ast	ast	NOUN
easat-3113	61	5	,	,	PUNCT
easat-3113	61	6	alt	alt	ADJ
easat-3113	61	7	,	,	PUNCT
easat-3113	61	8	total	total	ADJ
easat-3113	61	9	,	,	PUNCT
easat-3113	61	10	and	and	CCONJ
easat-3113	61	11	direct	direct	ADJ
easat-3113	61	12	bilirubin	bilirubin	NOUN
easat-3113	61	13	values	value	NOUN
easat-3113	61	14	was	be	AUX
easat-3113	61	15	calculated	calculate	VERB
easat-3113	61	16	for	for	ADP
easat-3113	61	17	each	each	DET
easat-3113	61	18	sample	sample	NOUN
easat-3113	61	19	before	before	ADV
easat-3113	61	20	and	and	CCONJ
easat-3113	61	21	after	after	ADP
easat-3113	61	22	the	the	DET
easat-3113	61	23	administration	administration	NOUN
easat-3113	61	24	of	of	ADP
easat-3113	61	25	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	61	26	acid	acid	PROPN
easat-3113	61	27	.	.	PUNCT
easat-3113	62	1	subsequently	subsequently	ADV
easat-3113	62	2	,	,	PUNCT
easat-3113	62	3	comparison	comparison	NOUN
easat-3113	62	4	tests	test	VERB
easat-3113	62	5	for	for	ADP
easat-3113	62	6	the	the	DET
easat-3113	62	7	differences	difference	NOUN
easat-3113	62	8	in	in	ADP
easat-3113	62	9	mean	mean	ADJ
easat-3113	62	10	levels	level	NOUN
easat-3113	62	11	of	of	ADP
easat-3113	62	12	ast	ast	NOUN
easat-3113	62	13	,	,	PUNCT
easat-3113	62	14	alt	alt	ADJ
easat-3113	62	15	,	,	PUNCT
easat-3113	62	16	total	total	ADJ
easat-3113	62	17	bilirubin	bilirubin	NOUN
easat-3113	62	18	,	,	PUNCT
easat-3113	62	19	and	and	CCONJ
easat-3113	62	20	direct	direct	ADJ
easat-3113	62	21	bilirubin	bilirubin	NOUN
easat-3113	62	22	between	between	ADP
easat-3113	62	23	groups	group	NOUN
easat-3113	62	24	were	be	AUX
easat-3113	62	25	conducted	conduct	VERB
easat-3113	62	26	using	use	VERB
easat-3113	62	27	the	the	DET
easat-3113	62	28	unpaired	unpaired	ADJ
easat-3113	62	29	t	t	NOUN
easat-3113	62	30	-	-	PUNCT
easat-3113	62	31	test	test	NOUN
easat-3113	62	32	for	for	ADP
easat-3113	62	33	normal	normal	ADJ
easat-3113	62	34	distribution	distribution	NOUN
easat-3113	62	35	or	or	CCONJ
easat-3113	62	36	the	the	DET
easat-3113	62	37	mann	mann	PROPN
easat-3113	62	38	-	-	PUNCT
easat-3113	62	39	whitney	whitney	PROPN
easat-3113	62	40	test	test	NOUN
easat-3113	62	41	for	for	ADP
easat-3113	62	42	abnormal	abnormal	ADJ
easat-3113	62	43	distribution	distribution	NOUN
easat-3113	62	44	.	.	PUNCT
easat-3113	63	1	the	the	DET
easat-3113	63	2	analysis	analysis	NOUN
easat-3113	63	3	yielded	yield	VERB
easat-3113	63	4	significant	significant	ADJ
easat-3113	63	5	results	result	NOUN
easat-3113	63	6	with	with	ADP
easat-3113	63	7	p<0.05	p<0.05	NOUN
easat-3113	63	8	.	.	PUNCT
easat-3113	64	1	before	before	SCONJ
easat-3113	64	2	the	the	DET
easat-3113	64	3	study	study	NOUN
easat-3113	64	4	was	be	AUX
easat-3113	64	5	conducted	conduct	VERB
easat-3113	64	6	,	,	PUNCT
easat-3113	64	7	the	the	DET
easat-3113	64	8	researcher	researcher	NOUN
easat-3113	64	9	submitted	submit	VERB
easat-3113	64	10	a	a	DET
easat-3113	64	11	research	research	NOUN
easat-3113	64	12	ethics	ethic	NOUN
easat-3113	64	13	from	from	ADP
easat-3113	64	14	the	the	DET
easat-3113	64	15	research	research	NOUN
easat-3113	64	16	ethics	ethic	NOUN
easat-3113	64	17	commission	commission	PROPN
easat-3113	64	18	of	of	ADP
easat-3113	64	19	dr	dr	PROPN
easat-3113	64	20	.	.	PROPN
easat-3113	64	21	soetomo	soetomo	PROPN
easat-3113	64	22	hospital	hospital	PROPN
easat-3113	64	23	.	.	PUNCT
easat-3113	65	1	the	the	DET
easat-3113	65	2	researcher	researcher	NOUN
easat-3113	65	3	had	have	AUX
easat-3113	65	4	obtained	obtain	VERB
easat-3113	65	5	approval	approval	NOUN
easat-3113	65	6	,	,	PUNCT
easat-3113	65	7	with	with	ADP
easat-3113	65	8	a	a	DET
easat-3113	65	9	registration	registration	NOUN
easat-3113	65	10	number	number	NOUN
easat-3113	65	11	:	:	PUNCT
easat-3113	65	12	1556	1556	NUM
easat-3113	65	13	/	/	SYM
easat-3113	65	14	loe/301.4.2	loe/301.4.2	PROPN
easat-3113	65	15	/	/	SYM
easat-3113	65	16	xii/2023	xii/2023	PROPN
easat-3113	65	17	.	.	PROPN
easat-3113	66	1	5077	5077	NUM
easat-3113	66	2	edelweiss	edelweiss	PROPN
easat-3113	66	3	applied	apply	VERB
easat-3113	66	4	science	science	NOUN
easat-3113	66	5	and	and	CCONJ
easat-3113	66	6	technology	technology	NOUN
easat-3113	66	7	issn	issn	PROPN
easat-3113	66	8	:	:	PUNCT
easat-3113	66	9	2576	2576	NUM
easat-3113	66	10	-	-	SYM
easat-3113	66	11	8484	8484	NUM
easat-3113	66	12	vol	vol	NOUN
easat-3113	66	13	.	.	PROPN
easat-3113	66	14	8	8	NUM
easat-3113	66	15	,	,	PUNCT
easat-3113	66	16	no	no	INTJ
easat-3113	66	17	.	.	NOUN
easat-3113	67	1	6	6	NUM
easat-3113	67	2	:	:	PUNCT
easat-3113	67	3	5075	5075	NUM
easat-3113	67	4	-	-	SYM
easat-3113	67	5	5081	5081	NUM
easat-3113	67	6	,	,	PUNCT
easat-3113	67	7	2024	2024	NUM
easat-3113	67	8	doi	doi	NOUN
easat-3113	67	9	:	:	PUNCT
easat-3113	67	10	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	67	11	©	©	PROPN
easat-3113	67	12	2024	2024	NUM
easat-3113	67	13	by	by	ADP
easat-3113	67	14	the	the	DET
easat-3113	67	15	authors	author	NOUN
easat-3113	67	16	;	;	PUNCT
easat-3113	67	17	licensee	licensee	PROPN
easat-3113	67	18	learning	learning	NOUN
easat-3113	67	19	gate	gate	NOUN
easat-3113	67	20	3	3	PROPN
easat-3113	67	21	.	.	PUNCT
easat-3113	67	22	results	result	VERB
easat-3113	67	23	this	this	DET
easat-3113	67	24	research	research	NOUN
easat-3113	67	25	involved	involve	VERB
easat-3113	67	26	a	a	DET
easat-3113	67	27	total	total	NOUN
easat-3113	67	28	of	of	ADP
easat-3113	67	29	65	65	NUM
easat-3113	67	30	infant	infant	NOUN
easat-3113	67	31	.	.	PUNCT
easat-3113	68	1	one	one	NUM
easat-3113	68	2	patient	patient	NOUN
easat-3113	68	3	was	be	AUX
easat-3113	68	4	removed	remove	VERB
easat-3113	68	5	due	due	ADP
easat-3113	68	6	to	to	ADP
easat-3113	68	7	an	an	DET
easat-3113	68	8	outlier	outlier	NOUN
easat-3113	68	9	,	,	PUNCT
easat-3113	68	10	notably	notably	ADV
easat-3113	68	11	an	an	DET
easat-3113	68	12	alt	alt	ADJ
easat-3113	68	13	level	level	NOUN
easat-3113	68	14	beyond	beyond	ADP
easat-3113	68	15	1000	1000	NUM
easat-3113	68	16	u	u	NOUN
easat-3113	68	17	/	/	SYM
easat-3113	68	18	l.	l.	PROPN
easat-3113	68	19	a	a	DET
easat-3113	68	20	total	total	NOUN
easat-3113	68	21	of	of	ADP
easat-3113	68	22	64	64	NUM
easat-3113	68	23	youngsters	youngster	NOUN
easat-3113	68	24	were	be	AUX
easat-3113	68	25	incorporated	incorporate	VERB
easat-3113	68	26	in	in	ADP
easat-3113	68	27	the	the	DET
easat-3113	68	28	final	final	ADJ
easat-3113	68	29	analysis	analysis	NOUN
easat-3113	68	30	.	.	PUNCT
easat-3113	69	1	the	the	DET
easat-3113	69	2	study	study	NOUN
easat-3113	69	3	participants	participant	NOUN
easat-3113	69	4	were	be	AUX
easat-3113	69	5	subsequently	subsequently	ADV
easat-3113	69	6	categorized	categorize	VERB
easat-3113	69	7	into	into	ADP
easat-3113	69	8	two	two	NUM
easat-3113	69	9	groups	group	NOUN
easat-3113	69	10	based	base	VERB
easat-3113	69	11	on	on	ADP
easat-3113	69	12	the	the	DET
easat-3113	69	13	liver	liver	NOUN
easat-3113	69	14	biopsy	biopsy	NOUN
easat-3113	69	15	funding	funding	PROPN
easat-3113	69	16	.	.	PUNCT
easat-3113	70	1	data	datum	NOUN
easat-3113	70	2	distribution	distribution	NOUN
easat-3113	70	3	tests	test	NOUN
easat-3113	70	4	were	be	AUX
easat-3113	70	5	performed	perform	VERB
easat-3113	70	6	using	use	VERB
easat-3113	70	7	shapiro	shapiro	PROPN
easat-3113	70	8	-	-	PUNCT
easat-3113	70	9	wilk	wilk	NOUN
easat-3113	70	10	in	in	ADP
easat-3113	70	11	both	both	DET
easat-3113	70	12	groups	group	NOUN
easat-3113	70	13	.	.	PUNCT
easat-3113	71	1	most	most	ADJ
easat-3113	71	2	of	of	ADP
easat-3113	71	3	the	the	DET
easat-3113	71	4	parameters	parameter	NOUN
easat-3113	71	5	in	in	ADP
easat-3113	71	6	this	this	DET
easat-3113	71	7	study	study	NOUN
easat-3113	71	8	had	have	VERB
easat-3113	71	9	normal	normal	ADJ
easat-3113	71	10	distribution	distribution	NOUN
easat-3113	71	11	.	.	PUNCT
easat-3113	72	1	continuous	continuous	ADJ
easat-3113	72	2	data	datum	NOUN
easat-3113	72	3	are	be	AUX
easat-3113	72	4	expressed	express	VERB
easat-3113	72	5	as	as	ADP
easat-3113	72	6	mean	mean	NOUN
easat-3113	72	7	±	±	NUM
easat-3113	72	8	standard	standard	ADJ
easat-3113	72	9	deviation	deviation	NOUN
easat-3113	72	10	for	for	ADP
easat-3113	72	11	data	datum	NOUN
easat-3113	72	12	that	that	PRON
easat-3113	72	13	follow	follow	VERB
easat-3113	72	14	a	a	DET
easat-3113	72	15	normal	normal	ADJ
easat-3113	72	16	distribution	distribution	NOUN
easat-3113	72	17	,	,	PUNCT
easat-3113	72	18	or	or	CCONJ
easat-3113	72	19	as	as	ADP
easat-3113	72	20	median	median	NOUN
easat-3113	72	21	(	(	PUNCT
easat-3113	72	22	minimum	minimum	NOUN
easat-3113	72	23	value	value	NOUN
easat-3113	72	24	-	-	PUNCT
easat-3113	72	25	maximum	maximum	NOUN
easat-3113	72	26	value	value	NOUN
easat-3113	72	27	)	)	PUNCT
easat-3113	72	28	for	for	ADP
easat-3113	72	29	data	datum	NOUN
easat-3113	72	30	that	that	PRON
easat-3113	72	31	do	do	AUX
easat-3113	72	32	not	not	PART
easat-3113	72	33	conform	conform	VERB
easat-3113	72	34	to	to	ADP
easat-3113	72	35	a	a	DET
easat-3113	72	36	normal	normal	ADJ
easat-3113	72	37	distribution	distribution	NOUN
easat-3113	72	38	.	.	PUNCT
easat-3113	73	1	an	an	DET
easat-3113	73	2	unpaired	unpaired	ADJ
easat-3113	73	3	comparison	comparison	NOUN
easat-3113	73	4	test	test	NOUN
easat-3113	73	5	was	be	AUX
easat-3113	73	6	conducted	conduct	VERB
easat-3113	73	7	between	between	ADP
easat-3113	73	8	groups	group	NOUN
easat-3113	73	9	utilizing	utilize	VERB
easat-3113	73	10	the	the	DET
easat-3113	73	11	mann	mann	PROPN
easat-3113	73	12	whitney	whitney	PROPN
easat-3113	73	13	test	test	NOUN
easat-3113	73	14	,	,	PUNCT
easat-3113	73	15	revealing	reveal	VERB
easat-3113	73	16	that	that	SCONJ
easat-3113	73	17	significant	significant	ADJ
easat-3113	73	18	differences	difference	NOUN
easat-3113	73	19	were	be	AUX
easat-3113	73	20	observed	observe	VERB
easat-3113	73	21	solely	solely	ADV
easat-3113	73	22	in	in	ADP
easat-3113	73	23	the	the	DET
easat-3113	73	24	parameters	parameter	NOUN
easat-3113	73	25	concerning	concern	VERB
easat-3113	73	26	the	the	DET
easat-3113	73	27	age	age	NOUN
easat-3113	73	28	of	of	ADP
easat-3113	73	29	drug	drug	NOUN
easat-3113	73	30	administration	administration	PROPN
easat-3113	73	31	(	(	PUNCT
easat-3113	73	32	table	table	NOUN
easat-3113	73	33	1	1	NUM
easat-3113	73	34	)	)	PUNCT
easat-3113	73	35	.	.	PUNCT
easat-3113	74	1	table	table	NOUN
easat-3113	74	2	1	1	NUM
easat-3113	74	3	.	.	PUNCT
easat-3113	75	1	study	study	PROPN
easat-3113	75	2	subject	subject	ADJ
easat-3113	75	3	characteristics	characteristic	NOUN
easat-3113	75	4	.	.	PUNCT
easat-3113	76	1	variable	variable	ADJ
easat-3113	76	2	liver	liver	NOUN
easat-3113	76	3	biopsy	biopsy	NOUN
easat-3113	76	4	p	p	PROPN
easat-3113	76	5	group	group	NOUN
easat-3113	76	6	1	1	NUM
easat-3113	76	7	(	(	PUNCT
easat-3113	76	8	n=15	n=15	NUM
easat-3113	76	9	)	)	PUNCT
easat-3113	76	10	group	group	NOUN
easat-3113	76	11	2	2	NUM
easat-3113	76	12	(	(	PUNCT
easat-3113	76	13	n=49	n=49	NUM
easat-3113	76	14	)	)	PUNCT
easat-3113	76	15	gender	gender	NOUN
easat-3113	76	16	,	,	PUNCT
easat-3113	76	17	n	n	CCONJ
easat-3113	76	18	(	(	PUNCT
easat-3113	76	19	%	%	INTJ
easat-3113	76	20	)	)	PUNCT
easat-3113	76	21	male	male	NOUN
easat-3113	76	22	9	9	NUM
easat-3113	76	23	(	(	PUNCT
easat-3113	76	24	28.1	28.1	NUM
easat-3113	76	25	)	)	PUNCT
easat-3113	76	26	23	23	NUM
easat-3113	76	27	(	(	PUNCT
easat-3113	76	28	71.9	71.9	NUM
easat-3113	76	29	)	)	PUNCT
easat-3113	76	30	0.555	0.555	NUM
easat-3113	76	31	female	female	NOUN
easat-3113	76	32	6	6	NUM
easat-3113	76	33	(	(	PUNCT
easat-3113	76	34	18.8	18.8	NUM
easat-3113	76	35	)	)	PUNCT
easat-3113	76	36	26	26	NUM
easat-3113	76	37	(	(	PUNCT
easat-3113	76	38	81.3	81.3	NUM
easat-3113	76	39	)	)	PUNCT
easat-3113	76	40	age	age	NOUN
easat-3113	76	41	on	on	ADP
easat-3113	76	42	drug	drug	NOUN
easat-3113	76	43	administration	administration	NOUN
easat-3113	76	44	(	(	PUNCT
easat-3113	76	45	months	month	NOUN
easat-3113	76	46	)	)	PUNCT
easat-3113	76	47	2	2	NUM
easat-3113	76	48	(	(	PUNCT
easat-3113	76	49	1	1	NUM
easat-3113	76	50	-	-	SYM
easat-3113	76	51	5	5	NUM
easat-3113	76	52	)	)	PUNCT
easat-3113	76	53	2	2	NUM
easat-3113	76	54	(	(	PUNCT
easat-3113	76	55	1	1	NUM
easat-3113	76	56	-	-	SYM
easat-3113	76	57	9	9	NUM
easat-3113	76	58	)	)	PUNCT
easat-3113	76	59	0.003	0.003	NUM
easat-3113	76	60	*	*	NOUN
easat-3113	76	61	body	body	NOUN
easat-3113	76	62	weight	weight	NOUN
easat-3113	76	63	(	(	PUNCT
easat-3113	76	64	kg	kg	NOUN
easat-3113	76	65	)	)	PUNCT
easat-3113	76	66	5	5	NUM
easat-3113	76	67	(	(	PUNCT
easat-3113	76	68	±1.19	±1.19	NOUN
easat-3113	76	69	)	)	PUNCT
easat-3113	76	70	4.9	4.9	NUM
easat-3113	76	71	(	(	PUNCT
easat-3113	76	72	±0.97	±0.97	NOUN
easat-3113	76	73	)	)	PUNCT
easat-3113	76	74	0.592	0.592	NUM
easat-3113	76	75	body	body	NOUN
easat-3113	76	76	height	height	NOUN
easat-3113	76	77	(	(	PUNCT
easat-3113	76	78	cm	cm	NOUN
easat-3113	76	79	)	)	PUNCT
easat-3113	76	80	58.9	58.9	NUM
easat-3113	76	81	(	(	PUNCT
easat-3113	76	82	±6.1	±6.1	NOUN
easat-3113	76	83	)	)	PUNCT
easat-3113	76	84	59	59	NUM
easat-3113	76	85	(	(	PUNCT
easat-3113	76	86	45	45	NUM
easat-3113	76	87	-	-	SYM
easat-3113	76	88	81	81	NUM
easat-3113	76	89	)	)	PUNCT
easat-3113	76	90	0.656	0.656	NUM
easat-3113	76	91	before	before	ADP
easat-3113	76	92	treatment	treatment	NOUN
easat-3113	76	93	ast	ast	NOUN
easat-3113	76	94	(	(	PUNCT
easat-3113	76	95	u	u	NOUN
easat-3113	76	96	/	/	SYM
easat-3113	76	97	l	l	NOUN
easat-3113	76	98	)	)	PUNCT
easat-3113	76	99	229.7	229.7	NUM
easat-3113	76	100	(	(	PUNCT
easat-3113	76	101	±136.7	±136.7	PROPN
easat-3113	76	102	)	)	PUNCT
easat-3113	76	103	231	231	NUM
easat-3113	76	104	(	(	PUNCT
easat-3113	76	105	42	42	NUM
easat-3113	76	106	-	-	SYM
easat-3113	76	107	911	911	NUM
easat-3113	76	108	)	)	PUNCT
easat-3113	76	109	0.330	0.330	NUM
easat-3113	76	110	alt(u	alt(u	PROPN
easat-3113	76	111	/	/	SYM
easat-3113	76	112	l	l	NOUN
easat-3113	76	113	)	)	PUNCT
easat-3113	76	114	138	138	NUM
easat-3113	76	115	(	(	PUNCT
easat-3113	76	116	38	38	NUM
easat-3113	76	117	-	-	SYM
easat-3113	76	118	450	450	NUM
easat-3113	76	119	)	)	PUNCT
easat-3113	76	120	164	164	NUM
easat-3113	76	121	(	(	PUNCT
easat-3113	76	122	30	30	NUM
easat-3113	76	123	-	-	SYM
easat-3113	76	124	641	641	NUM
easat-3113	76	125	)	)	PUNCT
easat-3113	76	126	0.161	0.161	NUM
easat-3113	76	127	total	total	ADJ
easat-3113	76	128	bilirubin	bilirubin	NOUN
easat-3113	76	129	(	(	PUNCT
easat-3113	76	130	mg	mg	PROPN
easat-3113	76	131	/	/	SYM
easat-3113	76	132	dl	dl	PROPN
easat-3113	76	133	)	)	PUNCT
easat-3113	76	134	7.7	7.7	NUM
easat-3113	76	135	(	(	PUNCT
easat-3113	76	136	±3.34	±3.34	NOUN
easat-3113	76	137	)	)	PUNCT
easat-3113	76	138	8	8	NUM
easat-3113	76	139	(	(	PUNCT
easat-3113	76	140	±2.4	±2.4	NOUN
easat-3113	76	141	)	)	PUNCT
easat-3113	76	142	0.716	0.716	NUM
easat-3113	76	143	direct	direct	ADJ
easat-3113	76	144	bilirubin	bilirubin	NOUN
easat-3113	76	145	(	(	PUNCT
easat-3113	76	146	mg	mg	PROPN
easat-3113	76	147	/	/	SYM
easat-3113	76	148	dl	dl	NOUN
easat-3113	76	149	)	)	PUNCT
easat-3113	76	150	10.7	10.7	NUM
easat-3113	76	151	(	(	PUNCT
easat-3113	76	152	±4.9	±4.9	PROPN
easat-3113	76	153	)	)	PUNCT
easat-3113	76	154	10.8	10.8	NUM
easat-3113	76	155	(	(	PUNCT
easat-3113	76	156	±3.6	±3.6	PROPN
easat-3113	76	157	)	)	PUNCT
easat-3113	76	158	0.968	0.968	NUM
easat-3113	76	159	after	after	ADP
easat-3113	76	160	treatment	treatment	NOUN
easat-3113	76	161	ast	ast	NOUN
easat-3113	76	162	(	(	PUNCT
easat-3113	76	163	u	u	NOUN
easat-3113	76	164	/	/	SYM
easat-3113	76	165	l	l	NOUN
easat-3113	76	166	)	)	PUNCT
easat-3113	76	167	193.1	193.1	NUM
easat-3113	76	168	(	(	PUNCT
easat-3113	76	169	±129	±129	PROPN
easat-3113	76	170	)	)	PUNCT
easat-3113	76	171	221	221	NUM
easat-3113	76	172	(	(	PUNCT
easat-3113	76	173	6	6	NUM
easat-3113	76	174	-	-	SYM
easat-3113	76	175	658	658	NUM
easat-3113	76	176	)	)	PUNCT
easat-3113	76	177	0.296	0.296	NUM
easat-3113	76	178	alt(u	alt(u	PROPN
easat-3113	76	179	/	/	SYM
easat-3113	76	180	l	l	NOUN
easat-3113	76	181	)	)	PUNCT
easat-3113	76	182	208	208	NUM
easat-3113	76	183	(	(	PUNCT
easat-3113	76	184	66	66	NUM
easat-3113	76	185	-	-	SYM
easat-3113	76	186	932	932	NUM
easat-3113	76	187	)	)	PUNCT
easat-3113	76	188	259	259	NUM
easat-3113	76	189	(	(	PUNCT
easat-3113	76	190	6	6	NUM
easat-3113	76	191	-	-	SYM
easat-3113	76	192	925	925	NUM
easat-3113	76	193	)	)	PUNCT
easat-3113	76	194	0.769	0.769	NUM
easat-3113	76	195	total	total	ADJ
easat-3113	76	196	bilirubin	bilirubin	NOUN
easat-3113	76	197	(	(	PUNCT
easat-3113	76	198	mg	mg	PROPN
easat-3113	76	199	/	/	SYM
easat-3113	76	200	dl	dl	PROPN
easat-3113	76	201	)	)	PUNCT
easat-3113	76	202	4.9	4.9	NUM
easat-3113	76	203	(	(	PUNCT
easat-3113	76	204	±3.8	±3.8	NOUN
easat-3113	76	205	)	)	PUNCT
easat-3113	76	206	6.5	6.5	NUM
easat-3113	76	207	(	(	PUNCT
easat-3113	76	208	±3.8	±3.8	NOUN
easat-3113	76	209	)	)	PUNCT
easat-3113	76	210	0.157	0.157	NUM
easat-3113	76	211	direct	direct	ADJ
easat-3113	76	212	bilirubin	bilirubin	NOUN
easat-3113	76	213	(	(	PUNCT
easat-3113	76	214	mg	mg	PROPN
easat-3113	76	215	/	/	SYM
easat-3113	76	216	dl	dl	NOUN
easat-3113	76	217	)	)	PUNCT
easat-3113	76	218	6.7	6.7	NUM
easat-3113	76	219	(	(	PUNCT
easat-3113	76	220	±5.4	±5.4	PROPN
easat-3113	76	221	)	)	PUNCT
easat-3113	76	222	11.2	11.2	NUM
easat-3113	76	223	(	(	PUNCT
easat-3113	76	224	±19	±19	PROPN
easat-3113	76	225	)	)	PUNCT
easat-3113	76	226	0.187	0.187	NUM
easat-3113	76	227	note	note	NOUN
easat-3113	76	228	:	:	PUNCT
easat-3113	76	229	*	*	PUNCT
easat-3113	76	230	significant	significant	ADJ
easat-3113	76	231	result	result	NOUN
easat-3113	76	232	(	(	PUNCT
easat-3113	76	233	p<0.05	p<0.05	NOUN
easat-3113	76	234	)	)	PUNCT
easat-3113	76	235	.	.	PUNCT
easat-3113	77	1	table	table	NOUN
easat-3113	77	2	2	2	NUM
easat-3113	77	3	.	.	X
easat-3113	77	4	level	level	NOUN
easat-3113	77	5	of	of	ADP
easat-3113	77	6	biomarker	biomarker	NOUN
easat-3113	77	7	before	before	ADV
easat-3113	77	8	and	and	CCONJ
easat-3113	77	9	after	after	ADP
easat-3113	77	10	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	77	11	acid	acid	PROPN
easat-3113	77	12	drug	drug	PROPN
easat-3113	77	13	administration	administration	NOUN
easat-3113	77	14	.	.	PUNCT
easat-3113	78	1	variable	variable	ADJ
easat-3113	78	2	pre	pre	ADJ
easat-3113	78	3	-	-	ADJ
easat-3113	78	4	udca	udca	ADJ
easat-3113	78	5	post	post	ADJ
easat-3113	78	6	-	-	ADJ
easat-3113	78	7	udca	udca	ADJ
easat-3113	78	8	p	p	NOUN
easat-3113	78	9	ast	ast	NOUN
easat-3113	78	10	group	group	NOUN
easat-3113	78	11	1	1	NUM
easat-3113	78	12	229.7	229.7	NUM
easat-3113	78	13	(	(	PUNCT
easat-3113	78	14	±136.7	±136.7	PROPN
easat-3113	78	15	)	)	PUNCT
easat-3113	78	16	193.1	193.1	NUM
easat-3113	78	17	(	(	PUNCT
easat-3113	78	18	±129	±129	PROPN
easat-3113	78	19	)	)	PUNCT
easat-3113	78	20	0.237	0.237	NUM
easat-3113	78	21	group	group	NOUN
easat-3113	78	22	2	2	NUM
easat-3113	78	23	231	231	NUM
easat-3113	78	24	(	(	PUNCT
easat-3113	78	25	42	42	NUM
easat-3113	78	26	-	-	SYM
easat-3113	78	27	911	911	NUM
easat-3113	78	28	)	)	PUNCT
easat-3113	78	29	221	221	NUM
easat-3113	78	30	(	(	PUNCT
easat-3113	78	31	6	6	NUM
easat-3113	78	32	-	-	SYM
easat-3113	78	33	658	658	NUM
easat-3113	78	34	)	)	PUNCT
easat-3113	78	35	0.048	0.048	NUM
easat-3113	78	36	*	*	PUNCT
easat-3113	78	37	alt	alt	PROPN
easat-3113	78	38	group	group	NOUN
easat-3113	78	39	1	1	NUM
easat-3113	78	40	138	138	NUM
easat-3113	78	41	(	(	PUNCT
easat-3113	78	42	38	38	NUM
easat-3113	78	43	-	-	SYM
easat-3113	78	44	450	450	NUM
easat-3113	78	45	)	)	PUNCT
easat-3113	78	46	208	208	NUM
easat-3113	78	47	(	(	PUNCT
easat-3113	78	48	66	66	NUM
easat-3113	78	49	-	-	SYM
easat-3113	78	50	932	932	NUM
easat-3113	78	51	)	)	PUNCT
easat-3113	78	52	0.031	0.031	NUM
easat-3113	78	53	*	*	NOUN
easat-3113	78	54	group	group	NOUN
easat-3113	78	55	2	2	NUM
easat-3113	78	56	164	164	NUM
easat-3113	78	57	(	(	PUNCT
easat-3113	78	58	30	30	NUM
easat-3113	78	59	-	-	SYM
easat-3113	78	60	641	641	NUM
easat-3113	78	61	)	)	PUNCT
easat-3113	78	62	259	259	NUM
easat-3113	78	63	(	(	PUNCT
easat-3113	78	64	6	6	NUM
easat-3113	78	65	-	-	SYM
easat-3113	78	66	925	925	NUM
easat-3113	78	67	)	)	PUNCT
easat-3113	78	68	0.006	0.006	NUM
easat-3113	78	69	*	*	PUNCT
easat-3113	78	70	total	total	ADJ
easat-3113	78	71	bilirubin	bilirubin	NOUN
easat-3113	78	72	group	group	NOUN
easat-3113	78	73	1	1	NUM
easat-3113	78	74	7.7	7.7	NUM
easat-3113	78	75	(	(	PUNCT
easat-3113	78	76	±3.34	±3.34	NOUN
easat-3113	78	77	)	)	PUNCT
easat-3113	78	78	4.9	4.9	NUM
easat-3113	78	79	(	(	PUNCT
easat-3113	78	80	±3.8	±3.8	NOUN
easat-3113	78	81	)	)	PUNCT
easat-3113	78	82	0.007	0.007	NUM
easat-3113	78	83	*	*	PUNCT
easat-3113	78	84	group	group	NOUN
easat-3113	78	85	2	2	NUM
easat-3113	78	86	8	8	NUM
easat-3113	78	87	(	(	PUNCT
easat-3113	78	88	±2.4	±2.4	PROPN
easat-3113	78	89	)	)	PUNCT
easat-3113	78	90	6.5	6.5	NUM
easat-3113	78	91	(	(	PUNCT
easat-3113	78	92	±3.8	±3.8	NOUN
easat-3113	78	93	)	)	PUNCT
easat-3113	78	94	0.866	0.866	NUM
easat-3113	78	95	direct	direct	ADJ
easat-3113	78	96	bilirubin	bilirubin	NOUN
easat-3113	78	97	group	group	NOUN
easat-3113	78	98	1	1	NUM
easat-3113	78	99	10.7	10.7	NUM
easat-3113	78	100	(	(	PUNCT
easat-3113	78	101	±4.9	±4.9	PROPN
easat-3113	78	102	)	)	PUNCT
easat-3113	78	103	6.7	6.7	NUM
easat-3113	78	104	(	(	PUNCT
easat-3113	78	105	±5.4	±5.4	PROPN
easat-3113	78	106	)	)	PUNCT
easat-3113	78	107	0.012	0.012	NUM
easat-3113	78	108	*	*	NOUN
easat-3113	78	109	group	group	NOUN
easat-3113	78	110	2	2	NUM
easat-3113	78	111	10.8	10.8	NUM
easat-3113	78	112	(	(	PUNCT
easat-3113	78	113	±3.6	±3.6	PROPN
easat-3113	78	114	)	)	PUNCT
easat-3113	78	115	11.2	11.2	NUM
easat-3113	78	116	(	(	PUNCT
easat-3113	78	117	±19	±19	PROPN
easat-3113	78	118	)	)	PUNCT
easat-3113	78	119	0.006	0.006	NUM
easat-3113	78	120	*	*	X
easat-3113	78	121	note	note	NOUN
easat-3113	78	122	:	:	PUNCT
easat-3113	78	123	*	*	PUNCT
easat-3113	78	124	significant	significant	ADJ
easat-3113	78	125	result	result	NOUN
easat-3113	78	126	(	(	PUNCT
easat-3113	78	127	p<0.05	p<0.05	NOUN
easat-3113	78	128	)	)	PUNCT
easat-3113	78	129	.	.	PUNCT
easat-3113	79	1	the	the	DET
easat-3113	79	2	results	result	NOUN
easat-3113	79	3	of	of	ADP
easat-3113	79	4	the	the	DET
easat-3113	79	5	examination	examination	NOUN
easat-3113	79	6	of	of	ADP
easat-3113	79	7	the	the	DET
easat-3113	79	8	four	four	NUM
easat-3113	79	9	liver	liver	NOUN
easat-3113	79	10	function	function	NOUN
easat-3113	79	11	biomarkers	biomarker	NOUN
easat-3113	79	12	after	after	ADP
easat-3113	79	13	administration	administration	NOUN
easat-3113	79	14	of	of	ADP
easat-3113	79	15	10	10	NUM
easat-3113	79	16	mg	mg	PROPN
easat-3113	79	17	/	/	SYM
easat-3113	79	18	kgbb	kgbb	PROPN
easat-3113	79	19	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	79	20	acid	acid	NOUN
easat-3113	79	21	for	for	ADP
easat-3113	79	22	2	2	NUM
easat-3113	79	23	weeks	week	NOUN
easat-3113	79	24	showed	show	VERB
easat-3113	79	25	significant	significant	ADJ
easat-3113	79	26	differences	difference	NOUN
easat-3113	79	27	,	,	PUNCT
easat-3113	79	28	except	except	SCONJ
easat-3113	79	29	for	for	ADP
easat-3113	79	30	the	the	DET
easat-3113	79	31	results	result	NOUN
easat-3113	79	32	of	of	ADP
easat-3113	79	33	the	the	DET
easat-3113	79	34	ast	ast	NOUN
easat-3113	79	35	in	in	ADP
easat-3113	79	36	group	group	NOUN
easat-3113	79	37	1	1	NUM
easat-3113	79	38	and	and	CCONJ
easat-3113	79	39	total	total	ADJ
easat-3113	79	40	bilirubin	bilirubin	NOUN
easat-3113	79	41	in	in	ADP
easat-3113	79	42	group	group	NOUN
easat-3113	79	43	2	2	NUM
easat-3113	79	44	(	(	PUNCT
easat-3113	79	45	table	table	NOUN
easat-3113	79	46	2	2	NUM
easat-3113	79	47	)	)	PUNCT
easat-3113	79	48	.	.	PUNCT
easat-3113	80	1	most	most	ADJ
easat-3113	80	2	liver	liver	NOUN
easat-3113	80	3	function	function	NOUN
easat-3113	80	4	indicators	indicator	NOUN
easat-3113	80	5	exhibited	exhibit	VERB
easat-3113	80	6	a	a	DET
easat-3113	80	7	decline	decline	NOUN
easat-3113	80	8	in	in	ADP
easat-3113	80	9	both	both	DET
easat-3113	80	10	cohorts	cohort	NOUN
easat-3113	80	11	.	.	PUNCT
easat-3113	81	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	81	2	acid	acid	PROPN
easat-3113	81	3	elevates	elevate	VERB
easat-3113	81	4	alt	alt	VERB
easat-3113	81	5	levels	level	NOUN
easat-3113	81	6	in	in	ADP
easat-3113	81	7	individuals	individual	NOUN
easat-3113	81	8	with	with	ADP
easat-3113	81	9	and	and	CCONJ
easat-3113	81	10	without	without	ADP
easat-3113	81	11	prior	prior	ADJ
easat-3113	81	12	liver	liver	NOUN
easat-3113	81	13	fibrosis	fibrosis	NOUN
easat-3113	81	14	.	.	PUNCT
easat-3113	82	1	a	a	DET
easat-3113	82	2	significant	significant	ADJ
easat-3113	82	3	reduction	reduction	NOUN
easat-3113	82	4	in	in	ADP
easat-3113	82	5	total	total	ADJ
easat-3113	82	6	and	and	CCONJ
easat-3113	82	7	direct	direct	ADJ
easat-3113	82	8	bilirubin	bilirubin	NOUN
easat-3113	82	9	levels	level	NOUN
easat-3113	82	10	was	be	AUX
easat-3113	82	11	recorded	record	VERB
easat-3113	82	12	in	in	ADP
easat-3113	82	13	group	group	NOUN
easat-3113	82	14	1	1	NUM
easat-3113	82	15	,	,	PUNCT
easat-3113	82	16	with	with	SCONJ
easat-3113	82	17	5078	5078	NUM
easat-3113	82	18	edelweiss	edelweiss	PROPN
easat-3113	82	19	applied	apply	VERB
easat-3113	82	20	science	science	NOUN
easat-3113	82	21	and	and	CCONJ
easat-3113	82	22	technology	technology	NOUN
easat-3113	82	23	issn	issn	PROPN
easat-3113	82	24	:	:	PUNCT
easat-3113	82	25	2576	2576	NUM
easat-3113	82	26	-	-	SYM
easat-3113	82	27	8484	8484	NUM
easat-3113	82	28	vol	vol	NOUN
easat-3113	82	29	.	.	PROPN
easat-3113	83	1	8	8	NUM
easat-3113	83	2	,	,	PUNCT
easat-3113	83	3	no	no	INTJ
easat-3113	83	4	.	.	NOUN
easat-3113	84	1	6	6	NUM
easat-3113	84	2	:	:	PUNCT
easat-3113	84	3	5075	5075	NUM
easat-3113	84	4	-	-	SYM
easat-3113	84	5	5081	5081	NUM
easat-3113	84	6	,	,	PUNCT
easat-3113	84	7	2024	2024	NUM
easat-3113	84	8	doi	doi	NOUN
easat-3113	84	9	:	:	PUNCT
easat-3113	84	10	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	84	11	©	©	PROPN
easat-3113	84	12	2024	2024	NUM
easat-3113	84	13	by	by	ADP
easat-3113	84	14	the	the	DET
easat-3113	84	15	authors	author	NOUN
easat-3113	84	16	;	;	PUNCT
easat-3113	84	17	licensee	licensee	PROPN
easat-3113	84	18	learning	learning	NOUN
easat-3113	84	19	gate	gate	NOUN
easat-3113	84	20	p=0.007	p=0.007	X
easat-3113	84	21	and	and	CCONJ
easat-3113	84	22	p=0.012	p=0.012	PRON
easat-3113	84	23	(	(	PUNCT
easat-3113	84	24	p<0.005	p<0.005	NOUN
easat-3113	84	25	)	)	PUNCT
easat-3113	84	26	.	.	PUNCT
easat-3113	85	1	a	a	DET
easat-3113	85	2	significant	significant	ADJ
easat-3113	85	3	reduction	reduction	NOUN
easat-3113	85	4	in	in	ADP
easat-3113	85	5	direct	direct	ADJ
easat-3113	85	6	bilirubin	bilirubin	NOUN
easat-3113	85	7	levels	level	NOUN
easat-3113	85	8	was	be	AUX
easat-3113	85	9	seen	see	VERB
easat-3113	85	10	in	in	ADP
easat-3113	85	11	group	group	NOUN
easat-3113	85	12	2	2	NUM
easat-3113	85	13	(	(	PUNCT
easat-3113	85	14	p=0.006	p=0.006	NOUN
easat-3113	85	15	)	)	PUNCT
easat-3113	85	16	.	.	PUNCT
easat-3113	86	1	the	the	DET
easat-3113	86	2	comparison	comparison	NOUN
easat-3113	86	3	analysis	analysis	NOUN
easat-3113	86	4	results	result	NOUN
easat-3113	86	5	indicated	indicate	VERB
easat-3113	86	6	a	a	DET
easat-3113	86	7	substantial	substantial	ADJ
easat-3113	86	8	elevation	elevation	NOUN
easat-3113	86	9	in	in	ADP
easat-3113	86	10	alt	alt	ADJ
easat-3113	86	11	levels	level	NOUN
easat-3113	86	12	in	in	ADP
easat-3113	86	13	both	both	DET
easat-3113	86	14	group	group	NOUN
easat-3113	86	15	1	1	NUM
easat-3113	86	16	and	and	CCONJ
easat-3113	86	17	group	group	NOUN
easat-3113	86	18	2	2	NUM
easat-3113	86	19	(	(	PUNCT
easat-3113	86	20	p=0.031	p=0.031	NOUN
easat-3113	86	21	and	and	CCONJ
easat-3113	86	22	p=0.006	p=0.006	NOUN
easat-3113	86	23	)	)	PUNCT
easat-3113	86	24	.	.	PUNCT
easat-3113	87	1	4	4	X
easat-3113	87	2	.	.	X
easat-3113	87	3	discussion	discussion	NOUN
easat-3113	87	4	the	the	DET
easat-3113	87	5	findings	finding	NOUN
easat-3113	87	6	of	of	ADP
easat-3113	87	7	this	this	DET
easat-3113	87	8	study	study	NOUN
easat-3113	87	9	demonstrate	demonstrate	VERB
easat-3113	87	10	that	that	SCONJ
easat-3113	87	11	the	the	DET
easat-3113	87	12	majority	majority	NOUN
easat-3113	87	13	of	of	ADP
easat-3113	87	14	liver	liver	NOUN
easat-3113	87	15	biomarker	biomarker	NOUN
easat-3113	87	16	levels	level	NOUN
easat-3113	87	17	diminished	diminish	VERB
easat-3113	87	18	following	follow	VERB
easat-3113	87	19	the	the	DET
easat-3113	87	20	injection	injection	NOUN
easat-3113	87	21	of	of	ADP
easat-3113	87	22	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	87	23	acid	acid	NOUN
easat-3113	87	24	in	in	ADP
easat-3113	87	25	both	both	DET
easat-3113	87	26	age	age	NOUN
easat-3113	87	27	cohorts	cohort	NOUN
easat-3113	87	28	.	.	PUNCT
easat-3113	88	1	korean	korean	ADJ
easat-3113	88	2	research	research	NOUN
easat-3113	88	3	in	in	ADP
easat-3113	88	4	2019	2019	NUM
easat-3113	88	5	indicated	indicate	VERB
easat-3113	88	6	that	that	SCONJ
easat-3113	88	7	levels	level	NOUN
easat-3113	88	8	of	of	ADP
easat-3113	88	9	alt	alt	ADJ
easat-3113	88	10	,	,	PUNCT
easat-3113	88	11	ast	ast	ADJ
easat-3113	88	12	,	,	PUNCT
easat-3113	88	13	and	and	CCONJ
easat-3113	88	14	gamma	gamma	NOUN
easat-3113	88	15	-	-	PUNCT
easat-3113	88	16	glutamyl	glutamyl	VERB
easat-3113	88	17	transferase	transferase	NOUN
easat-3113	88	18	(	(	PUNCT
easat-3113	88	19	ggt	ggt	NOUN
easat-3113	88	20	)	)	PUNCT
easat-3113	88	21	dropped	drop	VERB
easat-3113	88	22	by	by	ADP
easat-3113	88	23	40.3	40.3	NUM
easat-3113	88	24	%	%	NOUN
easat-3113	88	25	,	,	PUNCT
easat-3113	88	26	33.9	33.9	NUM
easat-3113	88	27	%	%	NOUN
easat-3113	88	28	,	,	PUNCT
easat-3113	88	29	and	and	CCONJ
easat-3113	88	30	23	23	NUM
easat-3113	88	31	%	%	NOUN
easat-3113	88	32	,	,	PUNCT
easat-3113	88	33	respectively	respectively	ADV
easat-3113	88	34	,	,	PUNCT
easat-3113	88	35	following	follow	VERB
easat-3113	88	36	4	4	NUM
easat-3113	88	37	weeks	week	NOUN
easat-3113	88	38	of	of	ADP
easat-3113	88	39	ursodeoxycholic	ursodeoxycholic	ADJ
easat-3113	88	40	acid	acid	NOUN
easat-3113	88	41	therapy	therapy	NOUN
easat-3113	88	42	[	[	X
easat-3113	88	43	17	17	NUM
easat-3113	88	44	]	]	PUNCT
easat-3113	88	45	.	.	PUNCT
easat-3113	89	1	a	a	DET
easat-3113	89	2	meta	meta	ADJ
easat-3113	89	3	-	-	PUNCT
easat-3113	89	4	analysis	analysis	NOUN
easat-3113	89	5	by	by	ADP
easat-3113	89	6	simentalmendía	simentalmendía	NOUN
easat-3113	89	7	demonstrated	demonstrate	VERB
easat-3113	89	8	comparable	comparable	ADJ
easat-3113	89	9	findings	finding	NOUN
easat-3113	89	10	,	,	PUNCT
easat-3113	89	11	indicating	indicate	VERB
easat-3113	89	12	that	that	SCONJ
easat-3113	89	13	the	the	DET
easat-3113	89	14	treatment	treatment	NOUN
easat-3113	89	15	of	of	ADP
easat-3113	89	16	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	89	17	acid	acid	NOUN
easat-3113	89	18	for	for	ADP
easat-3113	89	19	almost	almost	ADV
easat-3113	89	20	one	one	NUM
easat-3113	89	21	month	month	NOUN
easat-3113	89	22	significantly	significantly	ADV
easat-3113	89	23	reduced	reduce	VERB
easat-3113	89	24	ast	ast	NOUN
easat-3113	89	25	levels	level	NOUN
easat-3113	89	26	(	(	PUNCT
easat-3113	89	27	p	p	X
easat-3113	89	28	<	<	X
easat-3113	89	29	0.001	0.001	NUM
easat-3113	89	30	)	)	PUNCT
easat-3113	90	1	[	[	X
easat-3113	90	2	18	18	NUM
easat-3113	90	3	]	]	PUNCT
easat-3113	90	4	.	.	PUNCT
easat-3113	91	1	the	the	DET
easat-3113	91	2	alanine	alanine	NOUN
easat-3113	91	3	aminotransferase	aminotransferase	NOUN
easat-3113	91	4	enzyme	enzyme	NOUN
easat-3113	91	5	is	be	AUX
easat-3113	91	6	more	more	ADV
easat-3113	91	7	selective	selective	ADJ
easat-3113	91	8	for	for	ADP
easat-3113	91	9	hepatic	hepatic	ADJ
easat-3113	91	10	injury	injury	NOUN
easat-3113	91	11	and	and	CCONJ
easat-3113	91	12	possesses	possess	VERB
easat-3113	91	13	a	a	DET
easat-3113	91	14	longer	long	ADJ
easat-3113	91	15	half	half	ADJ
easat-3113	91	16	-	-	PUNCT
easat-3113	91	17	life	life	NOUN
easat-3113	91	18	of	of	ADP
easat-3113	91	19	45	45	NUM
easat-3113	91	20	to	to	PART
easat-3113	91	21	47	47	NUM
easat-3113	91	22	hours	hour	NOUN
easat-3113	91	23	,	,	PUNCT
easat-3113	91	24	as	as	SCONJ
easat-3113	91	25	it	it	PRON
easat-3113	91	26	is	be	AUX
easat-3113	91	27	mostly	mostly	ADV
easat-3113	91	28	located	locate	VERB
easat-3113	91	29	in	in	ADP
easat-3113	91	30	the	the	DET
easat-3113	91	31	cytoplasm	cytoplasm	NOUN
easat-3113	91	32	of	of	ADP
easat-3113	91	33	hepatocytes	hepatocyte	NOUN
easat-3113	91	34	[	[	X
easat-3113	91	35	19,20	19,20	X
easat-3113	91	36	]	]	PUNCT
easat-3113	91	37	.	.	PUNCT
easat-3113	92	1	this	this	DET
easat-3113	92	2	study	study	NOUN
easat-3113	92	3	's	's	PART
easat-3113	92	4	results	result	NOUN
easat-3113	92	5	indicated	indicate	VERB
easat-3113	92	6	that	that	SCONJ
easat-3113	92	7	alt	alt	VERB
easat-3113	92	8	levels	level	NOUN
easat-3113	92	9	in	in	ADP
easat-3113	92	10	both	both	DET
easat-3113	92	11	groups	group	NOUN
easat-3113	92	12	elevated	elevate	VERB
easat-3113	92	13	following	follow	VERB
easat-3113	92	14	the	the	DET
easat-3113	92	15	injection	injection	NOUN
easat-3113	92	16	of	of	ADP
easat-3113	92	17	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	92	18	acid	acid	NOUN
easat-3113	92	19	.	.	PUNCT
easat-3113	93	1	the	the	DET
easat-3113	93	2	findings	finding	NOUN
easat-3113	93	3	of	of	ADP
easat-3113	93	4	this	this	DET
easat-3113	93	5	investigation	investigation	NOUN
easat-3113	93	6	contradicted	contradict	VERB
easat-3113	93	7	earlier	early	ADJ
easat-3113	93	8	research	research	NOUN
easat-3113	93	9	.	.	PUNCT
easat-3113	94	1	a	a	DET
easat-3113	94	2	meta	meta	ADJ
easat-3113	94	3	-	-	PUNCT
easat-3113	94	4	analysis	analysis	NOUN
easat-3113	94	5	done	do	VERB
easat-3113	94	6	in	in	ADP
easat-3113	94	7	china	china	PROPN
easat-3113	94	8	indicated	indicate	VERB
easat-3113	94	9	that	that	SCONJ
easat-3113	94	10	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	94	11	acid	acid	PROPN
easat-3113	94	12	decreased	decrease	VERB
easat-3113	94	13	blood	blood	NOUN
easat-3113	94	14	transaminase	transaminase	NOUN
easat-3113	94	15	levels	level	NOUN
easat-3113	94	16	,	,	PUNCT
easat-3113	94	17	namely	namely	ADV
easat-3113	94	18	alt	alt	VERB
easat-3113	94	19	and	and	CCONJ
easat-3113	94	20	ast	ast	VERB
easat-3113	94	21	,	,	PUNCT
easat-3113	94	22	in	in	ADP
easat-3113	94	23	children	child	NOUN
easat-3113	94	24	with	with	ADP
easat-3113	94	25	cholestasis.15	cholestasis.15	NOUN
easat-3113	94	26	this	this	DET
easat-3113	94	27	elevation	elevation	NOUN
easat-3113	94	28	in	in	ADP
easat-3113	94	29	serum	serum	NOUN
easat-3113	94	30	levels	level	NOUN
easat-3113	94	31	actually	actually	ADV
easat-3113	94	32	did	do	AUX
easat-3113	94	33	not	not	PART
easat-3113	94	34	indicate	indicate	VERB
easat-3113	94	35	liver	liver	NOUN
easat-3113	94	36	fibrosis	fibrosis	NOUN
easat-3113	94	37	,	,	PUNCT
easat-3113	94	38	despite	despite	SCONJ
easat-3113	94	39	its	its	PRON
easat-3113	94	40	prevalence	prevalence	NOUN
easat-3113	94	41	in	in	ADP
easat-3113	94	42	hepatic	hepatic	ADJ
easat-3113	94	43	activity	activity	NOUN
easat-3113	94	44	.	.	PUNCT
easat-3113	95	1	the	the	DET
easat-3113	95	2	majority	majority	NOUN
easat-3113	95	3	of	of	ADP
easat-3113	95	4	individuals	individual	NOUN
easat-3113	95	5	with	with	ADP
easat-3113	95	6	liver	liver	NOUN
easat-3113	95	7	cirrhosis	cirrhosis	NOUN
easat-3113	95	8	had	have	VERB
easat-3113	95	9	no	no	DET
easat-3113	95	10	elevation	elevation	NOUN
easat-3113	95	11	in	in	ADP
easat-3113	95	12	alt	alt	ADJ
easat-3113	95	13	levels	level	NOUN
easat-3113	95	14	.	.	PUNCT
easat-3113	96	1	a	a	DET
easat-3113	96	2	retrospective	retrospective	ADJ
easat-3113	96	3	cohort	cohort	NOUN
easat-3113	96	4	study	study	NOUN
easat-3113	96	5	conducted	conduct	VERB
easat-3113	96	6	in	in	ADP
easat-3113	96	7	the	the	DET
easat-3113	96	8	united	united	PROPN
easat-3113	96	9	states	states	PROPN
easat-3113	96	10	revealed	reveal	VERB
easat-3113	96	11	that	that	SCONJ
easat-3113	96	12	70	70	NUM
easat-3113	96	13	out	out	ADP
easat-3113	96	14	of	of	ADP
easat-3113	96	15	78	78	NUM
easat-3113	96	16	cirrhosis	cirrhosis	NOUN
easat-3113	96	17	patients	patient	NOUN
easat-3113	96	18	(	(	PUNCT
easat-3113	96	19	89.7	89.7	NUM
easat-3113	96	20	%	%	NOUN
easat-3113	96	21	)	)	PUNCT
easat-3113	96	22	exhibited	exhibit	VERB
easat-3113	96	23	alt	alt	ADJ
easat-3113	96	24	levels	level	NOUN
easat-3113	96	25	within	within	ADP
easat-3113	96	26	the	the	DET
easat-3113	96	27	normal	normal	ADJ
easat-3113	96	28	range	range	NOUN
easat-3113	96	29	[	[	X
easat-3113	96	30	21	21	NUM
easat-3113	96	31	]	]	PUNCT
easat-3113	96	32	.	.	PUNCT
easat-3113	97	1	toxicity	toxicity	NOUN
easat-3113	97	2	of	of	ADP
easat-3113	97	3	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	97	4	acid	acid	PROPN
easat-3113	97	5	has	have	AUX
easat-3113	97	6	been	be	AUX
easat-3113	97	7	documented	document	VERB
easat-3113	97	8	in	in	ADP
easat-3113	97	9	several	several	ADJ
easat-3113	97	10	research	research	NOUN
easat-3113	97	11	.	.	PUNCT
easat-3113	98	1	following	follow	VERB
easat-3113	98	2	oral	oral	ADJ
easat-3113	98	3	dosing	dosing	NOUN
easat-3113	98	4	,	,	PUNCT
easat-3113	98	5	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	98	6	acid	acid	PROPN
easat-3113	98	7	is	be	AUX
easat-3113	98	8	absorbed	absorb	VERB
easat-3113	98	9	by	by	ADP
easat-3113	98	10	the	the	DET
easat-3113	98	11	gut	gut	NOUN
easat-3113	98	12	and	and	CCONJ
easat-3113	98	13	enters	enter	VERB
easat-3113	98	14	the	the	DET
easat-3113	98	15	portal	portal	ADJ
easat-3113	98	16	vein	vein	NOUN
easat-3113	98	17	.	.	PUNCT
easat-3113	99	1	in	in	ADP
easat-3113	99	2	the	the	DET
easat-3113	99	3	portal	portal	ADJ
easat-3113	99	4	triad	triad	ADJ
easat-3113	99	5	,	,	PUNCT
easat-3113	99	6	ursodeoxycholic	ursodeoxycholic	ADJ
easat-3113	99	7	acid	acid	NOUN
easat-3113	99	8	is	be	AUX
easat-3113	99	9	transported	transport	VERB
easat-3113	99	10	into	into	ADP
easat-3113	99	11	hepatocytes	hepatocyte	NOUN
easat-3113	99	12	in	in	ADP
easat-3113	99	13	a	a	DET
easat-3113	99	14	taurine	taurine	NOUN
easat-3113	99	15	-	-	PUNCT
easat-3113	99	16	bound	bind	VERB
easat-3113	99	17	form	form	NOUN
easat-3113	99	18	,	,	PUNCT
easat-3113	99	19	with	with	ADP
easat-3113	99	20	some	some	PRON
easat-3113	99	21	entering	enter	VERB
easat-3113	99	22	the	the	DET
easat-3113	99	23	biliary	biliary	ADJ
easat-3113	99	24	channel	channel	NOUN
easat-3113	99	25	.	.	PUNCT
easat-3113	100	1	tauro	tauro	PROPN
easat-3113	100	2	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	100	3	acid	acid	PROPN
easat-3113	100	4	(	(	PUNCT
easat-3113	100	5	tudca	tudca	NOUN
easat-3113	100	6	)	)	PUNCT
easat-3113	100	7	is	be	AUX
easat-3113	100	8	oxidised	oxidise	VERB
easat-3113	100	9	to	to	PART
easat-3113	100	10	become	become	VERB
easat-3113	100	11	lithocholic	lithocholic	ADJ
easat-3113	100	12	acid	acid	NOUN
easat-3113	100	13	(	(	PUNCT
easat-3113	100	14	lca	lca	PROPN
easat-3113	100	15	)	)	PUNCT
easat-3113	100	16	,	,	PUNCT
easat-3113	100	17	which	which	PRON
easat-3113	100	18	is	be	AUX
easat-3113	100	19	hepatotoxic	hepatotoxic	ADJ
easat-3113	101	1	[	[	X
easat-3113	101	2	22	22	NUM
easat-3113	101	3	]	]	PUNCT
easat-3113	101	4	.	.	PUNCT
easat-3113	102	1	lithocholic	lithocholic	ADJ
easat-3113	102	2	acid	acid	PROPN
easat-3113	102	3	may	may	AUX
easat-3113	102	4	induce	induce	VERB
easat-3113	102	5	non	non	ADJ
easat-3113	102	6	-	-	ADJ
easat-3113	102	7	specific	specific	ADJ
easat-3113	102	8	damage	damage	NOUN
easat-3113	102	9	to	to	ADP
easat-3113	102	10	the	the	DET
easat-3113	102	11	bacterial	bacterial	ADJ
easat-3113	102	12	cytoplasmic	cytoplasmic	ADJ
easat-3113	102	13	membrane	membrane	NOUN
easat-3113	102	14	owing	owe	VERB
easat-3113	102	15	to	to	ADP
easat-3113	102	16	its	its	PRON
easat-3113	102	17	lipophilicity	lipophilicity	NOUN
easat-3113	102	18	and	and	CCONJ
easat-3113	102	19	decontamination	decontamination	NOUN
easat-3113	102	20	properties	property	NOUN
easat-3113	102	21	[	[	X
easat-3113	102	22	23	23	NUM
easat-3113	102	23	]	]	PUNCT
easat-3113	102	24	.	.	PUNCT
easat-3113	103	1	this	this	DET
easat-3113	103	2	situation	situation	NOUN
easat-3113	103	3	may	may	AUX
easat-3113	103	4	endure	endure	VERB
easat-3113	103	5	longer	long	ADV
easat-3113	103	6	because	because	SCONJ
easat-3113	103	7	to	to	ADP
easat-3113	103	8	the	the	DET
easat-3113	103	9	relatively	relatively	ADV
easat-3113	103	10	extended	extended	ADJ
easat-3113	103	11	half	half	ADJ
easat-3113	103	12	-	-	PUNCT
easat-3113	103	13	life	life	NOUN
easat-3113	103	14	of	of	ADP
easat-3113	103	15	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	103	16	acid	acid	NOUN
easat-3113	103	17	,	,	PUNCT
easat-3113	103	18	which	which	PRON
easat-3113	103	19	ranges	range	VERB
easat-3113	103	20	from	from	ADP
easat-3113	103	21	3.5	3.5	NUM
easat-3113	103	22	to	to	ADP
easat-3113	103	23	5.8	5.8	NUM
easat-3113	103	24	days	day	NOUN
easat-3113	103	25	[	[	X
easat-3113	103	26	24	24	NUM
easat-3113	103	27	]	]	PUNCT
easat-3113	103	28	.	.	PUNCT
easat-3113	104	1	children	child	NOUN
easat-3113	104	2	with	with	ADP
easat-3113	104	3	cholestasis	cholestasis	NOUN
easat-3113	104	4	have	have	AUX
easat-3113	104	5	reduced	reduce	VERB
easat-3113	104	6	liver	liver	NOUN
easat-3113	104	7	maturity	maturity	NOUN
easat-3113	104	8	.	.	PUNCT
easat-3113	105	1	as	as	SCONJ
easat-3113	105	2	age	age	NOUN
easat-3113	105	3	progresses	progress	VERB
easat-3113	105	4	,	,	PUNCT
easat-3113	105	5	liver	liver	NOUN
easat-3113	105	6	function	function	NOUN
easat-3113	105	7	maturity	maturity	NOUN
easat-3113	105	8	and	and	CCONJ
easat-3113	105	9	weight	weight	NOUN
easat-3113	105	10	rise	rise	NOUN
easat-3113	105	11	.	.	PUNCT
easat-3113	106	1	this	this	PRON
easat-3113	106	2	often	often	ADV
easat-3113	106	3	happens	happen	VERB
easat-3113	106	4	at	at	ADP
easat-3113	106	5	the	the	DET
easat-3113	106	6	age	age	NOUN
easat-3113	106	7	of	of	ADP
easat-3113	106	8	two	two	NUM
easat-3113	106	9	years	year	NOUN
easat-3113	106	10	[	[	X
easat-3113	106	11	25,26	25,26	X
easat-3113	106	12	]	]	X
easat-3113	106	13	.	.	PUNCT
easat-3113	107	1	both	both	DET
easat-3113	107	2	total	total	ADJ
easat-3113	107	3	and	and	CCONJ
easat-3113	107	4	direct	direct	ADJ
easat-3113	107	5	bilirubin	bilirubin	NOUN
easat-3113	107	6	levels	level	NOUN
easat-3113	107	7	were	be	AUX
easat-3113	107	8	shown	show	VERB
easat-3113	107	9	to	to	PART
easat-3113	107	10	decrease	decrease	VERB
easat-3113	107	11	after	after	ADP
easat-3113	107	12	the	the	DET
easat-3113	107	13	administration	administration	NOUN
easat-3113	107	14	of	of	ADP
easat-3113	107	15	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	107	16	acid	acid	PROPN
easat-3113	107	17	to	to	ADP
easat-3113	107	18	both	both	PRON
easat-3113	107	19	of	of	ADP
easat-3113	107	20	the	the	DET
easat-3113	107	21	groups	group	NOUN
easat-3113	107	22	.	.	PUNCT
easat-3113	108	1	group	group	NOUN
easat-3113	108	2	1	1	NUM
easat-3113	108	3	had	have	VERB
easat-3113	108	4	significantly	significantly	ADV
easat-3113	108	5	different	different	ADJ
easat-3113	108	6	amounts	amount	NOUN
easat-3113	108	7	of	of	ADP
easat-3113	108	8	bilirubin	bilirubin	NOUN
easat-3113	108	9	than	than	ADP
easat-3113	108	10	group	group	NOUN
easat-3113	108	11	2	2	NUM
easat-3113	108	12	,	,	PUNCT
easat-3113	108	13	according	accord	VERB
easat-3113	108	14	to	to	ADP
easat-3113	108	15	the	the	DET
easat-3113	108	16	findings	finding	NOUN
easat-3113	108	17	of	of	ADP
easat-3113	108	18	this	this	DET
easat-3113	108	19	investigation	investigation	NOUN
easat-3113	108	20	.	.	PUNCT
easat-3113	109	1	when	when	SCONJ
easat-3113	109	2	used	use	VERB
easat-3113	109	3	as	as	ADP
easat-3113	109	4	a	a	DET
easat-3113	109	5	choleretic	choleretic	ADJ
easat-3113	109	6	agent	agent	NOUN
easat-3113	109	7	,	,	PUNCT
easat-3113	109	8	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	109	9	acid	acid	PROPN
easat-3113	109	10	has	have	VERB
easat-3113	109	11	the	the	DET
easat-3113	109	12	potential	potential	NOUN
easat-3113	109	13	to	to	PART
easat-3113	109	14	make	make	VERB
easat-3113	109	15	bile	bile	NOUN
easat-3113	109	16	fluid	fluid	NOUN
easat-3113	109	17	that	that	PRON
easat-3113	109	18	contains	contain	VERB
easat-3113	109	19	0.2	0.2	NUM
easat-3113	109	20	%	%	NOUN
easat-3113	109	21	bilirubin	bilirubin	NOUN
easat-3113	109	22	more	more	ADV
easat-3113	109	23	excreted	excrete	VERB
easat-3113	109	24	.	.	PUNCT
easat-3113	110	1	after	after	ADP
easat-3113	110	2	conducting	conduct	VERB
easat-3113	110	3	research	research	NOUN
easat-3113	110	4	at	at	ADP
easat-3113	110	5	the	the	DET
easat-3113	110	6	neonatal	neonatal	ADJ
easat-3113	110	7	intensive	intensive	ADJ
easat-3113	110	8	care	care	NOUN
easat-3113	110	9	unit	unit	NOUN
easat-3113	110	10	(	(	PUNCT
easat-3113	110	11	nicu	nicu	PROPN
easat-3113	110	12	)	)	PUNCT
easat-3113	110	13	of	of	ADP
easat-3113	110	14	dr	dr	PROPN
easat-3113	110	15	.	.	PROPN
easat-3113	110	16	moewardi	moewardi	PROPN
easat-3113	110	17	hospital	hospital	NOUN
easat-3113	110	18	,	,	PUNCT
easat-3113	110	19	it	it	PRON
easat-3113	110	20	was	be	AUX
easat-3113	110	21	found	find	VERB
easat-3113	110	22	that	that	SCONJ
easat-3113	110	23	the	the	DET
easat-3113	110	24	difference	difference	NOUN
easat-3113	110	25	in	in	ADP
easat-3113	110	26	total	total	ADJ
easat-3113	110	27	bilirubin	bilirubin	NOUN
easat-3113	110	28	levels	level	NOUN
easat-3113	110	29	between	between	ADP
easat-3113	110	30	the	the	DET
easat-3113	110	31	treatment	treatment	NOUN
easat-3113	110	32	group	group	NOUN
easat-3113	110	33	and	and	CCONJ
easat-3113	110	34	the	the	DET
easat-3113	110	35	control	control	NOUN
easat-3113	110	36	group	group	NOUN
easat-3113	110	37	was	be	AUX
easat-3113	110	38	3.18	3.18	NUM
easat-3113	110	39	±	±	NUM
easat-3113	110	40	3.32	3.32	NUM
easat-3113	110	41	.	.	PUNCT
easat-3113	111	1	on	on	ADP
easat-3113	111	2	the	the	DET
easat-3113	111	3	other	other	ADJ
easat-3113	111	4	hand	hand	NOUN
easat-3113	111	5	,	,	PUNCT
easat-3113	111	6	the	the	DET
easat-3113	111	7	difference	difference	NOUN
easat-3113	111	8	between	between	ADP
easat-3113	111	9	the	the	DET
easat-3113	111	10	two	two	NUM
easat-3113	111	11	groups	group	NOUN
easat-3113	111	12	was	be	AUX
easat-3113	111	13	1.67	1.67	NUM
easat-3113	111	14	±	±	NUM
easat-3113	111	15	4.50	4.50	NUM
easat-3113	111	16	(	(	PUNCT
easat-3113	111	17	p	p	X
easat-3113	111	18	<	<	NOUN
easat-3113	111	19	0.001	0.001	NUM
easat-3113	111	20	)	)	PUNCT
easat-3113	112	1	[	[	X
easat-3113	112	2	22,27	22,27	NOUN
easat-3113	112	3	]	]	PUNCT
easat-3113	112	4	.	.	PUNCT
easat-3113	113	1	the	the	DET
easat-3113	113	2	results	result	NOUN
easat-3113	113	3	of	of	ADP
easat-3113	113	4	this	this	DET
easat-3113	113	5	study	study	NOUN
easat-3113	113	6	indicate	indicate	VERB
easat-3113	113	7	that	that	SCONJ
easat-3113	113	8	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	113	9	acid	acid	NOUN
easat-3113	113	10	was	be	AUX
easat-3113	113	11	able	able	ADJ
easat-3113	113	12	to	to	PART
easat-3113	113	13	reduce	reduce	VERB
easat-3113	113	14	direct	direct	ADJ
easat-3113	113	15	bilirubin	bilirubin	NOUN
easat-3113	113	16	levels	level	NOUN
easat-3113	113	17	in	in	ADP
easat-3113	113	18	infant	infant	NOUN
easat-3113	113	19	with	with	ADP
easat-3113	113	20	cholestasis	cholestasis	NOUN
easat-3113	113	21	.	.	PUNCT
easat-3113	114	1	significant	significant	ADJ
easat-3113	114	2	differences	difference	NOUN
easat-3113	114	3	were	be	AUX
easat-3113	114	4	found	find	VERB
easat-3113	114	5	in	in	ADP
easat-3113	114	6	the	the	DET
easat-3113	114	7	both	both	DET
easat-3113	114	8	groups	group	NOUN
easat-3113	114	9	.	.	PUNCT
easat-3113	115	1	this	this	PRON
easat-3113	115	2	was	be	AUX
easat-3113	115	3	in	in	ADP
easat-3113	115	4	line	line	NOUN
easat-3113	115	5	with	with	ADP
easat-3113	115	6	the	the	DET
easat-3113	115	7	results	result	NOUN
easat-3113	115	8	of	of	ADP
easat-3113	115	9	a	a	DET
easat-3113	115	10	previous	previous	ADJ
easat-3113	115	11	systematic	systematic	ADJ
easat-3113	115	12	review	review	NOUN
easat-3113	115	13	studies	study	NOUN
easat-3113	115	14	showing	show	VERB
easat-3113	115	15	that	that	SCONJ
easat-3113	115	16	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	115	17	acid	acid	PROPN
easat-3113	115	18	administration	administration	NOUN
easat-3113	115	19	in	in	ADP
easat-3113	115	20	children	child	NOUN
easat-3113	115	21	with	with	ADP
easat-3113	115	22	cholestasis	cholestasis	NOUN
easat-3113	115	23	might	might	AUX
easat-3113	115	24	result	result	VERB
easat-3113	115	25	in	in	ADP
easat-3113	115	26	a	a	DET
easat-3113	115	27	significant	significant	ADJ
easat-3113	115	28	decrease	decrease	NOUN
easat-3113	115	29	in	in	ADP
easat-3113	115	30	direct	direct	ADJ
easat-3113	115	31	bilirubin	bilirubin	NOUN
easat-3113	115	32	levels	level	NOUN
easat-3113	115	33	[	[	X
easat-3113	115	34	18	18	NUM
easat-3113	115	35	]	]	PUNCT
easat-3113	115	36	.	.	PUNCT
easat-3113	116	1	cholestasis	cholestasis	NOUN
easat-3113	116	2	is	be	AUX
easat-3113	116	3	marked	mark	VERB
easat-3113	116	4	by	by	ADP
easat-3113	116	5	elevated	elevate	VERB
easat-3113	116	6	direct	direct	ADJ
easat-3113	116	7	bilirubin	bilirubin	NOUN
easat-3113	116	8	levels	level	NOUN
easat-3113	116	9	in	in	ADP
easat-3113	116	10	the	the	DET
easat-3113	116	11	bloodstream	bloodstream	NOUN
easat-3113	116	12	.	.	PUNCT
easat-3113	117	1	previous	previous	ADJ
easat-3113	117	2	studies	study	NOUN
easat-3113	117	3	done	do	VERB
easat-3113	117	4	in	in	ADP
easat-3113	117	5	china	china	PROPN
easat-3113	117	6	found	find	VERB
easat-3113	117	7	elevated	elevated	ADJ
easat-3113	117	8	liver	liver	NOUN
easat-3113	117	9	biomarker	biomarker	NOUN
easat-3113	117	10	values	value	NOUN
easat-3113	117	11	,	,	PUNCT
easat-3113	117	12	particularly	particularly	ADV
easat-3113	117	13	direct	direct	ADJ
easat-3113	117	14	bilirubin	bilirubin	NOUN
easat-3113	117	15	(	(	PUNCT
easat-3113	117	16	p<0.01	p<0.01	PROPN
easat-3113	117	17	)	)	PUNCT
easat-3113	117	18	,	,	PUNCT
easat-3113	117	19	in	in	ADP
easat-3113	117	20	children	child	NOUN
easat-3113	117	21	with	with	ADP
easat-3113	117	22	cholestasis	cholestasis	NOUN
easat-3113	117	23	compared	compare	VERB
easat-3113	117	24	to	to	ADP
easat-3113	117	25	their	their	PRON
easat-3113	117	26	healthy	healthy	ADJ
easat-3113	117	27	counterparts	counterpart	NOUN
easat-3113	117	28	.	.	PUNCT
easat-3113	118	1	in	in	ADP
easat-3113	118	2	contrast	contrast	NOUN
easat-3113	118	3	to	to	ADP
easat-3113	118	4	indirect	indirect	ADJ
easat-3113	118	5	bilirubin	bilirubin	NOUN
easat-3113	118	6	,	,	PUNCT
easat-3113	118	7	direct	direct	ADJ
easat-3113	118	8	bilirubin	bilirubin	NOUN
easat-3113	118	9	is	be	AUX
easat-3113	118	10	water	water	NOUN
easat-3113	118	11	-	-	PUNCT
easat-3113	118	12	soluble	soluble	ADJ
easat-3113	118	13	and	and	CCONJ
easat-3113	118	14	hence	hence	ADV
easat-3113	118	15	does	do	AUX
easat-3113	118	16	not	not	PART
easat-3113	118	17	need	need	VERB
easat-3113	118	18	a	a	DET
easat-3113	118	19	protein	protein	NOUN
easat-3113	118	20	transporter	transporter	NOUN
easat-3113	118	21	inside	inside	ADP
easat-3113	118	22	the	the	DET
easat-3113	118	23	bloodstream	bloodstream	NOUN
easat-3113	118	24	.	.	PUNCT
easat-3113	119	1	the	the	DET
easat-3113	119	2	conjugated	conjugate	VERB
easat-3113	119	3	bilirubin	bilirubin	NOUN
easat-3113	119	4	proceeds	proceed	NOUN
easat-3113	119	5	to	to	ADP
easat-3113	119	6	the	the	DET
easat-3113	119	7	colon	colon	NOUN
easat-3113	119	8	to	to	PART
easat-3113	119	9	facilitate	facilitate	VERB
easat-3113	119	10	excretion	excretion	NOUN
easat-3113	119	11	(	(	PUNCT
easat-3113	119	12	80	80	NUM
easat-3113	119	13	%	%	NOUN
easat-3113	119	14	)	)	PUNCT
easat-3113	119	15	as	as	ADP
easat-3113	119	16	urobilinogen	urobilinogen	VERB
easat-3113	119	17	via	via	ADP
easat-3113	119	18	faeces	faece	NOUN
easat-3113	119	19	and	and	CCONJ
easat-3113	119	20	urine	urine	NOUN
easat-3113	119	21	,	,	PUNCT
easat-3113	119	22	with	with	ADP
easat-3113	119	23	a	a	DET
easat-3113	119	24	little	little	ADJ
easat-3113	119	25	portion	portion	NOUN
easat-3113	119	26	being	be	AUX
easat-3113	119	27	reabsorbed	reabsorb	VERB
easat-3113	119	28	[	[	PUNCT
easat-3113	119	29	28	28	NUM
easat-3113	119	30	]	]	PUNCT
easat-3113	119	31	.	.	PUNCT
easat-3113	120	1	the	the	DET
easat-3113	120	2	toxicity	toxicity	NOUN
easat-3113	120	3	of	of	ADP
easat-3113	120	4	direct	direct	ADJ
easat-3113	120	5	bilirubin	bilirubin	NOUN
easat-3113	120	6	is	be	AUX
easat-3113	120	7	inferior	inferior	ADJ
easat-3113	120	8	to	to	ADP
easat-3113	120	9	that	that	PRON
easat-3113	120	10	of	of	ADP
easat-3113	120	11	indirect	indirect	ADJ
easat-3113	120	12	bilirubin	bilirubin	NOUN
easat-3113	120	13	.	.	PUNCT
easat-3113	121	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	121	2	acid	acid	PROPN
easat-3113	121	3	lowers	lower	VERB
easat-3113	121	4	bilirubin	bilirubin	NOUN
easat-3113	121	5	levels	level	NOUN
easat-3113	121	6	by	by	ADP
easat-3113	121	7	obstructing	obstruct	VERB
easat-3113	121	8	bilirubin	bilirubin	NOUN
easat-3113	121	9	reabsorption	reabsorption	NOUN
easat-3113	121	10	and	and	CCONJ
easat-3113	121	11	enhancing	enhance	VERB
easat-3113	121	12	bile	bile	NOUN
easat-3113	121	13	flow	flow	NOUN
easat-3113	121	14	and	and	CCONJ
easat-3113	121	15	faecal	faecal	ADJ
easat-3113	121	16	elimination	elimination	NOUN
easat-3113	121	17	[	[	X
easat-3113	121	18	29	29	NUM
easat-3113	121	19	]	]	PUNCT
easat-3113	121	20	.	.	PUNCT
easat-3113	122	1	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	122	2	acid	acid	PROPN
easat-3113	122	3	exhibits	exhibit	VERB
easat-3113	122	4	multiple	multiple	ADJ
easat-3113	122	5	mechanisms	mechanism	NOUN
easat-3113	122	6	that	that	PRON
easat-3113	122	7	protect	protect	VERB
easat-3113	122	8	hepatocytes	hepatocyte	NOUN
easat-3113	122	9	.	.	PUNCT
easat-3113	123	1	farnesoid	farnesoid	ADJ
easat-3113	123	2	x	x	X
easat-3113	123	3	receptor	receptor	NOUN
easat-3113	123	4	(	(	PUNCT
easat-3113	123	5	fxr	fxr	NOUN
easat-3113	123	6	)	)	PUNCT
easat-3113	123	7	is	be	AUX
easat-3113	123	8	a	a	DET
easat-3113	123	9	nuclear	nuclear	ADJ
easat-3113	123	10	receptor	receptor	NOUN
easat-3113	123	11	involved	involve	VERB
easat-3113	123	12	in	in	ADP
easat-3113	123	13	this	this	DET
easat-3113	123	14	process	process	NOUN
easat-3113	123	15	[	[	X
easat-3113	123	16	30	30	NUM
easat-3113	123	17	]	]	PUNCT
easat-3113	123	18	.	.	PUNCT
easat-3113	124	1	this	this	DET
easat-3113	124	2	receptor	receptor	NOUN
easat-3113	124	3	targets	target	VERB
easat-3113	124	4	40	40	NUM
easat-3113	124	5	genes	gene	NOUN
easat-3113	124	6	,	,	PUNCT
easat-3113	124	7	the	the	DET
easat-3113	124	8	majority	majority	NOUN
easat-3113	124	9	of	of	ADP
easat-3113	124	10	which	which	PRON
easat-3113	124	11	are	be	AUX
easat-3113	124	12	involved	involve	VERB
easat-3113	124	13	in	in	ADP
easat-3113	124	14	stimulating	stimulate	VERB
easat-3113	124	15	the	the	DET
easat-3113	124	16	bile	bile	NOUN
easat-3113	124	17	signalling	signal	VERB
easat-3113	124	18	pathway	pathway	NOUN
easat-3113	124	19	.	.	PUNCT
easat-3113	125	1	this	this	DET
easat-3113	125	2	nuclear	nuclear	ADJ
easat-3113	125	3	receptor	receptor	NOUN
easat-3113	125	4	enhances	enhance	VERB
easat-3113	125	5	bile	bile	NOUN
easat-3113	125	6	5079	5079	NUM
easat-3113	125	7	edelweiss	edelweiss	PROPN
easat-3113	125	8	applied	apply	VERB
easat-3113	125	9	science	science	NOUN
easat-3113	125	10	and	and	CCONJ
easat-3113	125	11	technology	technology	NOUN
easat-3113	125	12	issn	issn	PROPN
easat-3113	125	13	:	:	PUNCT
easat-3113	125	14	2576	2576	NUM
easat-3113	125	15	-	-	SYM
easat-3113	125	16	8484	8484	NUM
easat-3113	125	17	vol	vol	NOUN
easat-3113	125	18	.	.	PROPN
easat-3113	125	19	8	8	NUM
easat-3113	125	20	,	,	PUNCT
easat-3113	125	21	no	no	INTJ
easat-3113	125	22	.	.	NOUN
easat-3113	125	23	6	6	NUM
easat-3113	125	24	:	:	PUNCT
easat-3113	125	25	5075	5075	NUM
easat-3113	125	26	-	-	SYM
easat-3113	125	27	5081	5081	NUM
easat-3113	125	28	,	,	PUNCT
easat-3113	125	29	2024	2024	NUM
easat-3113	125	30	doi	doi	NOUN
easat-3113	125	31	:	:	PUNCT
easat-3113	125	32	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	125	33	©	©	PROPN
easat-3113	125	34	2024	2024	NUM
easat-3113	125	35	by	by	ADP
easat-3113	125	36	the	the	DET
easat-3113	125	37	authors	author	NOUN
easat-3113	125	38	;	;	PUNCT
easat-3113	125	39	licensee	licensee	PROPN
easat-3113	125	40	learning	learn	VERB
easat-3113	125	41	gate	gate	NOUN
easat-3113	125	42	excretion	excretion	NOUN
easat-3113	125	43	from	from	ADP
easat-3113	125	44	the	the	DET
easat-3113	125	45	liver	liver	NOUN
easat-3113	125	46	via	via	ADP
easat-3113	125	47	bsep	bsep	NOUN
easat-3113	125	48	and	and	CCONJ
easat-3113	125	49	abcb4	abcb4	NOUN
easat-3113	125	50	signalling	signal	VERB
easat-3113	125	51	pathways	pathway	NOUN
easat-3113	125	52	.	.	PUNCT
easat-3113	126	1	furthermore	furthermore	ADV
easat-3113	126	2	,	,	PUNCT
easat-3113	126	3	fxr	fxr	PROPN
easat-3113	126	4	inhibits	inhibit	VERB
easat-3113	126	5	hepatic	hepatic	ADJ
easat-3113	126	6	reuptake	reuptake	NOUN
easat-3113	126	7	and	and	CCONJ
easat-3113	126	8	intestinal	intestinal	ADJ
easat-3113	126	9	absorption	absorption	NOUN
easat-3113	126	10	via	via	ADP
easat-3113	126	11	shp	shp	NOUN
easat-3113	126	12	-	-	ADJ
easat-3113	126	13	fxr	fxr	NOUN
easat-3113	126	14	signalling	signal	VERB
easat-3113	126	15	[	[	X
easat-3113	126	16	31	31	NUM
easat-3113	126	17	]	]	PUNCT
easat-3113	126	18	.	.	PUNCT
easat-3113	127	1	asam	asam	PROPN
easat-3113	127	2	ursodeoksikolat	ursodeoksikolat	PROPN
easat-3113	127	3	adalah	adalah	PROPN
easat-3113	127	4	salah	salah	PROPN
easat-3113	127	5	satu	satu	PROPN
easat-3113	127	6	agonis	agonis	PROPN
easat-3113	127	7	fxr	fxr	PROPN
easat-3113	127	8	.	.	PUNCT
easat-3113	127	9	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	127	10	acid	acid	NOUN
easat-3113	127	11	functions	function	NOUN
easat-3113	127	12	as	as	ADP
easat-3113	127	13	an	an	DET
easat-3113	127	14	fxr	fxr	NOUN
easat-3113	127	15	agonist	agonist	NOUN
easat-3113	127	16	.	.	PUNCT
easat-3113	128	1	a	a	DET
easat-3113	128	2	study	study	NOUN
easat-3113	128	3	conducted	conduct	VERB
easat-3113	128	4	in	in	ADP
easat-3113	128	5	china	china	PROPN
easat-3113	128	6	found	find	VERB
easat-3113	128	7	evidence	evidence	NOUN
easat-3113	128	8	that	that	SCONJ
easat-3113	128	9	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	128	10	acid	acid	PROPN
easat-3113	128	11	may	may	AUX
easat-3113	128	12	enhance	enhance	VERB
easat-3113	128	13	enterohepatic	enterohepatic	ADJ
easat-3113	128	14	circulation	circulation	NOUN
easat-3113	128	15	by	by	ADP
easat-3113	128	16	inhibiting	inhibit	VERB
easat-3113	128	17	fxr	fxr	NOUN
easat-3113	128	18	signalling	signal	VERB
easat-3113	128	19	in	in	ADP
easat-3113	128	20	the	the	DET
easat-3113	128	21	ileum	ileum	NOUN
easat-3113	128	22	and	and	CCONJ
easat-3113	128	23	fgf15/19	fgf15/19	NOUN
easat-3113	128	24	in	in	ADP
easat-3113	128	25	the	the	DET
easat-3113	128	26	liver	liver	NOUN
easat-3113	128	27	.	.	PUNCT
easat-3113	129	1	the	the	DET
easat-3113	129	2	bilirubin	bilirubin	NOUN
easat-3113	129	3	signalling	signal	VERB
easat-3113	129	4	pathway	pathway	NOUN
easat-3113	129	5	in	in	ADP
easat-3113	129	6	humans	human	NOUN
easat-3113	129	7	remains	remain	VERB
easat-3113	129	8	poorly	poorly	ADV
easat-3113	129	9	understood	understand	VERB
easat-3113	129	10	[	[	X
easat-3113	129	11	32	32	NUM
easat-3113	129	12	]	]	PUNCT
easat-3113	129	13	.	.	PUNCT
easat-3113	130	1	in	in	ADP
easat-3113	130	2	a	a	DET
easat-3113	130	3	separate	separate	ADJ
easat-3113	130	4	trial	trial	NOUN
easat-3113	130	5	,	,	PUNCT
easat-3113	130	6	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	130	7	acid	acid	PROPN
easat-3113	130	8	shown	show	VERB
easat-3113	130	9	protective	protective	ADJ
easat-3113	130	10	effects	effect	NOUN
easat-3113	130	11	for	for	ADP
easat-3113	130	12	preterm	preterm	ADJ
easat-3113	130	13	newborns	newborn	NOUN
easat-3113	130	14	undergoing	undergo	VERB
easat-3113	130	15	parenteral	parenteral	ADJ
easat-3113	130	16	nourishment	nourishment	NOUN
easat-3113	130	17	.	.	PUNCT
easat-3113	131	1	a	a	DET
easat-3113	131	2	randomised	randomised	ADJ
easat-3113	131	3	experiment	experiment	NOUN
easat-3113	131	4	in	in	ADP
easat-3113	131	5	the	the	DET
easat-3113	131	6	nicu	nicu	NOUN
easat-3113	131	7	indicated	indicate	VERB
easat-3113	131	8	that	that	SCONJ
easat-3113	131	9	newborns	newborn	NOUN
easat-3113	131	10	administered	administer	VERB
easat-3113	131	11	ursodeoxycholic	ursodeoxycholic	NOUN
easat-3113	131	12	acid	acid	NOUN
easat-3113	131	13	treatment	treatment	NOUN
easat-3113	131	14	at	at	ADP
easat-3113	131	15	one	one	NUM
easat-3113	131	16	week	week	NOUN
easat-3113	131	17	of	of	ADP
easat-3113	131	18	age	age	NOUN
easat-3113	131	19	exhibited	exhibit	VERB
easat-3113	131	20	significantly	significantly	ADV
easat-3113	131	21	reduced	reduce	VERB
easat-3113	131	22	bilirubin	bilirubin	NOUN
easat-3113	131	23	levels	level	NOUN
easat-3113	131	24	compared	compare	VERB
easat-3113	131	25	to	to	ADP
easat-3113	131	26	those	those	PRON
easat-3113	131	27	who	who	PRON
easat-3113	131	28	did	do	AUX
easat-3113	131	29	not	not	PART
easat-3113	131	30	receive	receive	VERB
easat-3113	131	31	the	the	DET
easat-3113	131	32	medication	medication	NOUN
easat-3113	131	33	.	.	PUNCT
easat-3113	132	1	cholestasis	cholestasis	NOUN
easat-3113	132	2	was	be	AUX
easat-3113	132	3	absent	absent	ADJ
easat-3113	132	4	in	in	ADP
easat-3113	132	5	the	the	DET
easat-3113	132	6	therapy	therapy	NOUN
easat-3113	132	7	group	group	NOUN
easat-3113	132	8	(	(	PUNCT
easat-3113	132	9	0.0	0.0	NUM
easat-3113	132	10	%	%	NOUN
easat-3113	132	11	vs.	vs.	ADP
easat-3113	132	12	11.7	11.7	NUM
easat-3113	132	13	%	%	NOUN
easat-3113	132	14	,	,	PUNCT
easat-3113	132	15	p	p	X
easat-3113	132	16	<	<	X
easat-3113	132	17	0.05	0.05	NUM
easat-3113	132	18	)	)	PUNCT
easat-3113	133	1	[	[	X
easat-3113	133	2	33	33	NUM
easat-3113	133	3	]	]	PUNCT
easat-3113	133	4	.	.	PUNCT
easat-3113	134	1	another	another	DET
easat-3113	134	2	potential	potential	ADJ
easat-3113	134	3	explanation	explanation	NOUN
easat-3113	134	4	was	be	AUX
easat-3113	134	5	the	the	DET
easat-3113	134	6	duration	duration	NOUN
easat-3113	134	7	of	of	ADP
easat-3113	134	8	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	134	9	acid	acid	NOUN
easat-3113	134	10	treatment	treatment	NOUN
easat-3113	134	11	and	and	CCONJ
easat-3113	134	12	the	the	DET
easat-3113	134	13	timing	timing	NOUN
easat-3113	134	14	of	of	ADP
easat-3113	134	15	laboratory	laboratory	NOUN
easat-3113	134	16	assessments	assessment	NOUN
easat-3113	134	17	.	.	PUNCT
easat-3113	135	1	a	a	DET
easat-3113	135	2	pilot	pilot	NOUN
easat-3113	135	3	randomised	randomise	VERB
easat-3113	135	4	controlled	control	VERB
easat-3113	135	5	trial	trial	NOUN
easat-3113	135	6	administering	administer	VERB
easat-3113	135	7	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	135	8	acid	acid	NOUN
easat-3113	135	9	to	to	ADP
easat-3113	135	10	children	child	NOUN
easat-3113	135	11	with	with	ADP
easat-3113	135	12	hepatotoxicity	hepatotoxicity	NOUN
easat-3113	135	13	from	from	ADP
easat-3113	135	14	anti	anti	ADJ
easat-3113	135	15	-	-	ADJ
easat-3113	135	16	convulsants	convulsant	NOUN
easat-3113	135	17	indicated	indicate	VERB
easat-3113	135	18	a	a	DET
easat-3113	135	19	substantial	substantial	ADJ
easat-3113	135	20	reduction	reduction	NOUN
easat-3113	135	21	in	in	ADP
easat-3113	135	22	ast	ast	NOUN
easat-3113	135	23	and	and	CCONJ
easat-3113	135	24	alt	alt	VERB
easat-3113	135	25	values	value	NOUN
easat-3113	135	26	beginning	begin	VERB
easat-3113	135	27	a	a	DET
easat-3113	135	28	week	week	NOUN
easat-3113	135	29	post	post	NOUN
easat-3113	135	30	-	-	NOUN
easat-3113	135	31	administration	administration	NOUN
easat-3113	135	32	(	(	PUNCT
easat-3113	135	33	p	p	X
easat-3113	135	34	<	<	X
easat-3113	135	35	0.001	0.001	NUM
easat-3113	135	36	)	)	PUNCT
easat-3113	136	1	[	[	X
easat-3113	136	2	34	34	NUM
easat-3113	136	3	]	]	PUNCT
easat-3113	136	4	.	.	PUNCT
easat-3113	137	1	another	another	DET
easat-3113	137	2	research	research	NOUN
easat-3113	137	3	corroborated	corroborate	VERB
easat-3113	137	4	this	this	DET
easat-3113	137	5	finding	finding	NOUN
easat-3113	137	6	,	,	PUNCT
easat-3113	137	7	concluding	conclude	VERB
easat-3113	137	8	that	that	SCONJ
easat-3113	137	9	the	the	DET
easat-3113	137	10	elevation	elevation	NOUN
easat-3113	137	11	in	in	ADP
easat-3113	137	12	total	total	ADJ
easat-3113	137	13	bilirubin	bilirubin	NOUN
easat-3113	137	14	and	and	CCONJ
easat-3113	137	15	direct	direct	ADJ
easat-3113	137	16	bilirubin	bilirubin	NOUN
easat-3113	137	17	resulting	result	VERB
easat-3113	137	18	from	from	ADP
easat-3113	137	19	cholestasis	cholestasis	NOUN
easat-3113	137	20	improved	improve	VERB
easat-3113	137	21	following	follow	VERB
easat-3113	137	22	two	two	NUM
easat-3113	137	23	weeks	week	NOUN
easat-3113	137	24	of	of	ADP
easat-3113	137	25	treatment	treatment	NOUN
easat-3113	137	26	[	[	X
easat-3113	137	27	35	35	NUM
easat-3113	137	28	]	]	PUNCT
easat-3113	137	29	.	.	PUNCT
easat-3113	138	1	this	this	DET
easat-3113	138	2	study	study	NOUN
easat-3113	138	3	has	have	VERB
easat-3113	138	4	several	several	ADJ
easat-3113	138	5	limitations	limitation	NOUN
easat-3113	138	6	that	that	PRON
easat-3113	138	7	warrant	warrant	VERB
easat-3113	138	8	consideration	consideration	NOUN
easat-3113	138	9	.	.	PUNCT
easat-3113	139	1	this	this	DET
easat-3113	139	2	research	research	NOUN
easat-3113	139	3	utilised	utilise	VERB
easat-3113	139	4	a	a	DET
easat-3113	139	5	retrospective	retrospective	ADJ
easat-3113	139	6	cohort	cohort	NOUN
easat-3113	139	7	design	design	NOUN
easat-3113	139	8	,	,	PUNCT
easat-3113	139	9	with	with	ADP
easat-3113	139	10	data	datum	NOUN
easat-3113	139	11	collection	collection	NOUN
easat-3113	139	12	conducted	conduct	VERB
easat-3113	139	13	over	over	ADP
easat-3113	139	14	a	a	DET
easat-3113	139	15	brief	brief	ADJ
easat-3113	139	16	period	period	NOUN
easat-3113	139	17	.	.	PUNCT
easat-3113	140	1	this	this	DET
easat-3113	140	2	method	method	NOUN
easat-3113	140	3	prevents	prevent	VERB
easat-3113	140	4	the	the	DET
easat-3113	140	5	evaluation	evaluation	NOUN
easat-3113	140	6	of	of	ADP
easat-3113	140	7	the	the	DET
easat-3113	140	8	causal	causal	ADJ
easat-3113	140	9	relationship	relationship	NOUN
easat-3113	140	10	among	among	ADP
easat-3113	140	11	the	the	DET
easat-3113	140	12	variables	variable	NOUN
easat-3113	140	13	.	.	PUNCT
easat-3113	141	1	the	the	DET
easat-3113	141	2	small	small	ADJ
easat-3113	141	3	annual	annual	ADJ
easat-3113	141	4	incidence	incidence	NOUN
easat-3113	141	5	of	of	ADP
easat-3113	141	6	cholestasis	cholestasis	NOUN
easat-3113	141	7	results	result	NOUN
easat-3113	141	8	in	in	ADP
easat-3113	141	9	a	a	DET
easat-3113	141	10	limited	limited	ADJ
easat-3113	141	11	sample	sample	NOUN
easat-3113	141	12	size	size	NOUN
easat-3113	141	13	for	for	ADP
easat-3113	141	14	the	the	DET
easat-3113	141	15	study	study	NOUN
easat-3113	141	16	.	.	PUNCT
easat-3113	142	1	this	this	DET
easat-3113	142	2	study	study	NOUN
easat-3113	142	3	employs	employ	VERB
easat-3113	142	4	a	a	DET
easat-3113	142	5	retrospective	retrospective	ADJ
easat-3113	142	6	methodology	methodology	NOUN
easat-3113	142	7	utilising	utilise	VERB
easat-3113	142	8	secondary	secondary	ADJ
easat-3113	142	9	data	datum	NOUN
easat-3113	142	10	,	,	PUNCT
easat-3113	142	11	which	which	PRON
easat-3113	142	12	resulted	result	VERB
easat-3113	142	13	in	in	ADP
easat-3113	142	14	challenges	challenge	NOUN
easat-3113	142	15	in	in	ADP
easat-3113	142	16	obtaining	obtain	VERB
easat-3113	142	17	complete	complete	ADJ
easat-3113	142	18	data	datum	NOUN
easat-3113	142	19	and	and	CCONJ
easat-3113	142	20	a	a	DET
easat-3113	142	21	heightened	heightened	ADJ
easat-3113	142	22	risk	risk	NOUN
easat-3113	142	23	of	of	ADP
easat-3113	142	24	bias	bias	NOUN
easat-3113	142	25	.	.	PUNCT
easat-3113	143	1	this	this	DET
easat-3113	143	2	study	study	NOUN
easat-3113	143	3	was	be	AUX
easat-3113	143	4	conducted	conduct	VERB
easat-3113	143	5	at	at	ADP
easat-3113	143	6	a	a	DET
easat-3113	143	7	tertiary	tertiary	ADJ
easat-3113	143	8	referral	referral	NOUN
easat-3113	143	9	hospital	hospital	NOUN
easat-3113	143	10	.	.	PUNCT
easat-3113	144	1	consequently	consequently	ADV
easat-3113	144	2	,	,	PUNCT
easat-3113	144	3	identifying	identify	VERB
easat-3113	144	4	cholestasis	cholestasis	NOUN
easat-3113	144	5	patients	patient	NOUN
easat-3113	144	6	without	without	ADP
easat-3113	144	7	comorbid	comorbid	NOUN
easat-3113	144	8	conditions	condition	NOUN
easat-3113	144	9	necessitating	necessitate	VERB
easat-3113	144	10	multiple	multiple	ADJ
easat-3113	144	11	treatments	treatment	NOUN
easat-3113	144	12	proved	prove	VERB
easat-3113	144	13	challenging	challenge	VERB
easat-3113	144	14	in	in	ADP
easat-3113	144	15	order	order	NOUN
easat-3113	144	16	to	to	PART
easat-3113	144	17	mitigate	mitigate	VERB
easat-3113	144	18	confounding	confound	VERB
easat-3113	144	19	variables	variable	NOUN
easat-3113	144	20	.	.	PUNCT
easat-3113	145	1	this	this	DET
easat-3113	145	2	study	study	NOUN
easat-3113	145	3	did	do	AUX
easat-3113	145	4	not	not	PART
easat-3113	145	5	account	account	VERB
easat-3113	145	6	for	for	ADP
easat-3113	145	7	the	the	DET
easat-3113	145	8	use	use	NOUN
easat-3113	145	9	of	of	ADP
easat-3113	145	10	medications	medication	NOUN
easat-3113	145	11	other	other	ADJ
easat-3113	145	12	than	than	ADP
easat-3113	145	13	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	145	14	acid	acid	NOUN
easat-3113	145	15	among	among	ADP
easat-3113	145	16	the	the	DET
easat-3113	145	17	subjects	subject	NOUN
easat-3113	145	18	,	,	PUNCT
easat-3113	145	19	which	which	PRON
easat-3113	145	20	may	may	AUX
easat-3113	145	21	introduce	introduce	VERB
easat-3113	145	22	bias	bias	NOUN
easat-3113	145	23	into	into	ADP
easat-3113	145	24	the	the	DET
easat-3113	145	25	findings	finding	NOUN
easat-3113	145	26	.	.	PUNCT
easat-3113	146	1	this	this	DET
easat-3113	146	2	study	study	NOUN
easat-3113	146	3	provides	provide	VERB
easat-3113	146	4	a	a	DET
easat-3113	146	5	detailed	detailed	ADJ
easat-3113	146	6	examination	examination	NOUN
easat-3113	146	7	of	of	ADP
easat-3113	146	8	changes	change	NOUN
easat-3113	146	9	in	in	ADP
easat-3113	146	10	liver	liver	NOUN
easat-3113	146	11	function	function	NOUN
easat-3113	146	12	biomarker	biomarker	NOUN
easat-3113	146	13	values	value	NOUN
easat-3113	146	14	following	follow	VERB
easat-3113	146	15	the	the	DET
easat-3113	146	16	administration	administration	NOUN
easat-3113	146	17	of	of	ADP
easat-3113	146	18	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	146	19	acid	acid	PROPN
easat-3113	146	20	,	,	PUNCT
easat-3113	146	21	categorising	categorise	VERB
easat-3113	146	22	participants	participant	NOUN
easat-3113	146	23	into	into	ADP
easat-3113	146	24	two	two	NUM
easat-3113	146	25	groups	group	NOUN
easat-3113	146	26	.	.	PUNCT
easat-3113	147	1	5	5	X
easat-3113	147	2	.	.	X
easat-3113	147	3	conclusion	conclusion	NOUN
easat-3113	147	4	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	147	5	acid	acid	NOUN
easat-3113	147	6	presents	present	NOUN
easat-3113	147	7	promise	promise	NOUN
easat-3113	147	8	in	in	ADP
easat-3113	147	9	the	the	DET
easat-3113	147	10	treatment	treatment	NOUN
easat-3113	147	11	of	of	ADP
easat-3113	147	12	cholestasis	cholestasis	NOUN
easat-3113	147	13	or	or	CCONJ
easat-3113	147	14	as	as	ADP
easat-3113	147	15	an	an	DET
easat-3113	147	16	adjunct	adjunct	ADJ
easat-3113	147	17	therapy	therapy	NOUN
easat-3113	147	18	in	in	ADP
easat-3113	147	19	paediatric	paediatric	ADJ
easat-3113	147	20	patients	patient	NOUN
easat-3113	147	21	by	by	ADP
easat-3113	147	22	markedly	markedly	ADV
easat-3113	147	23	decreasing	decrease	VERB
easat-3113	147	24	bilirubin	bilirubin	NOUN
easat-3113	147	25	levels	level	NOUN
easat-3113	147	26	and	and	CCONJ
easat-3113	147	27	enhancing	enhance	VERB
easat-3113	147	28	liver	liver	NOUN
easat-3113	147	29	function	function	NOUN
easat-3113	147	30	.	.	PUNCT
easat-3113	148	1	the	the	DET
easat-3113	148	2	administration	administration	NOUN
easat-3113	148	3	of	of	ADP
easat-3113	148	4	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	148	5	acid	acid	PROPN
easat-3113	148	6	to	to	PART
easat-3113	148	7	infant	infant	VERB
easat-3113	148	8	with	with	ADP
easat-3113	148	9	cholestasis	cholestasis	NOUN
easat-3113	148	10	who	who	PRON
easat-3113	148	11	have	have	AUX
easat-3113	148	12	not	not	PART
easat-3113	148	13	acquired	acquire	VERB
easat-3113	148	14	liver	liver	NOUN
easat-3113	148	15	fibrosis	fibrosis	NOUN
easat-3113	148	16	results	result	NOUN
easat-3113	148	17	in	in	ADP
easat-3113	148	18	a	a	DET
easat-3113	148	19	more	more	ADV
easat-3113	148	20	favourable	favourable	ADJ
easat-3113	148	21	outcome	outcome	NOUN
easat-3113	148	22	.	.	PUNCT
easat-3113	149	1	the	the	DET
easat-3113	149	2	timely	timely	ADJ
easat-3113	149	3	recognition	recognition	NOUN
easat-3113	149	4	of	of	ADP
easat-3113	149	5	cholestasis	cholestasis	NOUN
easat-3113	149	6	is	be	AUX
easat-3113	149	7	essential	essential	ADJ
easat-3113	149	8	for	for	ADP
easat-3113	149	9	determining	determine	VERB
easat-3113	149	10	the	the	DET
easat-3113	149	11	ideal	ideal	ADJ
easat-3113	149	12	timing	timing	NOUN
easat-3113	149	13	for	for	ADP
easat-3113	149	14	medication	medication	NOUN
easat-3113	149	15	administration	administration	NOUN
easat-3113	149	16	.	.	PUNCT
easat-3113	150	1	funding	funding	NOUN
easat-3113	150	2	:	:	PUNCT
easat-3113	150	3	this	this	DET
easat-3113	150	4	study	study	NOUN
easat-3113	150	5	received	receive	VERB
easat-3113	150	6	no	no	DET
easat-3113	150	7	particular	particular	ADJ
easat-3113	150	8	grant	grant	NOUN
easat-3113	150	9	from	from	ADP
easat-3113	150	10	any	any	DET
easat-3113	150	11	funding	funding	NOUN
easat-3113	150	12	source	source	NOUN
easat-3113	150	13	in	in	ADP
easat-3113	150	14	the	the	DET
easat-3113	150	15	public	public	ADJ
easat-3113	150	16	,	,	PUNCT
easat-3113	150	17	commercial	commercial	ADJ
easat-3113	150	18	,	,	PUNCT
easat-3113	150	19	or	or	CCONJ
easat-3113	150	20	non	non	ADJ
easat-3113	150	21	-	-	ADJ
easat-3113	150	22	profit	profit	ADJ
easat-3113	150	23	sectors	sector	NOUN
easat-3113	150	24	.	.	PUNCT
easat-3113	151	1	authors	author	NOUN
easat-3113	151	2	’	'	PUNCT
easat-3113	151	3	contributions	contribution	NOUN
easat-3113	151	4	:	:	PUNCT
easat-3113	151	5	nh	nh	NUM
easat-3113	151	6	:	:	PUNCT
easat-3113	151	7	data	data	NOUN
easat-3113	151	8	collection	collection	NOUN
easat-3113	151	9	,	,	PUNCT
easat-3113	151	10	data	datum	NOUN
easat-3113	151	11	analysis	analysis	NOUN
easat-3113	151	12	,	,	PUNCT
easat-3113	151	13	conceptualization	conceptualization	NOUN
easat-3113	151	14	,	,	PUNCT
easat-3113	151	15	drafting	drafting	NOUN
easat-3113	151	16	,	,	PUNCT
easat-3113	151	17	manuscript	manuscript	NOUN
easat-3113	151	18	preparation	preparation	NOUN
easat-3113	151	19	;	;	PUNCT
easat-3113	151	20	bs	bs	NOUN
easat-3113	151	21	:	:	PUNCT
easat-3113	151	22	supervision	supervision	NOUN
easat-3113	151	23	,	,	PUNCT
easat-3113	151	24	analysis	analysis	NOUN
easat-3113	151	25	,	,	PUNCT
easat-3113	151	26	interpretation	interpretation	NOUN
easat-3113	151	27	;	;	PUNCT
easat-3113	151	28	cd	cd	PROPN
easat-3113	151	29	:	:	PUNCT
easat-3113	151	30	supervision	supervision	NOUN
easat-3113	151	31	,	,	PUNCT
easat-3113	151	32	analysis	analysis	NOUN
easat-3113	151	33	,	,	PUNCT
easat-3113	151	34	editing	editing	NOUN
easat-3113	151	35	,	,	PUNCT
easat-3113	151	36	interpretation	interpretation	NOUN
easat-3113	151	37	;	;	PUNCT
easat-3113	151	38	ra	ra	NOUN
easat-3113	151	39	:	:	PUNCT
easat-3113	151	40	manuscript	manuscript	NOUN
easat-3113	151	41	preparation	preparation	NOUN
easat-3113	151	42	,	,	PUNCT
easat-3113	151	43	editing	edit	VERB
easat-3113	151	44	copyright	copyright	NOUN
easat-3113	151	45	:	:	PUNCT
easat-3113	152	1	©	©	PROPN
easat-3113	152	2	2024	2024	NUM
easat-3113	152	3	by	by	ADP
easat-3113	152	4	the	the	DET
easat-3113	152	5	authors	author	NOUN
easat-3113	152	6	.	.	PUNCT
easat-3113	153	1	this	this	DET
easat-3113	153	2	article	article	NOUN
easat-3113	153	3	is	be	AUX
easat-3113	153	4	an	an	DET
easat-3113	153	5	open	open	ADJ
easat-3113	153	6	access	access	NOUN
easat-3113	153	7	article	article	NOUN
easat-3113	153	8	distributed	distribute	VERB
easat-3113	153	9	under	under	ADP
easat-3113	153	10	the	the	DET
easat-3113	153	11	terms	term	NOUN
easat-3113	153	12	and	and	CCONJ
easat-3113	153	13	conditions	condition	NOUN
easat-3113	153	14	of	of	ADP
easat-3113	153	15	the	the	DET
easat-3113	153	16	creative	creative	ADJ
easat-3113	153	17	commons	common	NOUN
easat-3113	153	18	attribution	attribution	NOUN
easat-3113	153	19	(	(	PUNCT
easat-3113	153	20	cc	cc	NOUN
easat-3113	153	21	by	by	ADP
easat-3113	153	22	)	)	PUNCT
easat-3113	153	23	license	license	NOUN
easat-3113	153	24	(	(	PUNCT
easat-3113	153	25	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-3113	153	26	)	)	PUNCT
easat-3113	153	27	.	.	PUNCT
easat-3113	154	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-3113	154	2	5080	5080	NUM
easat-3113	154	3	edelweiss	edelweiss	PROPN
easat-3113	154	4	applied	apply	VERB
easat-3113	154	5	science	science	NOUN
easat-3113	154	6	and	and	CCONJ
easat-3113	154	7	technology	technology	NOUN
easat-3113	154	8	issn	issn	PROPN
easat-3113	154	9	:	:	PUNCT
easat-3113	154	10	2576	2576	NUM
easat-3113	154	11	-	-	SYM
easat-3113	154	12	8484	8484	NUM
easat-3113	154	13	vol	vol	NOUN
easat-3113	154	14	.	.	PROPN
easat-3113	154	15	8	8	NUM
easat-3113	154	16	,	,	PUNCT
easat-3113	154	17	no	no	INTJ
easat-3113	154	18	.	.	NOUN
easat-3113	154	19	6	6	NUM
easat-3113	154	20	:	:	PUNCT
easat-3113	154	21	5075	5075	NUM
easat-3113	154	22	-	-	SYM
easat-3113	154	23	5081	5081	NUM
easat-3113	154	24	,	,	PUNCT
easat-3113	154	25	2024	2024	NUM
easat-3113	154	26	doi	doi	NOUN
easat-3113	154	27	:	:	PUNCT
easat-3113	154	28	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	154	29	©	©	PROPN
easat-3113	154	30	2024	2024	NUM
easat-3113	154	31	by	by	ADP
easat-3113	154	32	the	the	DET
easat-3113	154	33	authors	author	NOUN
easat-3113	154	34	;	;	PUNCT
easat-3113	154	35	licensee	licensee	PROPN
easat-3113	154	36	learning	learn	VERB
easat-3113	154	37	gate	gate	NOUN
easat-3113	154	38	references	reference	NOUN
easat-3113	154	39	[	[	X
easat-3113	154	40	1	1	NUM
easat-3113	154	41	]	]	X
easat-3113	154	42	moyer	moyer	PROPN
easat-3113	154	43	v	v	PROPN
easat-3113	154	44	,	,	PUNCT
easat-3113	154	45	freese	freese	PROPN
easat-3113	154	46	dk	dk	PROPN
easat-3113	154	47	,	,	PUNCT
easat-3113	154	48	whitington	whitington	PROPN
easat-3113	154	49	pf	pf	PROPN
easat-3113	154	50	,	,	PUNCT
easat-3113	154	51	olson	olson	NOUN
easat-3113	154	52	ad	ad	NOUN
easat-3113	154	53	,	,	PUNCT
easat-3113	154	54	brewer	brewer	NOUN
easat-3113	154	55	f	f	PROPN
easat-3113	154	56	,	,	PUNCT
easat-3113	154	57	colletti	colletti	ADJ
easat-3113	154	58	rb	rb	NOUN
easat-3113	154	59	,	,	PUNCT
easat-3113	154	60	et	et	PROPN
easat-3113	154	61	al	al	PROPN
easat-3113	154	62	.	.	PROPN
easat-3113	154	63	guideline	guideline	NOUN
easat-3113	154	64	for	for	ADP
easat-3113	154	65	the	the	DET
easat-3113	154	66	evaluation	evaluation	NOUN
easat-3113	154	67	of	of	ADP
easat-3113	154	68	cholestatic	cholestatic	ADJ
easat-3113	154	69	jaundice	jaundice	NOUN
easat-3113	154	70	in	in	ADP
easat-3113	154	71	infants	infant	NOUN
easat-3113	154	72	:	:	PUNCT
easat-3113	154	73	recommendations	recommendation	NOUN
easat-3113	154	74	of	of	ADP
easat-3113	154	75	the	the	DET
easat-3113	154	76	north	north	ADJ
easat-3113	154	77	american	american	ADJ
easat-3113	154	78	society	society	NOUN
easat-3113	154	79	for	for	ADP
easat-3113	154	80	pediatric	pediatric	ADJ
easat-3113	154	81	gastroenterology	gastroenterology	NOUN
easat-3113	154	82	,	,	PUNCT
easat-3113	154	83	hepatology	hepatology	NOUN
easat-3113	154	84	and	and	CCONJ
easat-3113	154	85	nutrition	nutrition	NOUN
easat-3113	154	86	.	.	PUNCT
easat-3113	155	1	j	j	PROPN
easat-3113	155	2	pediatr	pediatr	PROPN
easat-3113	155	3	gastroenterol	gastroenterol	PROPN
easat-3113	155	4	nutr	nutr	PROPN
easat-3113	155	5	.	.	PROPN
easat-3113	155	6	2004;(august):115–28	2004;(august):115–28	PROPN
easat-3113	155	7	.	.	PUNCT
easat-3113	156	1	doi:10.1097/00005176	doi:10.1097/00005176	NOUN
easat-3113	156	2	-	-	PUNCT
easat-3113	156	3	20040800000001	20040800000001	NUM
easat-3113	156	4	.	.	PUNCT
easat-3113	157	1	[	[	X
easat-3113	157	2	2	2	X
easat-3113	157	3	]	]	X
easat-3113	157	4	shah	shah	NOUN
easat-3113	157	5	r	r	PROPN
easat-3113	157	6	,	,	PUNCT
easat-3113	157	7	john	john	PROPN
easat-3113	157	8	s.	s.	PROPN
easat-3113	157	9	cholestatic	cholestatic	PROPN
easat-3113	157	10	jaundice	jaundice	PROPN
easat-3113	157	11	.	.	PUNCT
easat-3113	158	1	statpearls	statpearls	PROPN
easat-3113	158	2	publishing	publishing	NOUN
easat-3113	158	3	,	,	PUNCT
easat-3113	158	4	treasure	treasure	NOUN
easat-3113	158	5	island	island	NOUN
easat-3113	158	6	(	(	PUNCT
easat-3113	158	7	fl	fl	NOUN
easat-3113	158	8	)	)	PUNCT
easat-3113	158	9	;	;	PUNCT
easat-3113	158	10	2022	2022	NUM
easat-3113	158	11	.	.	PUNCT
easat-3113	159	1	1–9	1–9	NUM
easat-3113	159	2	p	p	NOUN
easat-3113	159	3	(	(	PUNCT
easat-3113	159	4	https://www.ncbi.nlm.nih.gov/books/nbk482279/#_article-19459_s1	https://www.ncbi.nlm.nih.gov/books/nbk482279/#_article-19459_s1	PROPN
easat-3113	159	5	_	_	NOUN
easat-3113	159	6	)	)	PUNCT
easat-3113	159	7	.	.	PUNCT
easat-3113	160	1	[	[	X
easat-3113	160	2	3	3	X
easat-3113	160	3	]	]	X
easat-3113	160	4	slusher	slusher	PROPN
easat-3113	160	5	tm	tm	PROPN
easat-3113	160	6	,	,	PUNCT
easat-3113	160	7	zamora	zamora	PROPN
easat-3113	160	8	tg	tg	PROPN
easat-3113	160	9	,	,	PUNCT
easat-3113	160	10	appiah	appiah	PROPN
easat-3113	160	11	d	d	PROPN
easat-3113	160	12	,	,	PUNCT
easat-3113	160	13	stanke	stanke	PROPN
easat-3113	160	14	ju	ju	PROPN
easat-3113	160	15	,	,	PUNCT
easat-3113	160	16	strand	strand	PROPN
easat-3113	160	17	ma	ma	PROPN
easat-3113	160	18	,	,	PUNCT
easat-3113	160	19	lee	lee	PROPN
easat-3113	160	20	bw	bw	PROPN
easat-3113	160	21	,	,	PUNCT
easat-3113	160	22	et	et	PROPN
easat-3113	160	23	al	al	PROPN
easat-3113	160	24	.	.	PUNCT
easat-3113	160	25	burden	burden	NOUN
easat-3113	160	26	of	of	ADP
easat-3113	160	27	severe	severe	ADJ
easat-3113	160	28	neonatal	neonatal	ADJ
easat-3113	160	29	jaundice	jaundice	NOUN
easat-3113	160	30	:	:	PUNCT
easat-3113	160	31	a	a	DET
easat-3113	160	32	systematic	systematic	ADJ
easat-3113	160	33	review	review	NOUN
easat-3113	160	34	and	and	CCONJ
easat-3113	160	35	meta	meta	ADJ
easat-3113	160	36	-	-	PUNCT
easat-3113	160	37	analysis	analysis	NOUN
easat-3113	160	38	.	.	PUNCT
easat-3113	161	1	bmj	bmj	VERB
easat-3113	161	2	paediatr	paediatr	ADV
easat-3113	161	3	open	open	ADJ
easat-3113	161	4	.	.	PUNCT
easat-3113	161	5	2017;1(1	2017;1(1	NUM
easat-3113	161	6	)	)	PUNCT
easat-3113	161	7	.	.	PUNCT
easat-3113	162	1	doi:10.1136	doi:10.1136	NOUN
easat-3113	162	2	/	/	SYM
easat-3113	162	3	bmjpo-2017	bmjpo-2017	NOUN
easat-3113	162	4	-	-	PUNCT
easat-3113	162	5	000105	000105	NUM
easat-3113	162	6	.	.	PUNCT
easat-3113	163	1	[	[	X
easat-3113	163	2	4	4	X
easat-3113	163	3	]	]	PUNCT
easat-3113	163	4	bhatia	bhatia	PROPN
easat-3113	163	5	v	v	PROPN
easat-3113	163	6	,	,	PUNCT
easat-3113	163	7	bavdekar	bavdekar	VERB
easat-3113	163	8	a	a	X
easat-3113	163	9	,	,	PUNCT
easat-3113	163	10	matthai	matthai	PROPN
easat-3113	163	11	j	j	PROPN
easat-3113	163	12	,	,	PUNCT
easat-3113	163	13	waikar	waikar	PROPN
easat-3113	163	14	y	y	PROPN
easat-3113	163	15	,	,	PUNCT
easat-3113	163	16	sibal	sibal	ADJ
easat-3113	163	17	a.	a.	NOUN
easat-3113	163	18	management	management	NOUN
easat-3113	163	19	of	of	ADP
easat-3113	163	20	neonatal	neonatal	ADJ
easat-3113	163	21	cholestasis	cholestasis	NOUN
easat-3113	163	22	:	:	PUNCT
easat-3113	163	23	consensus	consensus	NOUN
easat-3113	163	24	statement	statement	NOUN
easat-3113	163	25	of	of	ADP
easat-3113	163	26	the	the	DET
easat-3113	163	27	pediatric	pediatric	ADJ
easat-3113	163	28	gastroenterology	gastroenterology	NOUN
easat-3113	163	29	chapter	chapter	NOUN
easat-3113	163	30	of	of	ADP
easat-3113	163	31	indian	indian	PROPN
easat-3113	163	32	academy	academy	PROPN
easat-3113	163	33	of	of	ADP
easat-3113	163	34	pediatrics	pediatric	NOUN
easat-3113	163	35	.	.	PUNCT
easat-3113	164	1	indian	indian	PROPN
easat-3113	164	2	ped	ped	PROPN
easat-3113	164	3	.	.	PROPN
easat-3113	164	4	2014	2014	NUM
easat-3113	164	5	;	;	PUNCT
easat-3113	164	6	51:203–10	51:203–10	NUM
easat-3113	164	7	.	.	PUNCT
easat-3113	165	1	doi	doi	NOUN
easat-3113	165	2	:	:	PUNCT
easat-3113	165	3	10.1007	10.1007	NUM
easat-3113	165	4	/	/	SYM
easat-3113	165	5	s13312	s13312	ADJ
easat-3113	165	6	-	-	PUNCT
easat-3113	165	7	014	014	NUM
easat-3113	165	8	-	-	PUNCT
easat-3113	165	9	0375	0375	NUM
easat-3113	165	10	-	-	SYM
easat-3113	165	11	2	2	NUM
easat-3113	165	12	.	.	PUNCT
easat-3113	166	1	[	[	X
easat-3113	166	2	5	5	X
easat-3113	166	3	]	]	X
easat-3113	166	4	liu	liu	PROPN
easat-3113	166	5	ch	ch	PROPN
easat-3113	166	6	,	,	PUNCT
easat-3113	166	7	bowlus	bowlus	X
easat-3113	166	8	cl	cl	NOUN
easat-3113	166	9	.	.	PUNCT
easat-3113	167	1	treatment	treatment	NOUN
easat-3113	167	2	of	of	ADP
easat-3113	167	3	primary	primary	ADJ
easat-3113	167	4	biliary	biliary	NOUN
easat-3113	167	5	cholangitis	cholangitis	NOUN
easat-3113	167	6	:	:	PUNCT
easat-3113	167	7	first	first	ADJ
easat-3113	167	8	-	-	PUNCT
easat-3113	167	9	line	line	NOUN
easat-3113	167	10	and	and	CCONJ
easat-3113	167	11	second	second	ADJ
easat-3113	167	12	-	-	PUNCT
easat-3113	167	13	line	line	NOUN
easat-3113	167	14	therapies	therapy	NOUN
easat-3113	167	15	.	.	PUNCT
easat-3113	168	1	clin	clin	PROPN
easat-3113	168	2	liver	liver	PROPN
easat-3113	168	3	dis	dis	PROPN
easat-3113	168	4	(	(	PUNCT
easat-3113	168	5	hoboken	hoboken	PROPN
easat-3113	168	6	)	)	PUNCT
easat-3113	168	7	.	.	PUNCT
easat-3113	169	1	2022;26(4):705–26	2022;26(4):705–26	X
easat-3113	169	2	.	.	PUNCT
easat-3113	169	3	doi	doi	NOUN
easat-3113	169	4	:	:	PUNCT
easat-3113	169	5	10.1016	10.1016	NUM
easat-3113	169	6	/	/	SYM
easat-3113	169	7	j.cld.2022.06.012	j.cld.2022.06.012	NOUN
easat-3113	169	8	.	.	PUNCT
easat-3113	170	1	[	[	X
easat-3113	170	2	6	6	NUM
easat-3113	170	3	]	]	PUNCT
easat-3113	170	4	chascsa	chascsa	VERB
easat-3113	170	5	d	d	PROPN
easat-3113	170	6	,	,	PUNCT
easat-3113	170	7	carey	carey	PROPN
easat-3113	170	8	ej	ej	PROPN
easat-3113	170	9	,	,	PUNCT
easat-3113	170	10	lindor	lindor	PROPN
easat-3113	170	11	kd	kd	PROPN
easat-3113	170	12	.	.	PROPN
easat-3113	170	13	old	old	ADJ
easat-3113	170	14	and	and	CCONJ
easat-3113	170	15	new	new	ADJ
easat-3113	170	16	treatments	treatment	NOUN
easat-3113	170	17	for	for	ADP
easat-3113	170	18	primary	primary	ADJ
easat-3113	170	19	biliary	biliary	NOUN
easat-3113	170	20	cholangitis	cholangitis	NOUN
easat-3113	170	21	.	.	PUNCT
easat-3113	171	1	liver	liver	NOUN
easat-3113	171	2	int	int	NOUN
easat-3113	171	3	.	.	PUNCT
easat-3113	172	1	2017	2017	NUM
easat-3113	172	2	apr;37(4):490–9	apr;37(4):490–9	X
easat-3113	172	3	.	.	PUNCT
easat-3113	173	1	doi	doi	NOUN
easat-3113	173	2	:	:	PUNCT
easat-3113	173	3	10.1111	10.1111	NUM
easat-3113	173	4	/	/	SYM
easat-3113	173	5	liv.13294	liv.13294	NOUN
easat-3113	173	6	.	.	PUNCT
easat-3113	174	1	[	[	X
easat-3113	174	2	7	7	X
easat-3113	174	3	]	]	X
easat-3113	174	4	razori	razori	NOUN
easat-3113	174	5	mv	mv	PROPN
easat-3113	174	6	,	,	PUNCT
easat-3113	174	7	maidagan	maidagan	ADJ
easat-3113	174	8	pm	pm	NOUN
easat-3113	174	9	,	,	PUNCT
easat-3113	174	10	ciriaci	ciriaci	NOUN
easat-3113	174	11	n	n	CCONJ
easat-3113	174	12	,	,	PUNCT
easat-3113	174	13	andermatten	andermatten	ADJ
easat-3113	174	14	rb	rb	NOUN
easat-3113	174	15	,	,	PUNCT
easat-3113	174	16	barosso	barosso	PROPN
easat-3113	174	17	ir	ir	PROPN
easat-3113	174	18	,	,	PUNCT
easat-3113	174	19	martín	martín	PROPN
easat-3113	174	20	pl	pl	PROPN
easat-3113	174	21	,	,	PUNCT
easat-3113	174	22	et	et	PROPN
easat-3113	174	23	al	al	PROPN
easat-3113	174	24	.	.	PROPN
easat-3113	174	25	anticholestatic	anticholestatic	ADJ
easat-3113	174	26	mechanisms	mechanism	NOUN
easat-3113	174	27	of	of	ADP
easat-3113	174	28	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	174	29	acid	acid	NOUN
easat-3113	174	30	in	in	ADP
easat-3113	174	31	lipopolysaccharide	lipopolysaccharide	ADV
easat-3113	174	32	-	-	PUNCT
easat-3113	174	33	induced	induce	VERB
easat-3113	174	34	cholestasis	cholestasis	NOUN
easat-3113	174	35	.	.	PUNCT
easat-3113	175	1	biochem	biochem	PROPN
easat-3113	175	2	pharmacol	pharmacol	PROPN
easat-3113	175	3	.	.	PROPN
easat-3113	176	1	2019	2019	NUM
easat-3113	176	2	oct	oct	PROPN
easat-3113	176	3	;	;	PUNCT
easat-3113	176	4	168:48–56	168:48–56	NUM
easat-3113	176	5	.	.	PUNCT
easat-3113	177	1	doi	doi	NOUN
easat-3113	177	2	:	:	PUNCT
easat-3113	177	3	10.1016	10.1016	NUM
easat-3113	177	4	/	/	SYM
easat-3113	177	5	j.bcp.2019.06.009	j.bcp.2019.06.009	PROPN
easat-3113	177	6	.	.	PUNCT
easat-3113	178	1	[	[	X
easat-3113	178	2	8	8	NUM
easat-3113	178	3	]	]	X
easat-3113	178	4	ikegami	ikegami	PROPN
easat-3113	178	5	t	t	PROPN
easat-3113	178	6	,	,	PUNCT
easat-3113	178	7	matsuzaki	matsuzaki	PROPN
easat-3113	178	8	y.	y.	PROPN
easat-3113	178	9	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	178	10	acid	acid	PROPN
easat-3113	178	11	:	:	PUNCT
easat-3113	178	12	mechanism	mechanism	NOUN
easat-3113	178	13	of	of	ADP
easat-3113	178	14	action	action	NOUN
easat-3113	178	15	and	and	CCONJ
easat-3113	178	16	novel	novel	ADJ
easat-3113	178	17	clinical	clinical	ADJ
easat-3113	178	18	applications	application	NOUN
easat-3113	178	19	.	.	PUNCT
easat-3113	179	1	hepatol	hepatol	ADJ
easat-3113	179	2	res	re	NOUN
easat-3113	179	3	.	.	PUNCT
easat-3113	179	4	2008	2008	NUM
easat-3113	179	5	nov	nov	NOUN
easat-3113	179	6	23;38(2):123–31	23;38(2):123–31	NUM
easat-3113	179	7	.	.	PUNCT
easat-3113	180	1	doi	doi	NOUN
easat-3113	180	2	:	:	PUNCT
easat-3113	180	3	10.1111	10.1111	NUM
easat-3113	180	4	/	/	SYM
easat-3113	180	5	j.1872	j.1872	PROPN
easat-3113	180	6	-	-	PUNCT
easat-3113	180	7	034x.2007.00297	034x.2007.00297	NOUN
easat-3113	180	8	.	.	PUNCT
easat-3113	180	9	x.	x.	NOUN
easat-3113	181	1	[	[	X
easat-3113	181	2	9	9	NUM
easat-3113	181	3	]	]	X
easat-3113	181	4	yoshikawa	yoshikawa	PROPN
easat-3113	181	5	m	m	PROPN
easat-3113	181	6	,	,	PUNCT
easat-3113	181	7	tsujii	tsujii	PROPN
easat-3113	181	8	t	t	PROPN
easat-3113	181	9	,	,	PUNCT
easat-3113	181	10	matsumura	matsumura	PROPN
easat-3113	181	11	k	k	PROPN
easat-3113	181	12	,	,	PUNCT
easat-3113	181	13	yamao	yamao	PROPN
easat-3113	181	14	j	j	PROPN
easat-3113	181	15	,	,	PUNCT
easat-3113	181	16	matsumura	matsumura	PROPN
easat-3113	181	17	y	y	PROPN
easat-3113	181	18	,	,	PUNCT
easat-3113	181	19	kubo	kubo	PROPN
easat-3113	181	20	r	r	PROPN
easat-3113	181	21	,	,	PUNCT
easat-3113	181	22	et	et	PROPN
easat-3113	181	23	al	al	PROPN
easat-3113	181	24	.	.	PROPN
easat-3113	181	25	immunomodulatory	immunomodulatory	ADJ
easat-3113	181	26	effects	effect	NOUN
easat-3113	181	27	of	of	ADP
easat-3113	181	28	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	181	29	acid	acid	NOUN
easat-3113	181	30	on	on	ADP
easat-3113	181	31	immune	immune	ADJ
easat-3113	181	32	responses	response	NOUN
easat-3113	181	33	.	.	PUNCT
easat-3113	182	1	hepatology	hepatology	NOUN
easat-3113	182	2	.	.	PUNCT
easat-3113	183	1	1992	1992	NUM
easat-3113	183	2	aug;16(2):358–64	aug;16(2):358–64	PROPN
easat-3113	183	3	.	.	PUNCT
easat-3113	184	1	doi:10.1002	doi:10.1002	NOUN
easat-3113	184	2	/	/	SYM
easat-3113	184	3	hep.1840160213	hep.1840160213	NOUN
easat-3113	184	4	.	.	PUNCT
easat-3113	185	1	[	[	X
easat-3113	185	2	10	10	NUM
easat-3113	185	3	]	]	PUNCT
easat-3113	185	4	.	.	PUNCT
easat-3113	186	1	direktorat	direktorat	NOUN
easat-3113	186	2	jenderal	jenderal	PROPN
easat-3113	186	3	kefarmasian	kefarmasian	PROPN
easat-3113	186	4	dan	dan	PROPN
easat-3113	186	5	alat	alat	PROPN
easat-3113	186	6	kesehatan	kesehatan	PROPN
easat-3113	186	7	kementerian	kementerian	PROPN
easat-3113	186	8	kesehatan	kesehatan	PROPN
easat-3113	186	9	republik	republik	PROPN
easat-3113	186	10	indonesia	indonesia	PROPN
easat-3113	186	11	.	.	PUNCT
easat-3113	187	1	daftar	daftar	PROPN
easat-3113	187	2	obat	obat	PROPN
easat-3113	188	1	[	[	X
easat-3113	188	2	internet	internet	NOUN
easat-3113	188	3	]	]	X
easat-3113	188	4	.	.	PUNCT
easat-3113	189	1	2023	2023	NUM
easat-3113	190	1	[	[	X
easat-3113	190	2	cited	cite	VERB
easat-3113	190	3	2023	2023	NUM
easat-3113	190	4	may	may	AUX
easat-3113	190	5	20	20	NUM
easat-3113	190	6	]	]	PUNCT
easat-3113	190	7	(	(	PUNCT
easat-3113	190	8	https://e-fornas.kemkes.go.id/daftar_obat.php	https://e-fornas.kemkes.go.id/daftar_obat.php	NOUN
easat-3113	190	9	)	)	PUNCT
easat-3113	191	1	[	[	X
easat-3113	191	2	11	11	NUM
easat-3113	191	3	]	]	X
easat-3113	191	4	abdulah	abdulah	PROPN
easat-3113	191	5	r	r	PROPN
easat-3113	191	6	,	,	PUNCT
easat-3113	191	7	khairinisa	khairinisa	PROPN
easat-3113	191	8	ma	ma	PROPN
easat-3113	191	9	,	,	PUNCT
easat-3113	191	10	pratiwi	pratiwi	NOUN
easat-3113	191	11	aa	aa	NOUN
easat-3113	191	12	,	,	PUNCT
easat-3113	191	13	barliana	barliana	PROPN
easat-3113	191	14	mi	mi	PROPN
easat-3113	191	15	,	,	PUNCT
easat-3113	191	16	pradipta	pradipta	NOUN
easat-3113	191	17	is	be	AUX
easat-3113	191	18	,	,	PUNCT
easat-3113	191	19	halimah	halimah	NOUN
easat-3113	191	20	e	e	NOUN
easat-3113	191	21	,	,	PUNCT
easat-3113	191	22	et	et	PROPN
easat-3113	191	23	al	al	PROPN
easat-3113	191	24	.	.	PROPN
easat-3113	191	25	off	off	ADP
easat-3113	191	26	-	-	PUNCT
easat-3113	191	27	label	label	NOUN
easat-3113	191	28	paediatric	paediatric	ADJ
easat-3113	191	29	drug	drug	NOUN
easat-3113	191	30	use	use	NOUN
easat-3113	191	31	in	in	ADP
easat-3113	191	32	an	an	DET
easat-3113	191	33	indonesian	indonesian	ADJ
easat-3113	191	34	community	community	NOUN
easat-3113	191	35	setting	setting	NOUN
easat-3113	191	36	.	.	PUNCT
easat-3113	192	1	j	j	PROPN
easat-3113	192	2	clin	clin	PROPN
easat-3113	192	3	pharm	pharm	PROPN
easat-3113	192	4	ther	ther	ADV
easat-3113	192	5	.	.	PUNCT
easat-3113	193	1	2015;40(4):409–12	2015;40(4):409–12	NUM
easat-3113	193	2	.	.	PUNCT
easat-3113	194	1	doi:10.1111	doi:10.1111	PROPN
easat-3113	194	2	/	/	SYM
easat-3113	194	3	jcpt.12276	jcpt.12276	PROPN
easat-3113	194	4	.	.	PUNCT
easat-3113	195	1	[	[	X
easat-3113	195	2	12	12	NUM
easat-3113	195	3	]	]	PUNCT
easat-3113	195	4	pratiwi	pratiwi	NOUN
easat-3113	195	5	aa	aa	NOUN
easat-3113	195	6	,	,	PUNCT
easat-3113	195	7	khairinnisa	khairinnisa	VERB
easat-3113	195	8	ma	ma	PROPN
easat-3113	195	9	,	,	PUNCT
easat-3113	195	10	alfian	alfian	ADJ
easat-3113	195	11	sd	sd	NOUN
easat-3113	195	12	,	,	PUNCT
easat-3113	195	13	priyadi	priyadi	NOUN
easat-3113	195	14	a	a	PRON
easat-3113	195	15	,	,	PUNCT
easat-3113	195	16	pradipta	pradipta	NOUN
easat-3113	195	17	is	be	AUX
easat-3113	195	18	,	,	PUNCT
easat-3113	195	19	abdulah	abdulah	PROPN
easat-3113	195	20	r.	r.	PROPN
easat-3113	195	21	the	the	DET
easat-3113	195	22	prescription	prescription	NOUN
easat-3113	195	23	of	of	ADP
easat-3113	195	24	off	off	ADP
easat-3113	195	25	-	-	PUNCT
easat-3113	195	26	label	label	NOUN
easat-3113	195	27	drugs	drug	NOUN
easat-3113	195	28	towards	towards	ADP
easat-3113	195	29	0	0	NUM
easat-3113	195	30	–	–	SYM
easat-3113	195	31	2	2	NUM
easat-3113	195	32	years	year	NOUN
easat-3113	195	33	old	old	ADJ
easat-3113	195	34	pediatric	pediatric	ADJ
easat-3113	195	35	patients	patient	NOUN
easat-3113	195	36	in	in	ADP
easat-3113	195	37	community	community	NOUN
easat-3113	195	38	pharmacy	pharmacy	NOUN
easat-3113	195	39	in	in	ADP
easat-3113	195	40	bandung	bandung	PROPN
easat-3113	195	41	city	city	PROPN
easat-3113	195	42	.	.	PUNCT
easat-3113	196	1	peresepan	peresepan	PROPN
easat-3113	196	2	obat	obat	PROPN
easat-3113	196	3	-	-	PUNCT
easat-3113	196	4	obat	obat	PROPN
easat-3113	196	5	offlabel	offlabel	PROPN
easat-3113	196	6	pada	pada	PROPN
easat-3113	196	7	pasien	pasien	PROPN
easat-3113	196	8	anak	anak	PROPN
easat-3113	196	9	usia	usia	PROPN
easat-3113	196	10	0	0	PROPN
easat-3113	197	1	hingga	hingga	PROPN
easat-3113	197	2	2	2	PROPN
easat-3113	197	3	tahun	tahun	PROPN
easat-3113	197	4	di	di	PROPN
easat-3113	197	5	apotek	apotek	PROPN
easat-3113	197	6	kota	kota	PROPN
easat-3113	197	7	bandung	bandung	PROPN
easat-3113	197	8	.	.	PUNCT
easat-3113	198	1	2013;2(june):39	2013;2(june):39	NUM
easat-3113	198	2	.	.	PUNCT
easat-3113	199	1	[	[	X
easat-3113	199	2	13	13	NUM
easat-3113	199	3	]	]	PUNCT
easat-3113	199	4	bolisetty	bolisetty	VERB
easat-3113	199	5	s.	s.	PROPN
easat-3113	199	6	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	199	7	acid	acid	PROPN
easat-3113	199	8	newborn	newborn	ADJ
easat-3113	199	9	use	use	NOUN
easat-3113	199	10	only	only	ADV
easat-3113	199	11	.	.	PUNCT
easat-3113	200	1	neonatal	neonatal	ADJ
easat-3113	200	2	medicines	medicine	NOUN
easat-3113	200	3	formulary	formulary	ADJ
easat-3113	200	4	consensus	consensus	NOUN
easat-3113	200	5	group	group	NOUN
easat-3113	200	6	.	.	PUNCT
easat-3113	201	1	2021;1–4	2021;1–4	NUM
easat-3113	201	2	.	.	PUNCT
easat-3113	202	1	[	[	X
easat-3113	202	2	14	14	NUM
easat-3113	202	3	]	]	PUNCT
easat-3113	202	4	child	child	NOUN
easat-3113	202	5	health	health	PROPN
easat-3113	202	6	department	department	PROPN
easat-3113	202	7	.	.	PUNCT
easat-3113	203	1	kolestasis	kolestasis	PROPN
easat-3113	203	2	pada	pada	PROPN
easat-3113	203	3	bayi	bayi	PROPN
easat-3113	203	4	,	,	PUNCT
easat-3113	203	5	hepatitis	hepatitis	NOUN
easat-3113	203	6	akut	akut	NOUN
easat-3113	203	7	.	.	PUNCT
easat-3113	204	1	in	in	ADP
easat-3113	204	2	:	:	PUNCT
easat-3113	204	3	panduan	panduan	PROPN
easat-3113	204	4	praktik	praktik	PROPN
easat-3113	204	5	klinis	klinis	PROPN
easat-3113	204	6	.	.	PUNCT
easat-3113	205	1	surabaya	surabaya	PROPN
easat-3113	205	2	:	:	PUNCT
easat-3113	205	3	soetomo	soetomo	PROPN
easat-3113	205	4	genaral	genaral	ADJ
easat-3113	205	5	hospital	hospital	NOUN
easat-3113	205	6	;	;	PUNCT
easat-3113	205	7	2014	2014	NUM
easat-3113	205	8	.	.	PUNCT
easat-3113	206	1	p.	p.	NOUN
easat-3113	206	2	62–5	62–5	PROPN
easat-3113	206	3	.	.	PUNCT
easat-3113	207	1	[	[	X
easat-3113	207	2	15	15	NUM
easat-3113	207	3	]	]	X
easat-3113	207	4	huang	huang	PROPN
easat-3113	207	5	l	l	PROPN
easat-3113	207	6	,	,	PUNCT
easat-3113	207	7	li	li	PROPN
easat-3113	207	8	s	s	PROPN
easat-3113	207	9	,	,	PUNCT
easat-3113	207	10	chen	chen	PROPN
easat-3113	207	11	j	j	PROPN
easat-3113	207	12	,	,	PUNCT
easat-3113	207	13	zhu	zhu	PROPN
easat-3113	207	14	y	y	PROPN
easat-3113	207	15	,	,	PUNCT
easat-3113	207	16	lan	lan	PROPN
easat-3113	207	17	k	k	PROPN
easat-3113	207	18	,	,	PUNCT
easat-3113	207	19	zeng	zeng	PROPN
easat-3113	207	20	l	l	PROPN
easat-3113	207	21	,	,	PUNCT
easat-3113	207	22	et	et	PROPN
easat-3113	207	23	al	al	PROPN
easat-3113	207	24	.	.	PROPN
easat-3113	207	25	efficacy	efficacy	NOUN
easat-3113	207	26	and	and	CCONJ
easat-3113	207	27	safety	safety	NOUN
easat-3113	207	28	of	of	ADP
easat-3113	207	29	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	207	30	acid	acid	NOUN
easat-3113	207	31	in	in	ADP
easat-3113	207	32	children	child	NOUN
easat-3113	207	33	with	with	ADP
easat-3113	207	34	cholestasis	cholestasis	NOUN
easat-3113	207	35	:	:	PUNCT
easat-3113	207	36	a	a	DET
easat-3113	207	37	systematic	systematic	ADJ
easat-3113	207	38	review	review	NOUN
easat-3113	207	39	and	and	CCONJ
easat-3113	207	40	meta	meta	ADJ
easat-3113	207	41	-	-	PUNCT
easat-3113	207	42	analysis	analysis	NOUN
easat-3113	207	43	.	.	PUNCT
easat-3113	208	1	plos	plos	PROPN
easat-3113	208	2	one	one	NUM
easat-3113	208	3	.	.	PUNCT
easat-3113	209	1	2023;18(1):e0280691	2023;18(1):e0280691	NUM
easat-3113	209	2	.	.	PUNCT
easat-3113	209	3	doi	doi	NOUN
easat-3113	209	4	:	:	PUNCT
easat-3113	209	5	10.1371	10.1371	NUM
easat-3113	209	6	/	/	SYM
easat-3113	209	7	journal.pone.0280691	journal.pone.0280691	PROPN
easat-3113	210	1	[	[	X
easat-3113	210	2	16	16	NUM
easat-3113	210	3	]	]	PUNCT
easat-3113	210	4	suchy	suchy	NOUN
easat-3113	210	5	fj	fj	PROPN
easat-3113	210	6	.	.	PUNCT
easat-3113	210	7	neonatal	neonatal	ADJ
easat-3113	210	8	cholestasis	cholestasis	NOUN
easat-3113	210	9	.	.	PUNCT
easat-3113	211	1	pediatrics	pediatric	NOUN
easat-3113	211	2	in	in	ADP
easat-3113	211	3	review	review	NOUN
easat-3113	211	4	.	.	PUNCT
easat-3113	212	1	2021;25(11):388–96	2021;25(11):388–96	NUM
easat-3113	212	2	.	.	PUNCT
easat-3113	212	3	doi:10.1542	doi:10.1542	NOUN
easat-3113	212	4	/	/	SYM
easat-3113	212	5	neo.22	neo.22	NOUN
easat-3113	212	6	-	-	PUNCT
easat-3113	212	7	12	12	NUM
easat-3113	212	8	-	-	PUNCT
easat-3113	212	9	e819	e819	NUM
easat-3113	212	10	.	.	PUNCT
easat-3113	213	1	[	[	X
easat-3113	213	2	17	17	NUM
easat-3113	213	3	]	]	PUNCT
easat-3113	213	4	.	.	PUNCT
easat-3113	214	1	kim	kim	PROPN
easat-3113	214	2	dj	dj	PROPN
easat-3113	214	3	,	,	PUNCT
easat-3113	214	4	yoon	yoon	PROPN
easat-3113	214	5	s	s	PROPN
easat-3113	214	6	,	,	PUNCT
easat-3113	214	7	ji	ji	PROPN
easat-3113	214	8	sc	sc	PROPN
easat-3113	214	9	,	,	PUNCT
easat-3113	214	10	yang	yang	PROPN
easat-3113	214	11	j	j	PROPN
easat-3113	214	12	,	,	PUNCT
easat-3113	214	13	kim	kim	PROPN
easat-3113	214	14	yk	yk	PROPN
easat-3113	214	15	,	,	PUNCT
easat-3113	214	16	lee	lee	PROPN
easat-3113	214	17	s	s	PROPN
easat-3113	214	18	,	,	PUNCT
easat-3113	214	19	et	et	PROPN
easat-3113	214	20	al	al	PROPN
easat-3113	214	21	.	.	PUNCT
easat-3113	214	22	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	214	23	acid	acid	PROPN
easat-3113	214	24	improves	improve	VERB
easat-3113	214	25	liver	liver	NOUN
easat-3113	214	26	function	function	NOUN
easat-3113	214	27	via	via	ADP
easat-3113	214	28	phenylalanine	phenylalanine	NOUN
easat-3113	214	29	/	/	SYM
easat-3113	214	30	tyrosine	tyrosine	NOUN
easat-3113	214	31	pathway	pathway	NOUN
easat-3113	214	32	and	and	CCONJ
easat-3113	214	33	microbiome	microbiome	NOUN
easat-3113	214	34	remodelling	remodelling	NOUN
easat-3113	214	35	in	in	ADP
easat-3113	214	36	patients	patient	NOUN
easat-3113	214	37	with	with	ADP
easat-3113	214	38	liver	liver	NOUN
easat-3113	214	39	dysfunction	dysfunction	NOUN
easat-3113	214	40	.	.	PUNCT
easat-3113	215	1	sci	sci	PROPN
easat-3113	215	2	rep	rep	PROPN
easat-3113	215	3	.	.	PROPN
easat-3113	215	4	2018	2018	NUM
easat-3113	215	5	aug;8(1):11874	aug;8(1):11874	NOUN
easat-3113	215	6	.	.	PUNCT
easat-3113	216	1	doi:10.1038	doi:10.1038	NOUN
easat-3113	216	2	/	/	SYM
easat-3113	216	3	s41598	s41598	NOUN
easat-3113	216	4	-	-	PUNCT
easat-3113	216	5	018	018	NUM
easat-3113	216	6	-	-	PUNCT
easat-3113	216	7	30349	30349	NUM
easat-3113	216	8	-	-	SYM
easat-3113	216	9	1	1	NUM
easat-3113	216	10	.	.	PUNCT
easat-3113	217	1	[	[	X
easat-3113	217	2	18	18	NUM
easat-3113	217	3	]	]	PUNCT
easat-3113	217	4	.	.	PUNCT
easat-3113	218	1	simental	simental	ADJ
easat-3113	218	2	-	-	PUNCT
easat-3113	218	3	mendía	mendía	NOUN
easat-3113	218	4	m	m	NOUN
easat-3113	218	5	,	,	PUNCT
easat-3113	218	6	sánchez	sánchez	NOUN
easat-3113	218	7	-	-	PUNCT
easat-3113	218	8	garcía	garcía	VERB
easat-3113	218	9	a	a	DET
easat-3113	218	10	,	,	PUNCT
easat-3113	218	11	simental	simental	ADJ
easat-3113	218	12	-	-	PUNCT
easat-3113	218	13	mendía	mendía	NOUN
easat-3113	218	14	le	le	X
easat-3113	218	15	.	.	NOUN
easat-3113	218	16	effect	effect	NOUN
easat-3113	218	17	of	of	ADP
easat-3113	218	18	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	218	19	acid	acid	NOUN
easat-3113	218	20	on	on	ADP
easat-3113	218	21	liver	liver	NOUN
easat-3113	218	22	markers	marker	NOUN
easat-3113	218	23	:	:	PUNCT
easat-3113	218	24	a	a	DET
easat-3113	218	25	systematic	systematic	ADJ
easat-3113	218	26	review	review	NOUN
easat-3113	218	27	and	and	CCONJ
easat-3113	218	28	meta	meta	NOUN
easat-3113	218	29	-	-	PUNCT
easat-3113	218	30	analysis	analysis	NOUN
easat-3113	218	31	of	of	ADP
easat-3113	218	32	randomized	randomized	ADJ
easat-3113	218	33	placebo	placebo	NOUN
easat-3113	218	34	-	-	PUNCT
easat-3113	218	35	controlled	control	VERB
easat-3113	218	36	clinical	clinical	ADJ
easat-3113	218	37	trials	trial	NOUN
easat-3113	218	38	.	.	PUNCT
easat-3113	219	1	br	br	PROPN
easat-3113	220	1	j	j	PROPN
easat-3113	220	2	clin	clin	PROPN
easat-3113	220	3	pharmacol	pharmacol	PROPN
easat-3113	220	4	.	.	PUNCT
easat-3113	220	5	2020	2020	NUM
easat-3113	220	6	aug;86(8):1476–88	aug;86(8):1476–88	VERB
easat-3113	220	7	.	.	PUNCT
easat-3113	221	1	doi:10.1111	doi:10.1111	NOUN
easat-3113	221	2	/	/	SYM
easat-3113	221	3	bcp.14311	bcp.14311	NUM
easat-3113	221	4	.	.	PUNCT
easat-3113	222	1	[	[	X
easat-3113	222	2	19	19	NUM
easat-3113	222	3	]	]	PUNCT
easat-3113	222	4	meneses	menese	VERB
easat-3113	222	5	j	j	PROPN
easat-3113	222	6	,	,	PUNCT
easat-3113	222	7	sara	sara	PROPN
easat-3113	222	8	c	c	PROPN
easat-3113	222	9	,	,	PUNCT
easat-3113	222	10	pinto	pinto	NOUN
easat-3113	222	11	m	m	PROPN
easat-3113	222	12	,	,	PUNCT
easat-3113	222	13	santos	santos	PROPN
easat-3113	222	14	e	e	NOUN
easat-3113	222	15	,	,	PUNCT
easat-3113	222	16	silva	silva	PROPN
easat-3113	222	17	hm	hm	PROPN
easat-3113	222	18	.	.	PUNCT
easat-3113	223	1	incidental	incidental	PROPN
easat-3113	223	2	hypertransaminasemia	hypertransaminasemia	NOUN
easat-3113	223	3	in	in	ADP
easat-3113	223	4	children	child	NOUN
easat-3113	223	5	—	—	PUNCT
easat-3113	223	6	a	a	DET
easat-3113	223	7	stepwise	stepwise	ADJ
easat-3113	223	8	approach	approach	NOUN
easat-3113	223	9	in	in	ADP
easat-3113	223	10	primary	primary	ADJ
easat-3113	223	11	care	care	NOUN
easat-3113	223	12	.	.	PUNCT
easat-3113	224	1	eur	eur	PROPN
easat-3113	224	2	j	j	PROPN
easat-3113	224	3	pediatr	pediatr	PROPN
easat-3113	224	4	.	.	PUNCT
easat-3113	225	1	2023;1601–9	2023;1601–9	NUM
easat-3113	225	2	.	.	PUNCT
easat-3113	225	3	doi:10.1007	doi:10.1007	VERB
easat-3113	225	4	/	/	SYM
easat-3113	225	5	s00431	s00431	PROPN
easat-3113	225	6	-	-	PUNCT
easat-3113	225	7	023	023	NUM
easat-3113	225	8	-	-	PUNCT
easat-3113	225	9	04825	04825	NUM
easat-3113	225	10	-	-	PUNCT
easat-3113	225	11	4	4	NUM
easat-3113	225	12	.	.	PUNCT
easat-3113	226	1	[	[	X
easat-3113	226	2	20	20	NUM
easat-3113	226	3	]	]	X
easat-3113	226	4	serdaroglu	serdaroglu	PROPN
easat-3113	226	5	f	f	PROPN
easat-3113	226	6	,	,	PUNCT
easat-3113	226	7	koca	koca	PROPN
easat-3113	226	8	t	t	PROPN
easat-3113	226	9	,	,	PUNCT
easat-3113	226	10	dereci	dereci	PROPN
easat-3113	226	11	s	s	PROPN
easat-3113	226	12	,	,	PUNCT
easat-3113	226	13	akcam	akcam	ADJ
easat-3113	226	14	m.	m.	NOUN
easat-3113	226	15	the	the	DET
easat-3113	226	16	etiology	etiology	NOUN
easat-3113	226	17	of	of	ADP
easat-3113	226	18	hypertransaminasemia	hypertransaminasemia	NOUN
easat-3113	226	19	in	in	ADP
easat-3113	226	20	turkish	turkish	ADJ
easat-3113	226	21	children	child	NOUN
easat-3113	226	22	.	.	PUNCT
easat-3113	227	1	eur	eur	PROPN
easat-3113	227	2	j	j	PROPN
easat-3113	227	3	pediatr	pediatr	PROPN
easat-3113	227	4	.	.	PUNCT
easat-3113	228	1	2023;151–6	2023;151–6	PROPN
easat-3113	228	2	.	.	PUNCT
easat-3113	228	3	doi:10.17305	doi:10.17305	NOUN
easat-3113	228	4	/	/	SYM
easat-3113	228	5	bjbms.2016.982	bjbms.2016.982	PROPN
easat-3113	228	6	[	[	PUNCT
easat-3113	228	7	21	21	NUM
easat-3113	228	8	]	]	X
easat-3113	228	9	sullivan	sullivan	PROPN
easat-3113	228	10	mk	mk	PROPN
easat-3113	228	11	,	,	PUNCT
easat-3113	228	12	daher	daher	PROPN
easat-3113	228	13	hb	hb	PROPN
easat-3113	228	14	,	,	PUNCT
easat-3113	228	15	rockey	rockey	PROPN
easat-3113	228	16	dc	dc	PROPN
easat-3113	228	17	.	.	PROPN
easat-3113	229	1	normal	normal	ADJ
easat-3113	229	2	or	or	CCONJ
easat-3113	229	3	near	near	ADP
easat-3113	229	4	normal	normal	ADJ
easat-3113	229	5	aminotransferase	aminotransferase	NOUN
easat-3113	229	6	levels	level	NOUN
easat-3113	229	7	in	in	ADP
easat-3113	229	8	patients	patient	NOUN
easat-3113	229	9	with	with	ADP
easat-3113	229	10	alcoholic	alcoholic	ADJ
easat-3113	229	11	cirrhosis	cirrhosis	NOUN
easat-3113	229	12	.	.	PUNCT
easat-3113	230	1	am	be	AUX
easat-3113	230	2	j	j	PROPN
easat-3113	230	3	med	med	PROPN
easat-3113	230	4	sci	sci	PROPN
easat-3113	230	5	.	.	PUNCT
easat-3113	231	1	2024;363(6):484–9	2024;363(6):484–9	PROPN
easat-3113	231	2	.	.	PUNCT
easat-3113	232	1	doi	doi	NOUN
easat-3113	232	2	:	:	PUNCT
easat-3113	232	3	10.1016	10.1016	NUM
easat-3113	232	4	/	/	SYM
easat-3113	232	5	j.amjms.2021.09.012	j.amjms.2021.09.012	PROPN
easat-3113	232	6	.	.	PUNCT
easat-3113	233	1	[	[	X
easat-3113	233	2	22	22	NUM
easat-3113	233	3	]	]	PUNCT
easat-3113	233	4	kotb	kotb	PROPN
easat-3113	233	5	ma	ma	PROPN
easat-3113	233	6	.	.	PROPN
easat-3113	233	7	molecular	molecular	ADJ
easat-3113	233	8	mechanisms	mechanism	NOUN
easat-3113	233	9	of	of	ADP
easat-3113	233	10	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	233	11	acid	acid	NOUN
easat-3113	233	12	toxicity	toxicity	NOUN
easat-3113	233	13	&	&	CCONJ
easat-3113	233	14	side	side	NOUN
easat-3113	233	15	effects	effect	NOUN
easat-3113	233	16	:	:	PUNCT
easat-3113	233	17	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	233	18	acid	acid	PROPN
easat-3113	233	19	freezes	freeze	VERB
easat-3113	233	20	regeneration	regeneration	NOUN
easat-3113	233	21	&	&	CCONJ
easat-3113	233	22	induces	induce	VERB
easat-3113	233	23	hibernation	hibernation	NOUN
easat-3113	233	24	mode	mode	NOUN
easat-3113	233	25	.	.	PUNCT
easat-3113	234	1	int	int	PROPN
easat-3113	234	2	j	j	PROPN
easat-3113	234	3	mol	mol	ADP
easat-3113	234	4	sci	sci	PROPN
easat-3113	234	5	.	.	PUNCT
easat-3113	234	6	2012;13(7):8882–914	2012;13(7):8882–914	PROPN
easat-3113	234	7	.	.	PUNCT
easat-3113	235	1	doi:10.3390	doi:10.3390	NOUN
easat-3113	235	2	/	/	SYM
easat-3113	235	3	ijms13078882	ijms13078882	PROPN
easat-3113	235	4	.	.	PUNCT
easat-3113	236	1	[	[	X
easat-3113	236	2	23	23	NUM
easat-3113	236	3	]	]	PUNCT
easat-3113	236	4	gonzález	gonzález	PROPN
easat-3113	236	5	a	a	PROPN
easat-3113	236	6	,	,	PUNCT
easat-3113	236	7	casado	casado	PROPN
easat-3113	236	8	j	j	PROPN
easat-3113	236	9	,	,	PUNCT
easat-3113	236	10	chueca	chueca	NOUN
easat-3113	236	11	e	e	NOUN
easat-3113	236	12	,	,	PUNCT
easat-3113	236	13	salillas	salillas	PROPN
easat-3113	236	14	s	s	PROPN
easat-3113	236	15	,	,	PUNCT
easat-3113	236	16	velázquez	velázquez	NOUN
easat-3113	236	17	-	-	PUNCT
easat-3113	236	18	campoy	campoy	NOUN
easat-3113	236	19	a	a	DET
easat-3113	236	20	,	,	PUNCT
easat-3113	236	21	sancho	sancho	PROPN
easat-3113	236	22	j	j	PROPN
easat-3113	236	23	,	,	PUNCT
easat-3113	236	24	et	et	PROPN
easat-3113	236	25	al	al	PROPN
easat-3113	236	26	.	.	PUNCT
easat-3113	237	1	small	small	ADJ
easat-3113	237	2	molecule	molecule	NOUN
easat-3113	237	3	inhibitors	inhibitor	NOUN
easat-3113	237	4	of	of	ADP
easat-3113	237	5	the	the	DET
easat-3113	237	6	response	response	NOUN
easat-3113	237	7	regulator	regulator	NOUN
easat-3113	237	8	arsr	arsr	NOUN
easat-3113	237	9	exhibit	exhibit	NOUN
easat-3113	237	10	bactericidal	bactericidal	ADJ
easat-3113	237	11	activity	activity	NOUN
easat-3113	237	12	against	against	ADP
easat-3113	237	13	helicobacter	helicobacter	NOUN
easat-3113	237	14	pylori	pylori	NOUN
easat-3113	237	15	.	.	PUNCT
easat-3113	238	1	microorganisms	microorganism	NOUN
easat-3113	238	2	.	.	PUNCT
easat-3113	238	3	2020	2020	NUM
easat-3113	238	4	apr;8(4	apr;8(4	NOUN
easat-3113	238	5	)	)	PUNCT
easat-3113	238	6	.	.	PUNCT
easat-3113	239	1	doi:10.3390	doi:10.3390	PROPN
easat-3113	239	2	/	/	SYM
easat-3113	239	3	microorganisms8040503	microorganisms8040503	PROPN
easat-3113	239	4	.	.	PUNCT
easat-3113	240	1	[	[	X
easat-3113	240	2	24	24	NUM
easat-3113	240	3	]	]	X
easat-3113	240	4	angulo	angulo	PROPN
easat-3113	240	5	p.	p.	NOUN
easat-3113	240	6	use	use	NOUN
easat-3113	240	7	of	of	ADP
easat-3113	240	8	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	240	9	acid	acid	NOUN
easat-3113	240	10	in	in	ADP
easat-3113	240	11	patients	patient	NOUN
easat-3113	240	12	with	with	ADP
easat-3113	240	13	liver	liver	NOUN
easat-3113	240	14	disease	disease	NOUN
easat-3113	240	15	.	.	PUNCT
easat-3113	241	1	curr	curr	PROPN
easat-3113	241	2	gastroenterol	gastroenterol	PROPN
easat-3113	241	3	rep	rep	PROPN
easat-3113	241	4	.	.	PROPN
easat-3113	241	5	2002;4(1):37–44	2002;4(1):37–44	NUM
easat-3113	241	6	.	.	PUNCT
easat-3113	242	1	doi:10.1007	doi:10.1007	VERB
easat-3113	242	2	/	/	SYM
easat-3113	242	3	s11894	s11894	PROPN
easat-3113	242	4	-	-	ADJ
easat-3113	242	5	002	002	NUM
easat-3113	242	6	-	-	PUNCT
easat-3113	242	7	0036	0036	NUM
easat-3113	242	8	-	-	SYM
easat-3113	242	9	9	9	NUM
easat-3113	242	10	.	.	PUNCT
easat-3113	243	1	[	[	X
easat-3113	243	2	25	25	NUM
easat-3113	243	3	]	]	PUNCT
easat-3113	243	4	beath	beath	PROPN
easat-3113	243	5	s	s	PROPN
easat-3113	243	6	v.	v.	ADP
easat-3113	243	7	hepatic	hepatic	ADJ
easat-3113	243	8	function	function	NOUN
easat-3113	243	9	and	and	CCONJ
easat-3113	243	10	physiology	physiology	NOUN
easat-3113	243	11	in	in	ADP
easat-3113	243	12	the	the	DET
easat-3113	243	13	newborn	newborn	ADJ
easat-3113	243	14	.	.	PUNCT
easat-3113	244	1	seminars	seminar	NOUN
easat-3113	244	2	in	in	ADP
easat-3113	244	3	neonatology	neonatology	NOUN
easat-3113	244	4	.	.	PUNCT
easat-3113	245	1	2003;8(5):337–46	2003;8(5):337–46	NUM
easat-3113	245	2	.	.	PUNCT
easat-3113	245	3	doi	doi	NOUN
easat-3113	245	4	:	:	PUNCT
easat-3113	245	5	10.1016	10.1016	NUM
easat-3113	245	6	/	/	SYM
easat-3113	245	7	s1084	s1084	PROPN
easat-3113	245	8	-	-	PUNCT
easat-3113	245	9	2756(03)00066	2756(03)00066	NUM
easat-3113	245	10	-	-	SYM
easat-3113	245	11	6	6	NUM
easat-3113	245	12	.	.	PUNCT
easat-3113	246	1	[	[	X
easat-3113	246	2	26	26	NUM
easat-3113	246	3	]	]	PUNCT
easat-3113	246	4	suchy	suchy	NOUN
easat-3113	246	5	fj	fj	PROPN
easat-3113	246	6	.	.	PUNCT
easat-3113	247	1	functional	functional	ADJ
easat-3113	247	2	development	development	NOUN
easat-3113	247	3	of	of	ADP
easat-3113	247	4	the	the	DET
easat-3113	247	5	liver	liver	NOUN
easat-3113	247	6	.	.	PUNCT
easat-3113	248	1	in	in	ADP
easat-3113	248	2	:	:	PUNCT
easat-3113	248	3	suchy	suchy	NOUN
easat-3113	248	4	fj	fj	PROPN
easat-3113	248	5	,	,	PUNCT
easat-3113	248	6	sokol	sokol	PROPN
easat-3113	248	7	rj	rj	PROPN
easat-3113	248	8	,	,	PUNCT
easat-3113	248	9	balistreri	balistreri	PROPN
easat-3113	248	10	wf	wf	PROPN
easat-3113	248	11	,	,	PUNCT
easat-3113	248	12	editors	editor	NOUN
easat-3113	248	13	.	.	PUNCT
easat-3113	249	1	liver	liver	NOUN
easat-3113	249	2	disease	disease	NOUN
easat-3113	249	3	in	in	ADP
easat-3113	249	4	children	child	NOUN
easat-3113	249	5	.	.	PUNCT
easat-3113	250	1	cambridge	cambridge	PROPN
easat-3113	250	2	university	university	PROPN
easat-3113	250	3	press	press	NOUN
easat-3113	250	4	;	;	PUNCT
easat-3113	250	5	2021	2021	NUM
easat-3113	250	6	.	.	PUNCT
easat-3113	251	1	p.	p.	NOUN
easat-3113	251	2	12–25	12–25	NUM
easat-3113	251	3	.	.	PUNCT
easat-3113	252	1	doi:10.1017/9781108918978.002	doi:10.1017/9781108918978.002	NOUN
easat-3113	252	2	.	.	PUNCT
easat-3113	253	1	[	[	X
easat-3113	253	2	27	27	NUM
easat-3113	253	3	]	]	X
easat-3113	253	4	siong	siong	PROPN
easat-3113	253	5	p	p	PROPN
easat-3113	253	6	,	,	PUNCT
easat-3113	253	7	ariningrum	ariningrum	PROPN
easat-3113	253	8	d	d	PROPN
easat-3113	253	9	,	,	PUNCT
easat-3113	253	10	hidayah	hidayah	PROPN
easat-3113	253	11	d	d	PROPN
easat-3113	253	12	,	,	PUNCT
easat-3113	253	13	kawuryan	kawuryan	PROPN
easat-3113	253	14	dl	dl	PROPN
easat-3113	253	15	,	,	PUNCT
easat-3113	253	16	ilmu	ilmu	PROPN
easat-3113	253	17	d	d	PROPN
easat-3113	253	18	,	,	PUNCT
easat-3113	253	19	anak	anak	PROPN
easat-3113	253	20	k	k	PROPN
easat-3113	253	21	,	,	PUNCT
easat-3113	253	22	et	et	PROPN
easat-3113	253	23	al	al	PROPN
easat-3113	253	24	.	.	PROPN
easat-3113	253	25	pengaruh	pengaruh	PROPN
easat-3113	253	26	asam	asam	PROPN
easat-3113	253	27	ursodeoksikolat	ursodeoksikolat	PROPN
easat-3113	253	28	terhadap	terhadap	PROPN
easat-3113	253	29	kadar	kadar	PROPN
easat-3113	253	30	bilirubin	bilirubin	PROPN
easat-3113	253	31	total	total	NOUN
easat-3113	253	32	pada	pada	PROPN
easat-3113	253	33	pasien	pasien	PROPN
easat-3113	253	34	neonates	neonate	VERB
easat-3113	253	35	dengan	dengan	PROPN
easat-3113	253	36	kolestasis	kolestasis	PROPN
easat-3113	253	37	akibat	akibat	PROPN
easat-3113	253	38	sepsis	sepsis	NOUN
easat-3113	253	39	.	.	PUNCT
easat-3113	254	1	jurnal	jurnal	ADJ
easat-3113	254	2	medika	medika	PROPN
easat-3113	254	3	moewardi	moewardi	PROPN
easat-3113	254	4	.	.	PROPN
easat-3113	254	5	2018	2018	NUM
easat-3113	254	6	;	;	PUNCT
easat-3113	254	7	937:1–5	937:1–5	NUM
easat-3113	254	8	.	.	PUNCT
easat-3113	255	1	https://www.ncbi.nlm.nih.gov/books/nbk482279/#_article-19459_s1	https://www.ncbi.nlm.nih.gov/books/nbk482279/#_article-19459_s1	PUNCT
easat-3113	255	2	_	_	PRON
easat-3113	255	3	https://e-fornas.kemkes.go.id/daftar_obat.php	https://e-fornas.kemkes.go.id/daftar_obat.php	VERB
easat-3113	255	4	5081	5081	NUM
easat-3113	255	5	edelweiss	edelweiss	PROPN
easat-3113	255	6	applied	apply	VERB
easat-3113	255	7	science	science	NOUN
easat-3113	255	8	and	and	CCONJ
easat-3113	255	9	technology	technology	NOUN
easat-3113	255	10	issn	issn	PROPN
easat-3113	255	11	:	:	PUNCT
easat-3113	255	12	2576	2576	NUM
easat-3113	255	13	-	-	SYM
easat-3113	255	14	8484	8484	NUM
easat-3113	255	15	vol	vol	NOUN
easat-3113	255	16	.	.	PROPN
easat-3113	256	1	8	8	NUM
easat-3113	256	2	,	,	PUNCT
easat-3113	256	3	no	no	INTJ
easat-3113	256	4	.	.	NOUN
easat-3113	257	1	6	6	NUM
easat-3113	257	2	:	:	PUNCT
easat-3113	257	3	5075	5075	NUM
easat-3113	257	4	-	-	SYM
easat-3113	257	5	5081	5081	NUM
easat-3113	257	6	,	,	PUNCT
easat-3113	257	7	2024	2024	NUM
easat-3113	257	8	doi	doi	NOUN
easat-3113	257	9	:	:	PUNCT
easat-3113	257	10	10.55214/25768484.v8i6.3113	10.55214/25768484.v8i6.3113	NUM
easat-3113	257	11	©	©	PROPN
easat-3113	257	12	2024	2024	NUM
easat-3113	257	13	by	by	ADP
easat-3113	257	14	the	the	DET
easat-3113	257	15	authors	author	NOUN
easat-3113	257	16	;	;	PUNCT
easat-3113	257	17	licensee	licensee	PROPN
easat-3113	257	18	learning	learning	NOUN
easat-3113	257	19	gate	gate	NOUN
easat-3113	258	1	[	[	X
easat-3113	258	2	28	28	NUM
easat-3113	258	3	]	]	X
easat-3113	258	4	young	young	ADJ
easat-3113	258	5	cs	cs	PROPN
easat-3113	258	6	.	.	PROPN
easat-3113	258	7	core	core	NOUN
easat-3113	258	8	concepts	concept	NOUN
easat-3113	258	9	:	:	PUNCT
easat-3113	258	10	bilirubin	bilirubin	NOUN
easat-3113	258	11	metabolism	metabolism	NOUN
easat-3113	258	12	.	.	PUNCT
easat-3113	259	1	advanced	advanced	ADJ
easat-3113	259	2	sciences	science	NOUN
easat-3113	259	3	and	and	CCONJ
easat-3113	259	4	technologies	technology	NOUN
easat-3113	259	5	for	for	ADP
easat-3113	259	6	security	security	NOUN
easat-3113	259	7	applications	application	NOUN
easat-3113	259	8	.	.	PUNCT
easat-3113	260	1	2022;11(6):3–18	2022;11(6):3–18	NUM
easat-3113	260	2	.	.	PUNCT
easat-3113	261	1	[	[	X
easat-3113	261	2	29	29	NUM
easat-3113	261	3	]	]	X
easat-3113	261	4	farhadi	farhadi	NOUN
easat-3113	261	5	r	r	PROPN
easat-3113	261	6	,	,	PUNCT
easat-3113	261	7	keyhanian	keyhanian	ADJ
easat-3113	261	8	e	e	NOUN
easat-3113	261	9	,	,	PUNCT
easat-3113	261	10	naderisorki	naderisorki	PROPN
easat-3113	261	11	m	m	PROPN
easat-3113	261	12	,	,	PUNCT
easat-3113	261	13	ghara	ghara	PROPN
easat-3113	261	14	an	an	DET
easat-3113	261	15	.	.	PUNCT
easat-3113	261	16	effects	effect	NOUN
easat-3113	261	17	of	of	ADP
easat-3113	261	18	two	two	NUM
easat-3113	261	19	different	different	ADJ
easat-3113	261	20	doses	dose	NOUN
easat-3113	261	21	of	of	ADP
easat-3113	261	22	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	261	23	acid	acid	NOUN
easat-3113	261	24	on	on	ADP
easat-3113	261	25	indirect	indirect	ADJ
easat-3113	261	26	hyperbilirubinemia	hyperbilirubinemia	NOUN
easat-3113	261	27	in	in	ADP
easat-3113	261	28	neonates	neonate	NOUN
easat-3113	261	29	with	with	ADP
easat-3113	261	30	glucose-6	glucose-6	NOUN
easat-3113	261	31	-	-	PUNCT
easat-3113	261	32	phosphate	phosphate	NOUN
easat-3113	261	33	dehydrogenase	dehydrogenase	NOUN
easat-3113	261	34	deficiency	deficiency	NOUN
easat-3113	261	35	treated	treat	VERB
easat-3113	261	36	with	with	ADP
easat-3113	261	37	phototherapy	phototherapy	NOUN
easat-3113	261	38	:	:	PUNCT
easat-3113	261	39	a	a	DET
easat-3113	261	40	randomized	randomized	ADJ
easat-3113	261	41	controlled	control	VERB
easat-3113	261	42	trial	trial	NOUN
easat-3113	261	43	.	.	PUNCT
easat-3113	262	1	glob	glob	NOUN
easat-3113	262	2	pediatr	pediatr	ADJ
easat-3113	262	3	health	health	NOUN
easat-3113	262	4	.	.	PUNCT
easat-3113	263	1	2023	2023	NUM
easat-3113	263	2	;	;	PUNCT
easat-3113	263	3	10:1–8	10:1–8	X
easat-3113	263	4	.	.	PUNCT
easat-3113	264	1	doi	doi	PROPN
easat-3113	264	2	:	:	PUNCT
easat-3113	264	3	10.1177/2333794x231156055	10.1177/2333794x231156055	NOUN
easat-3113	264	4	.	.	PUNCT
easat-3113	265	1	[	[	X
easat-3113	265	2	30	30	NUM
easat-3113	265	3	]	]	SYM
easat-3113	265	4	kriegermeier	kriegermei	ADJ
easat-3113	265	5	a	a	PRON
easat-3113	265	6	,	,	PUNCT
easat-3113	265	7	green	green	PROPN
easat-3113	265	8	r.	r.	PROPN
easat-3113	265	9	pediatric	pediatric	ADJ
easat-3113	265	10	cholestatic	cholestatic	ADJ
easat-3113	265	11	liver	liver	NOUN
easat-3113	265	12	disease	disease	NOUN
easat-3113	265	13	:	:	PUNCT
easat-3113	265	14	review	review	NOUN
easat-3113	265	15	of	of	ADP
easat-3113	265	16	bile	bile	NOUN
easat-3113	265	17	acid	acid	NOUN
easat-3113	265	18	metabolism	metabolism	NOUN
easat-3113	265	19	and	and	CCONJ
easat-3113	265	20	discussion	discussion	NOUN
easat-3113	265	21	of	of	ADP
easat-3113	265	22	current	current	ADJ
easat-3113	265	23	and	and	CCONJ
easat-3113	265	24	emerging	emerge	VERB
easat-3113	265	25	therapies	therapy	NOUN
easat-3113	265	26	.	.	PUNCT
easat-3113	266	1	front	front	ADJ
easat-3113	266	2	med	med	PROPN
easat-3113	266	3	(	(	PUNCT
easat-3113	266	4	lausanne	lausanne	PROPN
easat-3113	266	5	)	)	PUNCT
easat-3113	266	6	.	.	PUNCT
easat-3113	267	1	2020	2020	NUM
easat-3113	267	2	;	;	PUNCT
easat-3113	267	3	7:149	7:149	NUM
easat-3113	267	4	.	.	PUNCT
easat-3113	267	5	doi:10.3389	doi:10.3389	NOUN
easat-3113	267	6	/	/	SYM
easat-3113	267	7	fmed.2020.00149	fmed.2020.00149	NOUN
easat-3113	267	8	.	.	PUNCT
easat-3113	268	1	[	[	X
easat-3113	268	2	31	31	NUM
easat-3113	268	3	]	]	PUNCT
easat-3113	268	4	matsubara	matsubara	PROPN
easat-3113	268	5	t	t	PROPN
easat-3113	268	6	,	,	PUNCT
easat-3113	268	7	li	li	PROPN
easat-3113	268	8	f	f	PROPN
easat-3113	268	9	,	,	PUNCT
easat-3113	268	10	gonzalez	gonzalez	PROPN
easat-3113	268	11	fj	fj	PROPN
easat-3113	268	12	.	.	PUNCT
easat-3113	269	1	fxr	fxr	PROPN
easat-3113	269	2	signaling	signal	VERB
easat-3113	269	3	in	in	ADP
easat-3113	269	4	the	the	DET
easat-3113	269	5	enterohepatic	enterohepatic	ADJ
easat-3113	269	6	system	system	NOUN
easat-3113	269	7	.	.	PUNCT
easat-3113	270	1	mol	mol	ADP
easat-3113	270	2	cell	cell	NOUN
easat-3113	270	3	endocrinol	endocrinol	NOUN
easat-3113	270	4	.	.	PUNCT
easat-3113	271	1	2013;368(1	2013;368(1	NOUN
easat-3113	271	2	–	–	PUNCT
easat-3113	271	3	2):17–29	2):17–29	NUM
easat-3113	271	4	.	.	PUNCT
easat-3113	271	5	doi	doi	NOUN
easat-3113	271	6	:	:	PUNCT
easat-3113	271	7	10.1016	10.1016	NUM
easat-3113	271	8	/	/	SYM
easat-3113	271	9	j.mce.2012.05.004	j.mce.2012.05.004	PROPN
easat-3113	271	10	.	.	PUNCT
easat-3113	272	1	[	[	X
easat-3113	272	2	32	32	NUM
easat-3113	272	3	]	]	X
easat-3113	272	4	zhang	zhang	PROPN
easat-3113	272	5	y	y	PROPN
easat-3113	272	6	,	,	PUNCT
easat-3113	272	7	jiang	jiang	PROPN
easat-3113	272	8	r	r	PROPN
easat-3113	272	9	,	,	PUNCT
easat-3113	272	10	zheng	zheng	PROPN
easat-3113	272	11	x	x	PROPN
easat-3113	272	12	,	,	PUNCT
easat-3113	272	13	lei	lei	PROPN
easat-3113	272	14	s	s	PROPN
easat-3113	272	15	,	,	PUNCT
easat-3113	272	16	huang	huang	PROPN
easat-3113	272	17	f	f	PROPN
easat-3113	272	18	,	,	PUNCT
easat-3113	272	19	xie	xie	PROPN
easat-3113	272	20	g	g	PROPN
easat-3113	272	21	,	,	PUNCT
easat-3113	272	22	et	et	PROPN
easat-3113	272	23	al	al	PROPN
easat-3113	272	24	.	.	PUNCT
easat-3113	272	25	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	272	26	acid	acid	PROPN
easat-3113	272	27	accelerates	accelerate	VERB
easat-3113	272	28	bile	bile	NOUN
easat-3113	272	29	acid	acid	NOUN
easat-3113	272	30	enterohepatic	enterohepatic	ADJ
easat-3113	272	31	circulation	circulation	NOUN
easat-3113	272	32	.	.	PUNCT
easat-3113	273	1	br	br	PROPN
easat-3113	273	2	j	j	PROPN
easat-3113	273	3	pharmacol	pharmacol	PROPN
easat-3113	273	4	.	.	PROPN
easat-3113	274	1	2019	2019	NUM
easat-3113	274	2	aug;176(16):2848–63	aug;176(16):2848–63	NOUN
easat-3113	274	3	.	.	PUNCT
easat-3113	275	1	doi:10.1111	doi:10.1111	NOUN
easat-3113	275	2	/	/	SYM
easat-3113	275	3	bph.14705	bph.14705	NOUN
easat-3113	275	4	.	.	PUNCT
easat-3113	276	1	[	[	X
easat-3113	276	2	33	33	NUM
easat-3113	276	3	]	]	X
easat-3113	276	4	liu	liu	PROPN
easat-3113	276	5	sy	sy	PROPN
easat-3113	276	6	,	,	PUNCT
easat-3113	276	7	chang	chang	PROPN
easat-3113	276	8	lw	lw	PROPN
easat-3113	276	9	,	,	PUNCT
easat-3113	276	10	wang	wang	PROPN
easat-3113	276	11	j	j	PROPN
easat-3113	276	12	,	,	PUNCT
easat-3113	276	13	xie	xie	PROPN
easat-3113	276	14	m	m	PROPN
easat-3113	276	15	,	,	PUNCT
easat-3113	276	16	chen	chen	PROPN
easat-3113	276	17	ll	ll	PROPN
easat-3113	276	18	,	,	PUNCT
easat-3113	276	19	liu	liu	PROPN
easat-3113	276	20	w.	w.	PROPN
easat-3113	276	21	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	276	22	acid	acid	PROPN
easat-3113	276	23	prevention	prevention	NOUN
easat-3113	276	24	on	on	ADP
easat-3113	276	25	cholestasis	cholestasis	NOUN
easat-3113	276	26	associated	associate	VERB
easat-3113	276	27	with	with	ADP
easat-3113	276	28	total	total	ADJ
easat-3113	276	29	parenteral	parenteral	ADJ
easat-3113	276	30	nutrition	nutrition	NOUN
easat-3113	276	31	in	in	ADP
easat-3113	276	32	preterm	preterm	ADJ
easat-3113	276	33	infants	infant	NOUN
easat-3113	276	34	:	:	PUNCT
easat-3113	276	35	a	a	DET
easat-3113	276	36	randomized	randomized	ADJ
easat-3113	276	37	trial	trial	NOUN
easat-3113	276	38	.	.	PUNCT
easat-3113	277	1	world	world	PROPN
easat-3113	277	2	journal	journal	PROPN
easat-3113	277	3	of	of	ADP
easat-3113	277	4	pediatrics	pediatric	NOUN
easat-3113	277	5	.	.	PUNCT
easat-3113	278	1	2022;18(2):100–8	2022;18(2):100–8	NUM
easat-3113	278	2	.	.	PUNCT
easat-3113	279	1	doi:10.1007	doi:10.1007	VERB
easat-3113	279	2	/	/	SYM
easat-3113	280	1	s12519	s12519	ADJ
easat-3113	280	2	-	-	PUNCT
easat-3113	280	3	021	021	NUM
easat-3113	280	4	-	-	PUNCT
easat-3113	280	5	00487	00487	NUM
easat-3113	280	6	-	-	PUNCT
easat-3113	280	7	0	0	NUM
easat-3113	280	8	.	.	PUNCT
easat-3113	281	1	[	[	X
easat-3113	281	2	34	34	NUM
easat-3113	281	3	]	]	PUNCT
easat-3113	281	4	asgarshirazi	asgarshirazi	PROPN
easat-3113	281	5	m	m	PROPN
easat-3113	281	6	,	,	PUNCT
easat-3113	281	7	shariat	shariat	PROPN
easat-3113	281	8	m	m	PROPN
easat-3113	281	9	,	,	PUNCT
easat-3113	281	10	mousavi	mousavi	PROPN
easat-3113	281	11	s.	s.	PROPN
easat-3113	281	12	comparison	comparison	NOUN
easat-3113	281	13	between	between	ADP
easat-3113	281	14	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	281	15	acid	acid	PROPN
easat-3113	281	16	and	and	CCONJ
easat-3113	281	17	silymarin	silymarin	NOUN
easat-3113	281	18	in	in	ADP
easat-3113	281	19	anticonvulsive	anticonvulsive	ADJ
easat-3113	281	20	drugs	drug	NOUN
easat-3113	281	21	induced	induce	VERB
easat-3113	281	22	hypertransaminasemia	hypertransaminasemia	ADV
easat-3113	281	23	.	.	PUNCT
easat-3113	282	1	inflamm	inflamm	PROPN
easat-3113	282	2	cell	cell	PROPN
easat-3113	282	3	signal	signal	NOUN
easat-3113	282	4	.	.	PUNCT
easat-3113	283	1	2015	2015	NUM
easat-3113	283	2	oct	oct	NOUN
easat-3113	283	3	27	27	NUM
easat-3113	283	4	;	;	PUNCT
easat-3113	283	5	doi:10.14800	doi:10.14800	NOUN
easat-3113	283	6	/	/	SYM
easat-3113	283	7	ics.971	ics.971	NOUN
easat-3113	283	8	.	.	PUNCT
easat-3113	284	1	[	[	X
easat-3113	284	2	35	35	NUM
easat-3113	284	3	]	]	X
easat-3113	284	4	ozdemir	ozdemir	X
easat-3113	284	5	a	a	PRON
easat-3113	284	6	,	,	PUNCT
easat-3113	284	7	kurtoglu	kurtoglu	PROPN
easat-3113	284	8	s	s	PROPN
easat-3113	284	9	,	,	PUNCT
easat-3113	284	10	halis	halis	ADJ
easat-3113	284	11	h	h	NOUN
easat-3113	284	12	,	,	PUNCT
easat-3113	284	13	bastug	bastug	PROPN
easat-3113	284	14	o.	o.	PROPN
easat-3113	284	15	an	an	DET
easat-3113	284	16	evaluation	evaluation	NOUN
easat-3113	284	17	of	of	ADP
easat-3113	284	18	ursodeoxycholic	ursodeoxycholic	PROPN
easat-3113	284	19	acid	acid	NOUN
easat-3113	284	20	treatment	treatment	NOUN
easat-3113	284	21	in	in	ADP
easat-3113	284	22	prolonged	prolonged	ADJ
easat-3113	284	23	unconjugated	unconjugated	ADJ
easat-3113	284	24	hyperbilirubinemia	hyperbilirubinemia	NOUN
easat-3113	284	25	due	due	ADP
easat-3113	284	26	to	to	ADP
easat-3113	284	27	breast	breast	NOUN
easat-3113	284	28	milk	milk	NOUN
easat-3113	284	29	.	.	PUNCT
easat-3113	285	1	niger	niger	PROPN
easat-3113	285	2	j	j	PROPN
easat-3113	285	3	clin	clin	PROPN
easat-3113	285	4	pract	pract	PROPN
easat-3113	285	5	.	.	PUNCT
easat-3113	286	1	2023	2023	NUM
easat-3113	286	2	;	;	PUNCT
easat-3113	286	3	26:1226–33	26:1226–33	NUM
easat-3113	286	4	.	.	PUNCT
easat-3113	287	1	doi	doi	NOUN
easat-3113	287	2	:	:	PUNCT
easat-3113	287	3	10.4103	10.4103	NUM
easat-3113	287	4	/	/	SYM
easat-3113	287	5	njcp.njcp_216_22	njcp.njcp_216_22	NOUN
easat-3113	287	6	.	.	PUNCT